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Leucine Rich Repeat Ig-Domain Containing Nogo Interacting Protein 3 (lingo3) Is
A Novel Regulator Of Mucosal Homeostasis
Abstract
The gastrointestinal (GI) epithelium is a wide array of cell lineages that
form a dynamic barrier to the external environment that regulates nutrient absorption, immunity and a
physical barrier against organisms entering the intestinal lamina propria. However, the specific proteins
expressed by epithelia to maintain GI function during homeostasis and inflammation and to promote
tissue repair following injury are incompletely understood. This body of work demonstrates that one
member of the Leucine rich repeat Ig domain containing nogo interacting protein family (LINGO) called
LINGO3 serves a critical and previously unappreciated role in maintaining the intestinal barrier under
homeostasis and in promoting tissue regeneration following acute tissue injury in the GI tract. Under
steady-state conditions in co-housed animals, Lingo3 gene deficient (Lingo3 KO) mice have a marked
dysregulation in the architecture of the adherens junction complex between small and large intestinal
epithelial cells, which correlated with increased intestinal permeability and serum endotoxin levels. This
mucosal barrier defect was also associated with a significant increase in Type 1 cytokines and proinflammatory myeloid lineage antigen presenting cells. Interestingly, Lingo3 deficiency did not confer
resistance or susceptibility to the enteropathogenic bacterium Citrobacter rodentium. However, when
Lingo3 KO mice were exposed to the dextran sodium sulfate (DSS) model of colitis, they developed
significantly worse disease than co-housed wild-type (WT) controls as defined by overall morbidity,
clinical score, reduced colon length, and histological changes, particularly during the recovery phase of
DSS. Curiously, this basal defect and DSS recovery phase defect was remarkably similar to the phenotype
of mice genetically deficient in Trefoil factor 2 (Tff2), a goblet cell-derived cytokine known to promote
tissue repair. This dissertation also demonstrates that treatment of DSS-treated WT mice with a longacting agonist of TFF2 (TFF2-Fc) promotes faster tissue recovery than Lingo3 KO mice. This enhanced
tissue recovery mediated by TFF2-Fc was associated with a greater number of intestinal epithelial cells
showing phosphorylation of ERK, which is a key transcription factor in the MAPK pathway that promotes
cellular proliferation. To directly test whether LINGO3 and TFF2 functioned to drive epithelial cell
regeneration distinct from their impact upon inflammation, we generated small and large intestinal
organoids. Results show that both Lingo3 deficient and Tff2 deficient organoids had defective growth
kinetics and impaired architectural structure. Strikingly, both Lingo3 deficient and Tff2 deficient small
intestinal organoids had decreased mRNA transcript levels of the intestinal stem cell marker, Lgr5,
implying that defects in stem cell abundance and/or function. In conclusion, the body of work comprising
this dissertation demonstrates that LINGO3 serves a previously unappreciated role in mucosal epithelial
cell barrier function under homeostasis and during tissue repair following colitic injury. This role partially
functions through the reparative cytokine TFF2, which collectively warrants further investigation into how
this putative TFF2-LINGO3 axis regulates enterocyte and intestinal stem cell function during health and
disease.
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ABSTRACT
LEUCINE RICH REPEAT IG-DOMAIN CONTAINING NOGO INTERACTING
PROTEIN 3 (LINGO3) IS A NOVEL REGULATOR OF MUCOSAL HOMEOSTASIS
AND
TISSUE REPAIR IN THE GASTROINTESTINAL TRACT
Kelly M. Zullo
De’Broski R. Herbert
The gastrointestinal (GI) epithelium is a wide array of cell lineages that
form a dynamic barrier to the external environment that regulates nutrient absorption,
immunity and a physical barrier against organisms entering the intestinal lamina propria.
However, the specific proteins expressed by epithelia to maintain GI function during
homeostasis and inflammation and to promote tissue repair following injury are
incompletely understood. This body of work demonstrates that one member of the Leucine
rich repeat Ig domain containing nogo interacting protein family (LINGO) called LINGO3
serves a critical and previously unappreciated role in maintaining the intestinal barrier
under homeostasis and in promoting tissue regeneration following acute tissue injury in the
GI tract. Under steady-state conditions in co-housed animals, Lingo3 gene deficient
(Lingo3 KO) mice have a marked dysregulation in the architecture of the adherens junction
complex between small and large intestinal epithelial cells, which correlated with increased
intestinal permeability and serum endotoxin levels. This mucosal barrier defect was also
associated with a significant increase in Type 1 cytokines and pro-inflammatory myeloid
lineage antigen presenting cells. Interestingly, Lingo3 deficiency did not confer resistance
or susceptibility to the enteropathogenic bacterium Citrobacter rodentium. However, when
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Lingo3 KO mice were exposed to the dextran sodium sulfate (DSS) model of colitis, they
developed significantly worse disease than co-housed wild-type (WT) controls as defined
by overall morbidity, clinical score, reduced colon length, and histological changes,
particularly during the recovery phase of DSS. Curiously, this basal defect and DSS
recovery phase defect was remarkably similar to the phenotype of mice genetically
deficient in Trefoil factor 2 (Tff2), a goblet cell-derived cytokine known to promote tissue
repair. This dissertation also demonstrates that treatment of DSS-treated WT mice with a
long-acting agonist of TFF2 (TFF2-Fc) promotes faster tissue recovery than Lingo3 KO
mice. This enhanced tissue recovery mediated by TFF2-Fc was associated with a greater
number of intestinal epithelial cells showing phosphorylation of ERK, which is a key
transcription factor in the MAPK pathway that promotes cellular proliferation. To directly
test whether LINGO3 and TFF2 functioned to drive epithelial cell regeneration distinct
from their impact upon inflammation, we generated small and large intestinal organoids.
Results show that both Lingo3 deficient and Tff2 deficient organoids had defective growth
kinetics and impaired architectural structure. Strikingly, both Lingo3 deficient and Tff2
deficient small intestinal organoids had decreased mRNA transcript levels of the intestinal
stem cell marker, Lgr5, implying that defects in stem cell abundance and/or function. In
conclusion, the body of work comprising this dissertation demonstrates that LINGO3
serves a previously unappreciated role in mucosal epithelial cell barrier function under
homeostasis and during tissue repair following colitic injury. This role partially functions
through the reparative cytokine TFF2, which collectively warrants further investigation
into how this putative TFF2-LINGO3 axis regulates enterocyte and intestinal stem cell
function during health and disease.
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Chapter 1: Introduction
1.1 The composition of the gastrointestinal mucosal barrier
The gastrointestinal (GI) tract is a complex organ whose predominant function is
to absorb nutrients. It is also the largest mucosal barrier surface within the body and must
regulate exposure to both commensal and pathogenic organisms (Kiela and Ghishan, 2016;
Oshima and Miwa, 2016; Vancamelbeke and Vermeire, 2017). Because of the multifunctional role of the GI tract, it is composed of a diverse subset of cells, molecules, and
proteins that are necessary to maintain homeostasis (Wiles et al., 2004).
Commensal bacteria live in the lumen of the barrier in symbiosis with the host.
These bacteria are comprised of 4 dominant phyla; Firmicutes, Bacteroidetes,
Actinobacteria, and Proteobacteria (Tlaskalova-Hogenova et al., 2011). Although it is well
accepted that these commensal bacteria are present within the GI tract, the exact role of
each microbial phyla is not well understood. However, it is known that the mammalian
host can derive factors from commensals, which allows for the maintenance of the mucosal
layer as well as influence homeostasis within the GI tract (Lee et al., 2013; MartinGallausiaux et al., 2018; Ohue et al., 2011). When this microbial diversity is disrupted, it
can lead to inflammatory disorders such as Crohn’s disease, Ulcerative colitis, or
outgrowth of pathogenic bacteria like Escherichia coli (E. coli) (Hiippala et al., 2018; Yu,
2018).
Along with commensal bacteria, a mucus biogel covers the barrier and acts as a
protective layer to prevent any bacteria or pathogens from entering into the lamina propria.
This mucus is a thick layer of viscous fluid comprised of secreted factors such as mucins,
antimicrobial peptides (AMP), and immunoglobins (Ig) that control and sense
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macromolecules and pathogens from coming in contact with the epithelium. Mucins
(MUC) are a family of large glycosylated proteins secreted from epithelial cells that
prevents microorganisms from easily invading the deeper tissues of the GI tract. To date,
there are 20 known mucins, each mucin has a functional role in killing bacteria, however,
some mucins such as MUC5B has been shown to maintain bacteria within the oral
microbiome (Cardenas et al., 2007; Corfield, 2015; Frenkel and Ribbeck, 2015; Wickstrom
et al., 2009). Additionally, some strains of mucin deficient mice such as Mucin2 (Muc2)
have an increase in colonic invasion, further demonstrating the functional role of mucins
in forming a protective layer at the mucosal interface with the external environment
(Johansson et al., 2008).
In addition to mucins, the GI mucus layer contains anti-microbial peptides (AMPs).
AMPs are an evolutionary conserved family of proteins comprised of defensins,
cathelicidins, and regenerating islet derived protein 3 (REGIII) proteins (Cash et al., 2006;
Pound et al., 2015; Salzman et al., 2003; Sass et al., 2010; Vaishnava et al., 2011; Wilson
et al., 1999; Yi et al., 2017). These proteins interact with bacterial cell membranes, form
pores, and lead to the membrane disruption, and subsequent killing of bacteria (Cash et al.,
2006; Vaishnava et al., 2011). Work from Lora Hooper's group first identified REGIIIg, a
lectin binding protein, secreted by Paneth cells that preferentially binds to peptidoglycans
of Gram-positive bacteria leading to a decrease in bacterial viability (Cash et al., 2006;
Vaishnava et al., 2011). While AMPs are important for homeostasis within the mucosa,
other proteins such as immunoglobulin A (IgA) can be secreted into the mucosa and entrap
receptor-binding domains of dietary antigens in mucus (Apter et al., 1993; Forbes et al.,
2008; Mantis et al., 2006; Silvey et al., 2001).
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This maintains microbial communities within the barrier, and sterically hinders
microbes from binding within the epithelium (Apter et al., 1993; Forbes et al., 2008; Mantis
et al., 2006; Silvey et al., 2001). Furthermore, upon receptor-binding, IgA can induce
antibody dependent cellular cytotoxicity (Black et al., 1996; Tagliabue et al., 1984;
Tagliabue et al., 1983). While mucins, AMPs, and IgA are essential for maintaining
commensal and pathogenic bacteria from interacting with the epithelium, the cells that
secrete these proteins are important for a better understanding of the signaling pathways
required during homeostasis and injury.
Epithelial subtypes that comprise the gastrointestinal tract
The GI epithelium renews every three to five days (Krndija et al., 2019). Within
the GI tract there are different subsets of epithelial cells that comprise the small intestine
and colon. The three main subsets of epithelial cells that comprise the barrier are
enterocytes, goblet cells, and intestinal stem cells which function as the second layer of
separation from the gut microbiota and host immune cells (Fig 1.1) (Barker et al., 2007;
Jit, 1953; Lauber et al., 1989; Moe, 1953; Reunanen et al., 2015; Specian and Neutra,
1980). Enterocytes are polarized cells that line the apical surface of the intestinal tract and
form the cellular polarity required for barrier integrity and transportation of
macromolecules across the epithelium (Massey-Harroche, 2000). Interestingly, as
enterocytes mature, they become more polarized such that enterocytes at the villus tip have
the highest membrane potential (Tsuchiya and Okada, 1982). The barrier integrity is further
reinforced by the apical junction complex (AJC). This complex of proteins is found
between enterocytes and forms tight junctions and adherens junction, the physical barrier
of the epithelium which prevents “leaky” areas. Key proteins of the AJC include: claudins,
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occludens, zonula occludens, cadherins, nectins, and integrins (Capaldo et al., 2014;
Coopman and Djiane, 2016; Duraivelan et al., 2018; Itoh et al., 1999; Kruse et al., 2019;
Rajasekaran et al., 2008) . Deficiency in any of these protein classes can result in pathogens
entering into the lamina propria and propagating inflammation and initiating an immune
response (Capaldo et al., 2014; Ulluwishewa et al., 2011). Besides cellular polarity,
enterocytes have microvilli on their surface which prevents pathogens, bacteria, and/or
particles from direct contact with the barrier. Additionally, these microvilli aid in digestion
of macromolecules. Furthermore, enterocytes can process luminal antigens and present
antigen to immune cells like CD8+ and CD4+ T cells, through the expression of major
histocompatibility complex (MHC) I and II proteins, respectively (Hershberg and Mayer,
2000).
Goblet cells are the mucus producing cells of the GI tract. Goblet cells can secrete
mucins, proteins, and trefoil factors, small proteins that promote intestinal repair,
migration, and restitution in response to external stimuli (McCauley and Guasch, 2015).
These cells are essential for maintaining the mucus layer and preventing bacteria from
interacting with the epithelium. In fact, germ-free mice have less goblet cells, reducing the
amount of mucus found within the GI tract because of the lack of commensals (Kjetland et
al., 2014). In addition to goblet cells, there are other secretory epithelial cells within the
barrier known as Paneth cells. Paneth cells are secretory cells found within the small
intestine that produce AMPs while the colon contains Paneth like cells. These cells secrete
AMPs and lysozymes which can aid in the killing of bacteria. Additionally, Paneth cells
are known to be a specialized cell within the stem cell niche and serve a role in tissue
regeneration (Schmitt et al., 2018).
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Lastly, intestinal stem cells (ISC) are found at the base of the crypt. The
composition of the stem cell niche is complex and diverse including four different types of
stem or stem-cell like cells including the Lgr5+ stem cell, +4 quiescent cells, transit
amplifying cells, and Paneth cells (Lauber et al., 1989). The stem cell niche is not only
necessary during continual renewal of the epithelium during homeostasis, but also plays a
critical role during injury and intestinal inflammation. The base of the crypt is where Lgr5+
stem cells are found. This has been shown to be the main stem cell found within the
intestinal crypts. Lgr5 is a G-protein coupled receptor with a leucine rich extracellular
domain that is a target gene of Wnts (Baker et al., 1991). Work from Hans Clever's
laboratory has demonstrated that Lgr5 gene expression is diminished when Wnt signaling
is inhibited. Furthermore, Lgr5 was expressed on cycling crypt columnar cells found
between Paneth cells, further suggesting that the Lgr5+ cell and Paneth cells were distinct
from each lineages (Baker et al., 1991). There are approximately three Lgr5+ cells per small
intestinal crypt while the colonic crypts have approximately six to eight (Baker et al., 1991;
Bjerknes and Cheng, 1999; Kozar et al., 2013; Ritsma et al., 2014; Snippert et al., 2010).
These Lgr5+ cells express high levels of Ki-67, a marker of proliferation, and self-renew
every twenty-four hours following depletion leading to the renewal of enterocytes, goblet
cells, and Paneth cells (Baker et al., 1991). Paneth cells or Paneth-like cells are found
adjacent to the Lgr5+ cells within the small intestine and colon, respectively. In addition to
secreting lysozymes and AMPs, Paneth cells also provide support to Lgr5+ cells through
cell-cell contact and secretion of epidermal growth factor (EGF), Wnt3a, and notch ligand
Delta-like 4 (DLL4), proteins that are necessary for LGR5 maintenance (Schmitt et al.,
2018).
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There are +4 quiescent cells found adjacent to the Paneth cells. +4 quiescent cells
were first identified at the +4 position of the stem cell niche and shown to retain DNA
label, suggestive of a slow cycling cell (Marshman et al., 2002; Potten et al., 1974). It is
estimated there are four to six +4 quiescent cells per crypt. These cells can self-renew and
give rise to all differentiated cell lineages. Although +4 cells have been shown to selfrenew, the gene markers used to identify these cells are not unique to this specific stem cell
lineage. To date proto-oncogene, polycomb ring finger (BMI1), telomerase reverse
transcriptase (TERT), homeodomain-only protein homeobox (HOPX), and leucine rich
repeats and immunoglobulin like domain 1 (LRIG1) are the main gene markers used to
identify these cells (Schmitt et al., 2018). Transit amplifying (TA) cells are found above
+4 quiescent cells. These cells are typically located at the crypt-villus junction and give
rise to enterocytes, goblet cells, and enteroendocrine cells. Each subset of epithelial cells
that form the stem cell niche are necessary for response during inflammation and injury,
however, exactly how each of these cell subsets are regulated and which subsets can form
compensatory mechanisms when one or more populations are diminished is not well
understood.
1.2 The immunobiology of regulating the mucosal barrier
Regulation of the intestinal stem cell niche
Work from the Clevers lab has demonstrated that Wnt signaling within the stem
cell niche is necessary for maintenance of Lgr5+ cells and crypt proliferation (Sato et al.,
2009). R-spondin 1 is a WNT ligand that binds to LGR5 and induces crypt hyperplasia.
Following binding to LGR5, WNTs simultaneously bind to LRP5/6 and frizzled, a Wnt
ligand, leading to the phosphorylation of LRP5/6 by CK1 and GSK3 (de Lau et al., 2011;
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Kim et al., 2008; Moparthi and Koch, 2019). Phosphorylation of LRP5/6 leads to the
recruitment of the disheveled complex to the plasma membrane which interacts with
Frizzled, other disheveled polymers, and Axin, leading to the destruction of the disheveled
complex and translocation of b-catenin to the nucleus (Carmon et al., 2012; Moparthi and
Koch, 2019). Within the nucleus, b -catenin binds to Lymphoid enhancer- binding factor/Tcell factor (LEF/TCF) complex and turns on transcription of Wnt responsive genes
(Carmon et al., 2012; Moparthi and Koch, 2019). The Wnt signaling pathway is crucial for
intestinal stem cell growth and differentiation (de Lau et al., 2011). However, a balance is
required to maintain homeostasis, therefore, to inactivate WNT signaling, ZNRF43, a stem
cell enriched gene with a protease associated domain, binds to
LRP5/6 preventing the phosphorylation of LRP5/6 and the degradation of the Frizzled/LRP
receptors (Moparthi and Koch, 2019). The outcome of this prevents undesired stem cell
growth and differentiation; therefore, maintaining the number of stem cells and
differentiated cells within the stem cell niche at all times.
In addition to WNT signaling, epidermal growth factor (EGF), Notch, and noggin
signaling are necessary for intestinal proliferation and expansion of crypt numbers,
respectively (Sato et al., 2009). As the Lgr5+ cell self-renews, daughter cells migrate up
the villus over 5 days, and differentiate into nutrient absorbing enterocytes and secretory
cells such as goblet cells producing mucins or hormones (Koo and Clevers, 2014; Sato et
al., 2009). At the tip of the villus these differentiated epithelial cells undergo apoptosis
allowing for space within the intestinal crypt for newly differentiated epithelial cells to
migrate throughout the villus. As the stem cell niche renews and differentiates, enterocytes
form the AJC to reinforce and polarize the barrier integrity.
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Regulation of the apical junction complex
At the tip of the villus, enterocytes express adhesion molecules that form the AJC.
As previously mentioned, this complex is composed of the tight junctions, located at the
apical side of the lumen, while the adherens junction are located closer to the basolateral
side of the membrane. The formation of this complex is necessary to prevent any pathogens
from entering into the lamina propria. Although the exact receptors and proteins that
promote the formation of the AJC are not known, the proteins required for the formation
of this structural complex are known.
The AJC consists of tight junctions, adherens junction, gap junctions, and
desmosomes. The tight junctions are comprised of a variety of transmembrane proteins
including claudins, occludens, and zonula occludens (ZO) (Fig 1.2) (Farquhar and Palade,
1963; Itoh et al., 1999). This complex can interact with the actin cytoskeleton and regulate
the transportation of nutrients, ions, and water molecules across the barrier (Payne et al.,
2006; Ulluwishewa et al., 2011; Van Itallie et al., 2015). Occludens and claudins can both
bind the ZO forming a tricellular protein complex (Gauberg et al., 2019; Raleigh et al.,
2011). Claudins are the structural backbone of the tight junction.
Claudins 1, 3, 4, 5, and 8 decrease paracellular permeability while claudin 2 can form
charge selective paracellular pores (Amasheh et al., 2002; Angelow et al., 2006; Cong et
al., 2015; Furuse et al., 2002; Piontek et al., 2008). Occludens regulate the diffusion of
small molecules such that if occludens are deleted from cells there is an increase in
paracellular flux and permeability, however transepithelial resistance is unaffected (AlSadi et al., 2011; Balda et al., 1996). Zonula occludens are plaque proteins identified by
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PSD95-DlgA-ZO-1 homology (PDZ) domains. ZO proteins contain three PDZ domains
which allows ZO-1 to interact with claudins, other ZO proteins to form dimers, and
interaction with junctional adhesion molecule A (JAM-A), respectively (Ulluwishewa et
al., 2011). Interestingly, plaque proteins can also function to reorganize the cytoskeleton
through binding directly to F-actin (Ulluwishewa et al., 2011). Junctional adhesion
molecules (JAMs) are transmembrane proteins found below the tight junctions. These
proteins are necessary for the assembly of the tight junction (Liu et al., 2000) and have also
been shown to bind effectors of the Rho-family of small GTPases (Mandell et al., 2005;
Severson et al., 2009).
Rho family of GTPases, protein kinase c (PKC), mitogen activated protein kinase
(MAPK), and myosin light chain kinase (MLCK) are the four main signaling proteins
known to regulate tight junctions, interactions between AJC proteins, and the actin- myosin
ring (Basuroy et al., 2006; Farhadi et al., 2006; Turner et al., 1997). RHO kinases can
phosphorylate the myosin II regulatory light chain inducing contraction of the actinmyosin ring (Kimura et al., 1996; Nusrat et al., 1995; Shen et al., 2006). Furthermore,
Walsh et al. demonstrated that inhibition of RHO kinases prevents localization of tight
junction proteins in cultured T84 human colonic epithelial cell monolayers, supporting the
hypothesis that RHO kinases are sufficient for tight junction localizations and assembly
(Walsh et al., 2001). Intestinal epithelial cells express multiple isoforms of PKC which can
redistribute ZO-1 and increase transepithelial electrical resistance (TEER), a measure of
paracellular ion permeability. Furthermore, epidermal growth factor (EGF) secreted from
intestinal stem cells can activate MAPK and prevent tight junction disruption from
chemical induced injury caused by hydrogen peroxide (Basuroy et al., 2006). In addition,

9

extracellular signal kinase (ERK) can interact directly with occludens to prevent chemical
disruption of tight junctions (Basuroy et al., 2006). Following the formation of the tight
junction complex, commensals can also increase the expression of ZO proteins, however
the exact mechanism of how commensals or metabolites from commensals promotes
induction of ZO proteins is not known (Madsen et al., 2001).
Below tight junctions and JAMs are the adherens junction (Fig 1.2). The adherens
junction is comprised of cadherins and nectins, two transmembrane adhesive receptors.
Epithelial cadherin (E-cadherin) is expressed by epithelial cells and contains five
immunoglobin like extracellular cadherin repeat domains (Coopman and Djiane, 2016;
Tunggal et al., 2005). These domains can form cis and trans dimers with cadherins on the
same cell and with adjacent cells, respectively (Shapiro and Weis, 2009; Wu et al., 2010).
The cytoplasmic tail of E-cadherin interacts with catenin proteins, mainly b-catenin,
preventing b-catenin from entering into the nucleus and binding Lef, which initiates
transcription. Upon binding of E-cadherin to b-catenin, b-catenin binds a-catenin linking
E-cadherin to the actin cytoskeleton (Aberle et al., 1994). Additionally, E-cadherin also
binds to integrins such as integrin alpha e also known as CD103 (Van den Bossche et al.,
2012). Because CD103 is an integrin that is expressed by a variety of cells including
epithelial cells as well as immune cell subsets this binding can allow for cell specific
interaction to the adherens junctions (Van den Bossche et al., 2012).
Nectins are single pass transmembrane proteins with three Ig-like loops that allow
for dimerization of nectins and promotion of cell-cell adhesion as well as apical- basolateral
polarity (Takahashi et al., 1999; Takai and Nakanishi, 2003). The cytoplasmic tail of
nectins contain a PDZ domain that binds afadin, the actin binding protein necessary for
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anchoring nectins to the actin cytoskeleton (Takahashi et al., 1999; Takai and Nakanishi,
2003) This anchoring allows adherens junction to mature and readily localizes cadherin to
cell-cell junctions (Fig 1.2) (Campbell et al., 2017). In the absence of E-cadherin, tight
junctions as well as desmosomes do not properly form, suggesting the essential role of this
protein in barrier formation (Tunggal et al., 2005). Additionally, E-cadherin deficient mice
have worsened colitis following administration with dextran sodium sulfate (DSS), a
chemical that is water soluble, negatively charged sulfated polysaccharide which is
administered in drinking water (Grill et al., 2015; Judd et al., 2015; Kurt-Jones et al., 2007).
Furthermore, polymorphisms within E-cadherin are associated with Crohn’s disease
(Muise et al., 2009). This intricate formation of the AJC forms a barrier within the GI
epithelium preventing commensal or pathogenic bacteria from translocating into the lamina
propria. However, if there is a barrier breach, either injury induced or chemically induced,
the lamina propria is full of immune cell subsets readily available to launch an immune
response.
Immune cell subsets of the gastrointestinal tract
Within the lamina propria there are two main antigen presenting cells (APC),
dendritic cells (DC) and macrophages, both of which can present antigens to T cells and
elicit an immune response (Fig 1.3). Importantly, there are more than just one subset of
these cells, specifically, dendritic cells can be conventional DC 1 (cDC1) identified by the
chemokine receptor X-C motif 1 (XCR1), conventional dendritic cell 2 (cDC2) identified
by the signal regulatory protein-a (SIRPa), as well as plasmacytoid dendritic cells (pDC)
(Cella et al., 1999; Piqueras et al., 2006; Schiavi et al., 2015). Within the small intestine
and large intestine there are different abundancies of these DC subtypes, however, the
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function of the DCs remains the same across each tissue. cDC1 can be characterized by the
surface markers CD11c+ MHCII+ XCR1+, however these cells can also either be CD103+
or CD103-. The expression of CD103 allows these DCs to transmigrate through the barrier
and sample antigen within the lumen as well as interact and bind to E-cadherin on IECs
(Schulz et al., 2009). Additionally, the CD103+ DCs have also been shown to migrate to
the lymph node and activate T cells (Schulz et al., 2009)). This interaction has been shown
to maintain T lymphocytes within the mucosa (Schon et al., 1999). T lymphocytes can
become polarized towards a Type 1 immune response (TH1), Type 2 immune response
(TH2), and towards anti-inflammatory responses such as those elicited from T-regulatory
(Treg) cells (Shale et al., 2013). CD103 deficient mice not only have reduced numbers of
T lymphocytes within the mucosa, but in addition have reduced retention of Tregs within
wounds (Suffia et al., 2005). Importantly, cDC cells can migrate to the draining lymph
node of the GI tract, the mesenteric lymph node (MLN) and re-enter into the GI tract,
allowing these cells to elicit immune responses in both locations.
The other major APC within the GI tract are macrophages, which can be divided
into two subtypes; macrophage 1 (M1) or macrophage 2 (M2). M1 macrophages are
typically associated with Type 1 immune responses while M2 macrophages are associated
with wound healing and Type 2 immune responses (Mills et al., 2000; Nathan et al., 1983;
Stein et al., 1992). Similar to DCs, within the mucosa, macrophages can be transepithelial
and sample antigen within the lumen of the GI tract through expression of CX3CR1 (Niess
et al., 2005). In contract to DCs, macrophages are poor in activating naïve T lymphocytes
and thus present antigen to previously activated T cells (Schulz et al., 2009).
Following antigen presentation, naïve CD4+ T cells can become activated to elicit
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an immune response. Within the lamina propria there are Type 17 (TH17), Type 1 (TH1),
Type 22 (TH22), Type 2(TH2), and Type 9 (TH9) CD4+ T cells (Fig 1.3) (Kara et al.,
2014). Each subset secretes different sets of cytokines that drive pro- and antiinflammatory responses as well as regulate the activation of APCs. Importantly, T cells can
migrate from the lamina propria into the MLN and back, a process that is augmented when
there is a barrier breach (Kara et al., 2014). In the next chapter, we will further discuss the
cytokines that these cells secrete and how these cells respond to different barrier breaches.
In addition to CD4+ T cells, CD8+ T cells are also present in the intestine. In contrast to
CD4+ T cells providing T cell help, CD8+ T cells are cytolytic (Jiang et al., 2003; Lykens
et al., 2011; Mouchacca et al., 2015; Salti et al., 2011; Yang et al., 2019b). CD8 T cells can
secrete perforin as well as granzyme B promoting clearance of bacteria, pathogens, and
viruses (Jiang et al., 2003; Lykens et al., 2011; Mouchacca et al., 2015; Salti et al., 2011;
Yang et al., 2019b).
Furthermore, innate lymphoid cells (ILCs), are a subset of cells first identified in
the early 2000s to be present within the barrier surfaces such as the GI mucosa (Fig 1.3).
There are three subsets (ILC1, ILC2, ILC3) which are characteristically distinct from Thelper cells because they do not express recombinant T cell receptors but are functionally
very similar to TH1, TH2, or TH17 cells, respectively (Artis and Spits, 2015). Innate
lymphoid cells also do not express B or myeloid cell markers, thus are lineage negative,
however they do express the IL-2 (CD25) receptor and the IL-7 (CD127) receptor (Artis
and Spits, 2015). Within the GI mucosa, ILC1 cells are abundant in the upper GI tract while
ILC3 and lymphoid tissue inducer (LTi) cells, a subset of ILC3, are found in abundance
within the colon, and ILC2 cells are expressed in very low amounts in the entire GI tract
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(Kramer et al., 2017). ILC1 have been shown to be important in immunity against
intracellular bacteria while ILC3 and LTi have been shown to be important in immunity
against extracellular bacteria (Geremia et al., 2011; Hanash et al., 2012; Kirchberger et al.,
2013; Sonnenberg et al., 2011). Interestingly, both subsets have been shown to have roles
in the induction of inflammatory responses that drive colitis (Geremia et al., 2011; Hanash
et al., 2012; Kirchberger et al., 2013; Sonnenberg et al., 2011). ILC1 cells also include
natural killer (NK) cells. NK cells have cytolytic activity and can secrete enzymes that are
pore forming (perforin 1) to mediate apoptosis in a cell- specific manner (Chattopadhyay
et al., 2009).
All of these different immune cell subsets work in conjunction with one another to
elicit immune responses when there is a barrier breach within the mucosa. Each cell type
can secrete a variety of cytokines and enzymes to lead to inflammation, cell death, or limit
inflammation through anti-inflammatory responses. The balance of these elicited immune
responses limits gross pathology, ulcers, bacterial outgrowth, colitis, as well as cancer.
1.3 Regulation of the mucosal barrier
Type 1 immune responses
Following a barrier breach, a number of immune responses are elicited to limit
pathology and damage to the mucosa. Upon injury, the first line of defense, are the IECs.
Intestinal epithelial cells can secrete interleukin 18 (IL-18), interleukin 1b (IL-1 b), as well
as TNF to drive a TH1 immune response (Nowarski et al., 2015; Roulis et al., 2011;
Waterhouse and Stadnyk, 1999). Secretion of IL-18 can promote TH17 cellular
differentiation as well as increase Treg effector function (Harrison et al., 2015).
Furthermore, the secretion of IL-18 can induce macrophages to produce interferon gamma
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(IFNg) as well as promote OX40 ligand (OX40L) expression on DCs. The expression of
OX40L on DCs allow for binding to OX40, the receptor of OX40L, that is expressed on T
cells and promote T-cell survival (Maxwell et al., 2006; Szpakowski et al., 2015). Upon
activation, DCs can secrete pro-inflammatory cytokines such as interleukin-12/23p40 (IL12/23p40) which in turn promotes TH1 cells to become activated and secrete IFNg and
TNF (Reinhardt et al., 2006). Secretion of IFNg acts in a positive feedback loop, because
IFNg can activate macrophages to produce IL-12/23p40, leading to a persistent
inflammatory immune response (Cohen et al., 2015). To counteract this immune response
and limit inflammation, the anti-inflammatory cytokine interleukin-10 (IL-10) is secreted
by macrophages and T-reg cells. The secretion of IL-10 is crucial for limiting inflammation
and tissue injury (Rubtsov et al., 2008).
Other than TH1 cells, TH17 cells and TH22 cells are also necessary for intestinal
inflammatory control. These cells secrete interleukin 22 (IL-22) as well interleukin-17A
(IL17A) that can promote chemokines to attract immune specific cell subsets to the site of
injury, as well as promote AMPs, respectively. Interleukin-22 can be secreted from TH17,
TH22, ILC3, and LTi cells. Importantly, IL-22 can also induce expression of REGIIIg and
REGIIIb from intestinal epithelial cells causing bacteria cell death (Bachmann et al., 2010;
Zindl et al., 2013). Furthermore, IL-22 has been implicated in wound repair through
promotion of intestinal stem cell mediated epithelial regeneration (Lindemans et al., 2015).
Lindemans et al. demonstrated that IL-22 increases the growth of intestinal organoids,
reduces intestinal pathology of graft versus host disease, and increases the recovery of
Lgr5+ stem cells in graft versus host disease (Lindemans et al., 2015). Although Type 1
immune responses are elicited during bacterial invasion, Type 2 immune responses are also
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elicited during helminth infections allergen-induced epithelial damage.
Type 2 immune responses
Intestinal epithelial cells can secrete thymic stromal lymphopoietin (TSLP), the
alarmin, interleukin 33 (IL-33), as well as interleukin-25 (IL-25) (Kim et al., 2013; Saenz
et al., 2013; Taylor et al., 2009; Xiao et al., 2019; Zeuthen et al., 2008). These cytokines
can promote M2 polarization leading to the secretion of interleukin 4 (IL-4), interleukin 13
(IL-13), and TGFb which in turn polarizes a TH2 cell response (Pichery et al., 2012;
Schiering et al., 2014; Xiao et al., 2019). Furthermore, following release of IL-33 there is
a subsequent promotion of T-regulatory cell expansion (Schiering et al., 2014). Outside of
promoting type 2 responses, IL-33 can also improve wound healing (He et al., 2017;
Lopetuso et al., 2018).
Regenerative proteins in mucosa barrier homeostasis
In addition to cytokine secretion, there are small proteins known as Trefoil factors
(TFFs) secreted from goblet cells that play a crucial role in epithelial repair. The Trefoil
factor family of proteins was first identified in the 1990s and shown to be a family of three
small (7-14kDa) proteins (TFF1, TFF2, TFF3) expressed within mucosal barriers including
the lung and GI tract (Thim, 1989). These proteins contain a distinct domain known as the
Trefoil domain that is 38-39 amino acid residues containing 6 cysteines linked by disulfide
bonds to form a three-leaved structure (Thim, 1989). TFF1 and TFF3 contain only one
domain while TFF2 contains two Trefoil domains (Thim, 1989). When first identified,
TFF1 and TFF2 were found to be expressed in the stomach of humans while TFF3 was
expressed within the intestinal tract, however, work published from our lab as well as
others have demonstrated in mice TFF2 is also expressed within the GI tract (McBerry et
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al., 2012; Podolsky et al., 1993; Suemori et al., 1991; Tomita et al., 1995; Wills-Karp et
al., 2012).
TFF proteins have been implicated in functional roles promoting epithelial
restitution or the migration of cells to the site of injury, inhibition of apoptosis, as well a
cellular proliferation (Buda et al., 2012; Hoffmann, 2005; Playford et al., 1995). Playford
et al. demonstrated enhanced migration of HT29 cells, a human colon carcinoma line, when
grown on collagen gel and treated with human TFF2 (Playford et al., 1995). During
cellular restitution, cells need to detach from their cell-cell contacts in order to migrate,
thus a mechanism that prevents cellular apoptosis when these cells detach from their cellcell contacts would to enhance restitution and potentially promote faster recovery from
injury. Taupin et al demonstrated that following transfection with TFF3, HT-29 cells were
resistant to serum withdrawal while vector control cells were sensitive and had
increased apoptosis (Taupin et al., 2000). Taupin et al. further demonstrated that TFF3 can
inhibit apoptosis in both a p53 dependent and independent manner (Taupin et al., 2000).
During the restitution phase of colitis, TFF3 protein levels are increased; however,
studies are contradictory over whether or not Tff3 deficient mice are more susceptible to
colitis (Belle et al., 2019; Kjellev et al., 2007; Mashimo et al., 1996; Podolsky et al., 2009;
Renes et al., 2002). These data suggest that TFF3 may be sufficient, but not necessary for
healing during colitis. Furthermore, these data demonstrate that TFF proteins are crucial
regenerative proteins of the mucosa. While TFFs are typically secreted from goblet cells
during injury, TFF2 has also been shown to be expressed in spleen, peritoneal cells,
macrophages, as well as embryonic fibroblasts, suggestive that this protein has functional
roles in immune responses elicited during inflammation and injury (Kurt-Jones et al., 2007;
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McBerry et al., 2012). McBerry et al. demonstrated that TFF2 acts on macrophages and
DCs to negatively regulate IL-12/23p40, such that Tff2 deficient mice have enhanced Type
1 immune responses and immunity against Toxoplasma gondii, an obligate intracellular
protozoan that crosses the GI epithelium and disseminates into the central nervous system
(McBerry et al., 2012). In addition, Tff2 deficient mice mount enhanced Type 1 immune
responses and have more severe colitis that WT controls following DSS administration
(Judd et al., 2015; Kurt-Jones et al., 2007). Furthermore, TFF2 production can induce IL33 leading to enhanced Type 2 immunity during allergic and Nippostrongylus brasiliensis
infection (Wills-Karp et al., 2012). These data all support the role of Trefoil factors during
injury and wound healing. Although these proteins have been studied since the early 90's
and have been shown to have functional roles during injury and inflammatory responses,
exactly how TFFs signal to promote these functions is not well understood.
To date there have been a number of putative TFF receptors (Chinery and Cox,
1995; Chinery et al., 1993; Dubeykovskaya et al., 2009; Gajhede et al., 1993). It has been
shown that Trefoils form a complex with mucins, allowing for resistance to proteases and
mechanical stress, however, the exact proteins involved in this complex have not be
identified (Gajhede et al., 1993). Because the TFF proteins function at sites of injury, it is
postulated that potential Trefoil receptors would be within the same vicinity of the injury
site. Importantly, cellular binding sites have been found within all TFFs, further suggesting
a Trefoil binding partner (Chinery and Cox, 1995; Chinery et al., 1993; Poulsen et al., 2003;
Poulsen et al., 1998). Thim et al. found using affinity chromatography on TFF2 that there
were two potential receptors, a CRP-ductin gene expressed within intestinal crypts as well
as a B subunit of fibronectin receptor (Thim and Mortz, 2000). However, future studies
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were unable to prove direct binding of TFF2 to these receptors, suggestive that the two
receptors and TFF2 were not a protein-ligand pair (Otto and Thim, 2005; Thim and Mortz,
2000). The strongest evidence to date that there is a putative TFF2 receptor is work from
Dubeykovskaya et al. Dubeykovskaya et al demonstrated in vitro that TFF2 requires
CXCR4 for calcium mobilization, ERK1/2 activation, and AKT activation, two
downstream signaling cascades of Trefoils (Dubeykovskaya et al., 2009). Additionally,
Engevik et al demonstrates that Tff2 deficient gastric organoids have delayed repair
following injury and that inhibition of CXCR4 in the presence of exogenous TFF2 was
unable to rescue repair (Engevik et al., 2019). Interestingly, these data never show direct
binding between CXCR4 and TFF2 using standard binding assays such as coimmunoprecipitation, proximity ligation assays, or surface plasmon resonance (Drescher
et al., 2018; Kaboord and Perr, 2008; Weibrecht et al., 2010). Furthermore, these studies
do not demonstrate that Cxcr4 deficient mice phenocopy Tff2 deficient mice, a result that
would be hypothesized to occur without either the receptor or ligand.
Recent evidence has demonstrated that TFF3 interacts with leucine rich repeat and
immunoglobulin-like domain- containing nogo receptor-interacting protein 2 (LINGO2) to
regulate epidermal growth factor receptor (EGFR) activation (Belle et al., 2019). Belle et
al. demonstrated that TFF3 and LINGO2 directly bind using co- immunoprecipitation and
proximity ligation assays, are colocalized and expressed on the cell surface of transfected
TFF3 or LINGO2 cells (Belle et al., 2019). Furthermore, this work demonstrates that
LINGO2 can bind to EGFR and administration with TFF3 reverses that binding (Belle et
al., 2019). These data were the first in vitro and in vivo evidence of a putative TFF3 binding
partner, additionally, LINGO2 was a protein that previously had no known function.
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The LINGO family of proteins
Leucine rich repeat and immunoglobulin-like domain-containing nogo receptorinteracting proteins are a family of four homologous receptors (LINGO1-4). The LINGO
proteins are Type 1 transmembrane proteins that contain 12 extracellular leucine rich
repeats, an immunoglobin C2 domain, and an intracellular cytoplasmic tail (Haines and
Rigby, 2008). The LINGOs have different expression patterns within mouse tissues;
however, all four proteins are expressed during embryogenesis ranging from 8.5 days post
coitum (dpc) to 10.5 dpc (Haines and Rigby, 2008). Interestingly, in adult mice the
expression patterns of each LINGO family member are different while LINGO1 is highly
expressed within the brain and spinal cord, LINGO 2-4 are expressed within the GI tract
in addition to the central nervous system (Belle et al., 2019; Haines and Rigby, 2008).
Prior to the work from the Herbert lab investigating the role of LINGO2 in the GI tract,
LINGO1 was the only family member that had been studied. LINGO1 has been shown to
form a complex with two other proteins, NOGO-66/p75 neurotrophin receptor complex.
Upon forming a ternary complex, the proteins can signal to promote myelin inhibition (Mi
et al., 2004). Furthermore, upon deletion or blocking of LINGO1 there is enhanced survival
of dopaminergic neurons (Inoue et al., 2007). Interestingly, the cytoplasmic domain of
LINGO1 contains a canonical EGFR tyrosine phosphorylation site, suggesting that this
protein/protein complex can interact and regulate EGFR signaling (Mi et al., 2004); (Inoue
et al., 2007). Inoue et al. demonstrated that LINGO1 and EGFR directly bind and that
LINGO1 decreases EGFR in a dose dependent manner (Inoue et al., 2007). Taken together
these data demonstrate that LINGO1 forms a ternary complex to elicit a signaling response
that inhibits neuronal outgrowth (axon regeneration) through downregulation of growth
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factor signaling and promote myelin inhibition. Because the LINGO family members have
60-90% sequence homology, it is possible that the other LINGO family members also work
in a complex to promote/ inhibit EGFR signaling and regeneration (Haines and Rigby,
2008; Mi et al., 2004).
Recent work from Belle et al. demonstrates that LINGO2 is expressed within the
GI tract of humans and can bind to EGFR, similar to LINGO1, as well as TFF3 (Belle et
al., 2019). Furthermore, LINGO2 was necessary for TFF3 induced cell survival as well as
STAT3 and EGFR activation, such that Lingo2 deficient mice had excess intestinal EGFR
activation and worsened colitis (Belle et al., 2019). These data in support with the work on
LINGO1 suggest that the LINGO family members interact in a complex to regulate growth
and regeneration, regardless of the tissues that the proteins are expressed in. However,
further studies will need to be performed to better understand the roles of LINGOs in the
GI tract and their putative roles in wound repair during mucosa injury.
1.4 The effects of a defective gastrointestinal barrier
Microbial driven defects of gastrointestinal barrier: Leaky gut syndrome
The previous sections have discussed the regulatory mechanisms and major
proteins involved in controlling the maintenance and homeostasis of the GI barrier.
However, understanding how defects in the GI barrier drives intestinal diseases is crucial
for better understanding of the current paradigm as well as novel mechanisms that regulate
intestinal inflammation and barrier dysregulation. As previously described, commensal
bacteria live in close proximity to the mucosa of the GI tract. Work from Earle et al has
demonstrated that within the mucosa, dietary changes can lead to thinning of the mucus
layer and increased inflammation (Earle et al., 2015). Interestingly, in germ- free mice,
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when diets have reduced microbiota accessible carbohydrates, commensals are in closer
proximity to the epithelium (Earle et al., 2015). Dietary changes are just one environmental
cue that can lead to dysregulated mucosa, non-steroidal anti-inflammatory (NSAID) use,
alcohol use, bacterial infections, and chronic inflammation can all lead to commensals
entering into the gastrointestinal mucosa (Berkley et al., 2005; Maseda et al., 2019; Nieman
et al., 2006; Purohit et al., 2008). Because commensals live in symbiosis with the host it is
thought that these symbionts are tolerogenic, preventing the immune system from
recognition of these bacteria and eliciting an immune response against commensals. In the
context of inflammation or a barrier breach, commensal specific T cells can induce memory
specific immune responses; however, the exact implications for this is not well studied
(Atarashi et al., 2011; Hand et al., 2012; Ivanov et al., 2009).
Citrobacter rodentium (C. rodentium), is a Gram-negative enteropathogenic
bacteria, that infects rodents and is the homologue to human enteropathogenic Escherichia
coli (E.coli). C. rodentium is a member of the attaching and effacing (A/E) bacteria family
and contains the locus of enterocyte effacement (LEE) (Deng et al., 2001). LEE encodes a
Type III secretion system and the genes necessary to form the A/E lesion, an actin rich
pedestal that forms on the plasma membrane of hosts’ intestinal epithelial cells (Deng et
al., 2003; Schauer and Falkow, 1993a, b). Upon pedestal formation C. rodentium secretes
bacterial proteins, such as espB, that are necessary for bacterial colonization (Deng et al.,
2001; Liu et al., 1999; Newman et al., 1999). Upon infection the bacteria colonize the
caecum and are shed within the feces (Wiles et al., 2004). Following colonization, C.
rodentium disrupts the tight junction integrity, leading to commensal bacteria
dissemination into the lamina propria, which causes massive inflammation and pathology
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(Flynn and Buret, 2008; Garber et al., 2018; Guttman et al., 2006; Thanabalasuriar et al.,
2013). Additionally, because this bacterium is shed in the feces, coprophagia leads to
continual infection in rodents and dissemination of bacteria to the large and small intestine
(Johansson et al., 2008; Wiles et al., 2006).
Upon colonization and dissemination C. rodentium induces a TH17 and TH1
immune response, colonic hyperplasia (thickening of the colon), and diarrhea (Fig 1.4).
Work from Simmons et al demonstrate that both CD4+ T cells and B cells are crucial for
immunity against C. rodentium, however CD8+ T cells are dispensable (Simmons et al.,
2003). Recent work from Sonnenberg et al has demonstrated the during the early
timepoints of infection, two innate immune responses are critical for early control; ILC3
and LTi cellular responses (Sonnenberg et al., 2011). C57BL/6 mice can excrete and clear
C. rodentium typically within 3 weeks of infection, however genetic deficiencies of proper
TH17 or TH1 immune responses lead to death (Wiles et al., 2004; Wiles et al., 2006).
Importantly, because C. rodentium causes colonic hyperplasia as well as localized
inflammation within the GI tract, it is a system used to model Crohn’s disease, Ulcerative
Colitis, as well as colon tumorigenesis (Chandrakesan et al., 2014; Higgins et al., 1999).
Inflammatory bowel disease: subsets and model systems
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the GI tract
that is further categorized into two subsets Crohn’s disease (affects any region of the GI
tract) and Ulcerative colitis (limited to colon) (Fakhoury et al., 2014). Within the United
States, approximately 3 million people have inflammatory bowel disease (Dahlhamer et
al., 2016). Although this disease was first defined in the 1930s, there is no cure (Feuerstein
and Cheifetz, 2017). Patients typically present with weight loss, diarrhea, bloody stool,
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abdominal pain, fatigue, and/or fevers with the median age of onset being 30 (Burgmann
et al., 2006; Cheifetz, 2013; Dahlhamer et al., 2016).
Although the causative effect of IBD is not well understood, it is thought that
environmental factors such as stress and GI infections as well as genetic risk factors
including familial risk, mutations in pattern recognition receptors like nucleotide-binding
oligomerization domain containing protein 2 (NOD2), and defects in signaling pathways
involved in epithelial function and adaptive immunity are all contributing factors (Cleynen
et al., 2016; Hugot et al., 2001; Loftus, 2004; Ng et al., 2013; Ogura et al., 2001). To date,
there are few treatment options available to patients. Treatments can include blockade of
the inflammatory signaling pathways such as anti-IL12/23 or anti- TNF, as well as surgical
re-sectioning of the GI tract in the affected region (Chateau and Peyrin-Biroulet, 2019;
Feuerstein and Cheifetz, 2017; Ribaldone et al., 2019; Sands et al., 2019). To better
understand the pathogenesis of this disease and further develop potential curative therapies,
more research needs to be undertaken.
There are a number of different model systems used to study IBD. As previously
discussed, C. rodentium is one of these model systems, however, another model system is
dextran sodium sulfate (DSS) administration (Fig 1.4). DSS can be given in a number of
quantities ranging from 1-5%, with 5% leading to the most inflammatory injury and 1%
leading to the least inflammatory injury(Chassaing et al., 2014). The exact mechanism of
how DSS induces intestinal inflammation is unknown, however, it is expected that
inflammation is an effect of the denudation of epithelium caused by administration of the
chemical. Upon administration, mice typically begin to lose weight around day 3 post
administration and show signs of clinical manifestations of disease (diarrhea, bloody stool,
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lack of grooming, weight loss) (Chassaing et al., 2014). The amount of DSS administered
can be variable depending on the question being asked, for example to evaluate a relapsing
IBD similar to what is observed in Crohn’s patients, a lower DSS dose will be administered
for 6 days, then stopped and started again 4-6 days afterwards (Chassaing et al., 2014;
Fakhoury et al., 2014). However, if evaluating the onset of IBD and specifically the
signaling molecules/ pathways involved in repair and regeneration, DSS is administered
for 6 days where the mice show clinical manifestations of disease and then returned to
normal drinking water for 4-6 days in order to allow for reduced inflammation and recovery
from injury (Chassaing et al., 2014; Fakhoury et al., 2014). Because DSS denudes the
epithelium, Lgr5+ stem cells are necessary for repair (Davidson et al., 2012). Additionally,
recent studies have shown that Paneth cells play a major role in epithelial regeneration
during DSS (Schmitt et al., 2018). Furthermore, TFFs have been shown to be increased
following DSS administration and have implications in recovery (Judd et al., 2015; Renes
et al., 2002). Importantly, DSS has typically been implicated as a myeloid-driven model
because this model remains intact when T and B cell deficiency mice are used (Kim et al.,
2006). However, IL-10 secretion from T-reg cells can promote tissue recovery (Guo et al.,
2019; Yang et al., 2019a). Following administration, DSS leads to immune infiltration,
namely myeloid cells, smooth muscle hyperplasia, and a decrease in colon length, all
clinical symptoms observed in IBD patients (Chassaing et al., 2014; Fakhoury et al., 2014).
During the recovery phase, goblet cells can be found replenishing the colon, as well as an
induction of stem cell activity.
Although oral administration of DSS was originally hypothesized to drive colon
specific injury reflective of Ulcerative colitis, recent studies have shown that DSS can also
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cause epithelial denudation and inflammation in small intestine. This indicates that DSS
can also be used as a representative animal model of Crohn’s disease that affects more
proximal regions of the GI tract (Geier et al., 2009; Yazbeck et al., 2011). The usage of
DSS in animal models has allowed for a better understanding of the role myeloid cells have
in IBD as well as development of treatments such as anti-IL-12/23 for IBD. However, a
benefit of the DSS model is that one can specifically study the immune mechanisms behind
the recovery phase, unlike any of the other IBD models such as T-cell driven colitis. Mice
deficient in AJC proteins such as E-cadherin or Claudin-2 are more susceptible to DSS
colitis with increased ulcerations and a loss of crypt architecture and regeneration (Grill et
al., 2015; Nishida et al., 2013). Additionally, during DSS administration mice lose
expression of ZO-1 by day 7 post administration (Poritz et al., 2007). Interestingly,
overexpression of claudin-2 can protect against colitis, further supporting the evidence that
tight junction proteins are crucial during recovery of DSS (Ahmad et al., 2014).
Understanding the recovery phase of colitis is crucial not only to identify better treatment
options for these patients, but also for the development of a putative cure for these patients.
1.5 Overview
The work comprising this dissertation reveals a novel role for the orphan Type 1
transmembrane receptor LINGO3 as a regulator of the GI epithelium during homeostasis
and post injury in promoting GI tissue recovery during DSS-induced colitis. Chapter 2
demonstrates that Lingo3 is expressed in at three different mucosal sites, the ileum, colon,
and lung, and is exclusively expressed on intestinal epithelial cells isolated from the small
intestine and colon. LINGO3 is not expressed on immune cell subsets isolated from the
MLN or spleen. Interestingly, in rectosigmoid samples from healthy human subjects,
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LINGO3 is expressed in at least two locations: 1) on the apical surface of the GI tract where
enterocytes are located and 2) on cells within the base of the intestinal crypt where the
intestinal stem cell niche is located. Upon deletion of Lingo3, there is an increase in
intestinal permeability that is most likely due to dysregulated adherens junctions. This
conclusion is based on data generated by electron microscopy, revealing a decrease in
Cdh1 and Itgae, which are genes known as essential components of the adherens junction.
On a protein level, the data show that Lingo3 deficient mice have a decrease in E-cadherin
. Furthermore, the lack of Lingo3 also results in a dysregulation in mucosal barrier
formation accompanied by an increased number of DCs and increased in frequency of TH1
cells within GI tissues and mesenteric lymph node tissues.
To assess if LINGO3 was important for tissue repair following colitic injury, cohoused WT and Lingo 3 KO mice were administered a moderate dose of DSS. Lingo3
deficient mice had an increased severity of DSS-induced colitis associated with an increase
in morbidity as determined by weight loss, increased clinical score, decreased colon length,
lack of crypt architecture, and delayed goblet cell replenishment. Because Lingo3 deficient
mice displayed a similar phenotype to Tff2 deficient mice during DSS-induced colitis,
experiments were designed to assessed if TFF2 and LINGO3 were functioning in a similar
pathway. Indeed, data generated in chapter 2 demonstrate that although we do not have
strong evidence that TFF2 and LINGO3 directly bind to each other, we successfully
demonstrated that TFF2 promoted a faster recovery during DSS-induced colitis in WT
mice, but not in Lingo3 deficient mice. This enhanced recovery with TFF2-Fc
administration correlated with enhanced activation of ERK in WT mice but not in Lingo3
KO mice.
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My work demonstrates that LINGO3 and TFF2 signaling pathways seems to have
a beneficial role in the proper maintenance and/or function of the intestinal stem cell niche.
This contention comes from data that demonstrate a growth and architectural defect within
Lingo3 and Tff2 deficient organoids when compared to WT organoids. These data are
consistent with the defects in tissue recovery following DSS-induced colitis observed in
both Lingo3 and Tff2 deficient mouse strains.
Chapter 3 demonstrates that Lingo3 deficiency does not confer resistance or
susceptibility to the enteropathogenic bacterium, C. rodentium.. These data are somewhat
surprising given that Lingo3 deficiency increased the basal level of Type 1 cytokine
production, which is generally thought responsible for promoting host protection against
microbes. Overall, the work in this dissertation has important implications for expanding
the body of knowledge pertinent to epithelial cell signaling and function within the GI
mucosa, which are topics discussed in greater detail within Chapter 4. Moreover, that
LINGO3 was demonstrated herein to possess important functional roles within the
intestinal stem cell niche, formation of the adherens junction, and recovery from colitic
injury are major areas that require further investigation in future studies beyond the work
completed in this dissertation. The implications for LINGO3 within these three areas will
be discussed in Chapter 4. It is important to note, that the work in the remaining factors
focuses strictly on the GI tract, however, LINGO3 and TFF2 have been shown to be
expressed in other mucosa such as the lung (Belle et al., 2019; Wills-Karp et al., 2012),
therefore additional implications of this work extent to mucosal surfaces outside of the GI
tract such as the upper airways and lung.
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Figures

Figure 1.1 The intestinal epithelium forms the barrier between the mucus layer
(green) and the lamina propria (beige). The epithelium is composed of anti-microbial
peptides, mucins, and commensals which are present in the lumen of the GI tract. Goblet
cells, and enterocytes compose the majority of the intestinal epithelial cells while Lgr5+,
Paneth, and transit amplifying cell compose the stem cell niche.
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Figure 1.2 Schematic of the apical junction complex composition. The apical junction
complex is comprised of claudins, occludens, zonula occludens, junctional adhesion
molecules (JAMs), and the adherens junctions, which are positioned on the basolateral side
of enterocytes and anchor to the actin cytoskeleton. The adherens junctions consist of Ecadherin-integrins-b-catenin in addition to nectins that bind the actin binding protein
afadin.
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Figure 1.3 Immune cell subsets that comprise the lamina propria. Under inflammatory
conditions, professional antigen presenting cells (dendritic cells and macrophages),
propagate a specific immune response (Type 1 Vs Type 2), activated T cells (TH1, TH2,
TH17, TH22, TH9) produce cytokines (indicated by arrows). Furthermore, innate
lymphoid cells (ILC1-3) can elicit TH1, TH2, TH17 immune responses, following tissue
injury or infection with various types of organisms (pathogenic or commensal). During
steady state conditions, these immune cells are considered largely tolerogenic and fail to
produce substantial amounts of cytokines.
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Figure 1.4 Two different types of gastrointestinal injury. 1) Infection with the
enteropathogen C. rodentium results in an A/E lesion on intestinal epithelial cells. PostA/E lesion formation, C. rodentium secretes bacterial proteins into the lamina propria
resulting in the disruption of tight junctions between epithelial, which can allow
commensal organisms to enter into the lamina propria. The colonization with C. rodentium
together with commensals entering into the lamina propria culminates in development of a
robust a Type 1 immune response. 2) Following administration of the toxic carbohydrate
dextran sodium sulfate (DSS), the intestinal epithelium is severely damaged resulting in
exposure of the basement membrane. This denudation of the epithelium induces
macrophages and DCs to secrete IL12/23p40 and TH1 cells to secrete IFNg and TNF.
Furthermore, macrophages as well as Treg cells secrete IL-10 to control the inflammation.
Lgr5+ stem cells, Paneth cells, and TFF secreting goblet cells are necessary for regeneration
of intestinal architecture during the recovery phase of DSS-induced colitis.
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Chapter 2: LINGO3 enforces mucosal barrier integrity and controls tissue repair
during colitis
Abstract
Mucosal epithelia are exposed to potentially damaging stimuli, yet pathways that restore
homeostasis following injury remain incompletely known. Herein, we show that the
transmembrane receptor, leucine rich repeat and immunoglobulin like domain containing
nogo receptor interacting protein 3 (LINGO3) is necessary for mucosal integrity and tissue
regeneration following dextran sodium sulfate (DSS)-induced colitis. In humans, upper
respiratory and intestinal epithelia express LINGO3 near Trefoil factor 2 (TFF2). In naïve
mice, Lingo3 deficiency impairs E-cadherin expression, increases microbial translocation
and accumulation of activated intestinal dendritic and TH1 cells. TFF2 administration
accelerated healing post-DSS in wildtype, but not Lingo3 knockout mice. TFF2-driven
protective effects like ERK1/2 activation, were LINGO3 dependent, but regulation of
caspase-3 and Ki-67 were LINGO3 independent. Either TFF2 or LINGO3 deficiency
impaired budding/growth of gastrointestinal organoids and reduced expression of Lgr5.
Combined, we propose LINGO3 as a novel regulator of intestinal integrity and
regeneration under steady-state and injurious conditions.
Introduction
Diverse epithelial cell lineages form a dynamic protective barrier to the external
environment and form a semi-permeable shield for the body against mechanical, chemical,
and organismal injury (Oshima and Miwa, 2016; Yu, 2018). Tissue injury, particularly in
the gastrointestinal (GI) tract initiates mobilization of epithelial progenitors in the crypt
stem cell niche, and changes the gene expression profiles of enterocytes, M cells, goblet
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cells, enteroendocrine cells, Paneth cells, and tuft cells (Andersson-Rolf et al., 2017;
Peterson and Artis, 2014; Yen and Wright, 2006). Epithelial secretions including cytokines
to reactive nitrogen and oxygen intermediates and lipid mediators protect mucosal tissues
against invasion by organisms to curtail inflammation and further promote repair, but the
knowledge of these soluble mediators is incomplete (Glover et al., 2016; Ortiz-Masia et
al., 2010; Peterson and Artis, 2014). Notably, the Trefoil factor family (TFF1, TFF2, TFF3)
peptides drive largely enigmatic pathways of tissue repair and immunoregulation at the
mucosal interface (Aihara et al., 2017). TFFs are constitutively present within mucus
secretions and regulate epithelial biology through restitution, cellular migration, regulation
of tight junction proteins, and inhibition of epithelial cell apoptosis, but how these proteins
exert their function(s) remains unclear (Cai et al., 2016; Hanisch et al., 2017; Hung et al.,
2018; Le et al., 2016).
TFFs may promote wound healing through receptor-mediated signal transduction
events and/or indirectly by modifying the rheological properties of mucus (Aihara et al.,
2017; Thim and Mortz, 2000; Yong et al., 2013). CXCR4, (the stromal derived factor 1
(SDF-1) receptor), responds to TFF2 at high concentrations (Dubeykovskaya et al., 2009).
However, there is no data from in vivo experimentation to indicate that CXCR4 deficiency
impairs tissue repair. We and others have found that Tff2 deficient mice (Tff2 KO) have
worsened disease post dextran sodium sulfate (DSS) colitis, increased pro-inflammatory
cytokine secretion IFNg, IL-6, IL-1b, and inducible nitric oxide synthase (iNOS) as well
as defective mucosal barrier integrity under baseline conditions, but no such data have been
reported for CXCR4 deficiency (Judd et al., 2015; Kurt-Jones et al., 2007; McBerry et al.,
2012). Thus, we sought to identify and characterize extracellular transmembrane proteins
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that upon deletion, would recapitulate features of TFF2 deficiency.
This study provides evidence that the orphan receptor leucine rich repeat and
immunoglobulin like domain containing nogo receptor interacting protein 3 (LINGO3)
functions in mucosal tissue repair and is partially responsible for TFF2 responsiveness.
Although TFF2 and LINGO3 weakly interact, our loss of function studies shows that
Lingo3 knockout (Lingo3 KO) mice display basal defects in intestinal mucosal barrier
integrity, defective E-cadherin expression, and inflammatory cell accumulation. Also,
Lingo3 KO and Tff2 KO strains had cell-intrinsic defects in intestinal organoid formation
and defective recovery from DSS- induced colitis. Therapeutic TFF2-Fc administration
accelerated healing following colitic disease in WT, but not in Lingo3 KO mice, which
together indicates that LINGO3 is a novel reparative protein that regulates mucosal
epithelial cell biology.
Results
Identification of LINGO3 as a mucosal epithelial protein in mice and humans.
Despite reports implicating CXCR4 in TFF2-mediated signal transduction, there
have been no reports validating a TFF2-CXCR4 axis in vivo. (Dubeykovskaya et al., 2009)
Therefore, we employed the TRICEPs approach (Frei et al., 2012; Frei et al., 2013) using
human rTFF2 as bait to identify potentially novel extracellular membrane-associated
proteins. Results from this screen led us to focus on the type 1 transmembrane orphan
receptor LINGO3 that contains a 40 amino acid (AA) cytoplasmic tail containing two
serines and one tyrosine residue (Fig. 2.1a). To study LINGO3 in detail, a CRISPR-CAS9
gene-editing approach was used to generate Lingo3 deficient mice. Lingo3 specific
sgRNAs were generated to target the translational start site in exon 2 and injected into
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C57BL/6 blastocysts with CAS9 protein. A founder line with a heterozygous 70 bp deletion
downstream of initiator ATG was identified, outcrossed to C57Bl/6 WT mice, then bred to
homozygosity, and confirmed to lack off-target deletions using SNP analysis (Fig 2.2a-e).
TaqMan assays were used to determine Lingo3 mRNA expression levels in naïve wildtype
(WT) and Lingo3 knock out (Lingo3 KO) biopsies taken from lung, small intestine and
colon. Lingo3 mRNA transcripts were readily evident in WT, but not Lingo3 KO (Fig.
2.1b). Lingo3 mRNA transcripts were also detected using SYBR green assays in liver,
spleen, brain, and heart, but not in the bone marrow or kidney (Fig 2.2f). On a cellular
basis, isolated intestinal epithelial cells (IEC) had Lingo3 expression, but not CD4+ (T
cells), B220+ (B cells), or CD11b+CD11c+ (myeloid cells) (Fig. 2.1c). Although we tested
for LINGO3 protein levels using several commercially available and in-house generated
anti-mouse LINGO3 antibodies, none were found to be specific. However, a validated antihuman LINGO3pAb was employed to ask whether LINGO3 was expressed on human
intestinal epithelia. Co-immunofluorescence staining using anti-human LINGO3 pAb and
anti-human TFF2 pAb (to identify goblet cells) on formalin fixed paraffin embedded
(FFPE) rectosigmoid specimens from normal human subjects was used to determine if
LINGO3 was expressed in the vicinity of TFF2. TFF2 (red) localized to goblet cells within
intestinal crypts, whereas LINGO3 (green) was expressed on colonic enterocytes and
sparsely along crypt base with no staining in the isotype-matched Ab controls (Fig. 2.1di). The expression of LINGO3 protein along the crypt base is consistent with previous
reports suggesting that Lingo3 mRNA is expressed on Lgr5+ cells and transit-amplifying
cells (Haber et al., 2017; Hsu et al., 2014; Rangel-Huerta and Maldonado, 2017). To
evaluate other mucosal epithelia surfaces, we stained nasal polyp tissues obtained from
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patients with chronic rhinosinusitis (Kohanski et al., 2018; Patel et al., 2018; Workman et
al., 2018). Data revealed LINGO3 (green) expression on epithelia in a spatially distinct
pattern from the punctate TFF2 (red) staining inside of goblet cells, with no staining in the
isotype matched Ab control (Fig. 2.1j-n). These data suggested that LINGO3 was
expressed on mucosal epithelia in the vicinity of goblet cell derived TFF2.
TFF2 weakly interacts with LINGO3.
We postulated that if TFF2 interacted with LINGO3, then we should be able to
demonstrate TFF2-LINGO3 localization at the cell membrane and TFF2-mediated
restitution in a LINGO3 dependent manner (Aihara et al., 2017; Dubeykovskaya et al.,
2009; Engevik et al., 2019; Hung et al., 2018). To determine if TFF2 and LINGO3 would
interact at the cell membrane, flow cytometry was used to establish whether overexpression of LINGO3-GFP, LINGO2-GFP, or CXCR4-GFP fusion constructs transfected
into HEK293 cells would allow binding to soluble, recombinant (r)TFF2 (TFF2-647), Ctrl
Ig (IgG-647), or rSDF-1 (SDF-1-647) (Fig. 2.3a-b). Data show a 6-10 fold higher
frequency of TFF2-647-bound to LINGO3-GFP transfectants than TFF2-LINGO2
transfectants or TFF2-CXCR4 transfectants, respectively (Fig. 2.3c-f). There was
negligible binding with IgG-LINGO3 control. The frequency of TFF2-bound LINGO3GFP transfectants was slightly lower than the frequency of double positive SDF-1-647
CXCR4-GFP cells, which had the highest frequency of binding in this assay as expected
for a known receptor-ligand interaction (Fig. 2.3g). As an alternative approach, coimmunoprecipitation experiments were performed to test whether Flag-tagged LINGO3
would bind to affinity-purified TFF2-Fc-fusion protein (Fig. 2.3h). To do this, CHO cells
were transfected with either empty vector or Flag-tagged LINGO3 for 72hrs, lysed and
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complexed with soluble Fc or TFF2-Fc followed by protein G pulldown and
immunoblotting against the Flag epitope. A moderate signal was detected in the TFF2LINGO3 sample, but not with Fc only, indicating a weak interaction (Fig. 2.3i-j). We
reasoned that if TFF2 mediated signals required LINGO3, then Lingo3 deficient epithelial
monolayers should be deficient in restitution, a hallmark of TFF biological activity
(Engevik et al., 2019; Hung et al., 2018; Meyer zum Buschenfelde et al., 2006). Therefore,
WT and Lingo3 KO monolayers of primary sinonasal epithelial cells grown under airliquid interface conditions were subjected to scratch wound assays ±rTFF2 (Lee et al.,
2014) (DePoortere et al., 2013). Changes in initial trans-epithelial electrical resistance
(TEER) values were used to evaluate differences in barrier integrity. After the scratch,
TEER rebound values in rTFF2-treated WT cultures were significantly increased, but there
was no impact on Lingo3 KO epithelia (Fig. 2.3k). These data indicated TFF2 promoted
barrier restoration in a LINGO3 dependent manner.
Lingo3 deficiency increases TH1 cell frequency and disrupts mucosal barrier
integrity.
Mucosal epithelia and microbial communities are in a bi-directional
communicative circuit, with perturbations on either side resulting in inflammationassociated tissue pathology (Nowarski et al., 2015; Thiemann et al., 2017). To test whether
Lingo3 deficiency could potentially disrupt intestinal barrier integrity in vivo, cohorts of
WT and Lingo3 KO mice were orally inoculated with 440mg/kg of FITC-dextran (4 kDa)
and serum levels of fluorescence were measured as a surrogate for paracellular intestinal
permeability (Joly Condette et al., 2014; Patel et al., 2012; Wang et al., 2015; Woting and
Blaut, 2018). Strikingly, Lingo3 KO mice had 3-fold greater FITC-dextran levels than WT
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controls (Fig. 2.4a). To evaluate the intestinal microbiome, microbial composition of fecal
pellets collected from naïve WT and Lingo3 KO mice were analyzed using 16S rRNA gene
sequencing. There was a moderate change in microbial composition between strains (Fig.
2.5a), but there were no overt pathophysiological or obvious histological differences in
colon or small intestine tissues between strains at 6-9 weeks old (Fig. 2.4b and Fig. 2.5bc). There was no evidence of colon shortening in naïve Lingo3 KO mice (Fig. 2.5d).
We surmised that basally impaired barrier integrity in Lingo3 KO mice would lead
to bacterial translocation. Indeed, serum endotoxin levels were 3-fold higher in Lingo3 KO
mice compared to WT (Fig. 2.5e). Because increased endotoxin levels can initiate
inflammation, we used flow cytometry to quantify different myeloid antigen presenting
cell (APC) populations (macrophages (M Ø) and dendritic cells (DC)) within mesenteric
lymph nodes (MLN) of WT vs. Lingo3 KO mice (Fig. 2.6a). There was a statistically
significant increase in the number of CD11c+ MHCII+ (activated DC) cells within Lingo3
KO mice compared to co-housed WT (Fig. 2.4c-d). Within the activated DC pool, the
number, of CD103+XCR1+, XCR1+CD103-, and XCR1-CD103-SIRPa+ cell subsets, were
all significantly increased in Lingo3 KO mice as compared to WT (Fig. 2.4e- j). This was
interesting since XCR1+CD103+ and SIRPa+ are known markers for conventional dendritic
cell type 1 and type 2 (cDC1 and cDC2), respectively (Guilliams et al., 2016). There were
no differences in CD103+XCR1- DC or CD64+ tissue M Ø (Fig. 2.6b-g).
Because the CD103+XCR1+ (cDC1) subset can drive Type 1 immune responses we
also evaluated the frequency and number of activated/effector TH1 cells defined by CD44
expression and intracellular staining for IFNγ and TNF (Fig. 2.6h) (Guan et al., 2009;
Harpur et al., 2019). Both IFN-γ+ and TNF+ frequencies within MLN CD4+
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effector/memory (CD44HI CD62LLO) and central memory (CD44HI CD62HI) populations
were significantly higher in Lingo3 KO as compared to WT (Fig. 2.4k-m). IFNγ+TNF+
CD4+T cells within the colon lamina propria were also significantly increased in Lingo3
KO compared to WT (Fig. 2.4n). There were no differences between strains in the
CD44LOCD62LHI naïve CD4+ T cell gate (data not shown). No differences were observed
in effector/memory CD8+ T cells (data not shown). This indicated that Lingo3 deficiency
increased Type 1 immune responses within the large intestine and regional lymph nodes
under steady-state conditions.
Lingo3 KO mice have micro-anatomical defects in the adherens junction region of
intestinal epithelial cells.
Endotoxin leakage from the gut indicated potential defects in IEC cell-cell
adhesion. Transmission electron microscopy (TEM) was used to evaluate IEC junctional
regions under steady-state conditions. As expected, WT IECs within jejunum and colon
displayed closely apposed junctional regions with a clearly evident apical junction
complex. In contrast, IECs of Lingo3 KO mice displayed aberrantly wide and disordered
junctional spaces consistent with defective IEC barrier capability (Fig. 2.7a-b). Consistent
with this hypothesis, quantification of Cdh1(E-cadherin) mRNA transcript levels revealed
significantly decreased Cdh1 transcripts in Lingo3 KO colons compared to WT controls
(Fig. 2.7c ). Because E-cadherin is known to bind and interact with integrin alpha e (CD103
encoded by Itgae), an integrin expressed on both epithelial cells and dendritic cells
(Schlickum et al., 2008; Van den Bossche et al., 2012), we also measured Itgae mRNA
transcripts, revealing that Lingo3 deficiency also reduced Itgae levels (Fig. 2.7d).
Strikingly, E-cadherin protein levels in colon tissue were markedly reduced in Lingo3 KO
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compared to WT as determined by western blotting (Fig 2.7e-f). Together, this indicated
that Lingo3 deficiency in mice significantly disrupted efficient IEC barrier function.
Lingo3 KO mice have enhanced sensitivity to DSS induced colitis and epithelial
intrinsic defect in intestinal stem cell gene expression.
Given these basal defects in structural integrity and mild inflammatory cell
activation caused by Lingo3 deficiency under steady-state conditions, we next asked
whether these animals had increased susceptibility to DSS-colitis or defects in the healing
response following cessation of DSS treatment (Rani et al., 2011). Age-matched, cohoused cohorts of WT and Lingo3 KO mice were administered 2.5% DSS ad libitum in the
drinking water over 6 days, then returned to normal drinking water and monitored for an
additional 4 days for weight change and disease activity index (DAI) to study the early
recovery phase. While on DSS (day 0-5) there were no significant differences in weight
change, DAI score, or histological appearance between Lingo3 KO and WT mice. In
contrast, starting on day 6 when DSS was removed, Lingo3 KO mice began to show
histological signs of worsened disease, albeit not statistically significant (Fig. 2.8a-j).
During the healing phase following the cessation of DSS treatment, Lingo3 KO mice failed
to regain body weight (Fig. 2.9a, Fig. 2.10a) and had increased DAI scores compared to
WT mice that gained weight and decreased their DAI scores (Fig. 2.9b). Colon lengths
were shorter in Lingo3 KO mice compared to WT on day 10 (Fig. 2.9c). Furthermore,
Lingo3 KO mice had worsened pathology as determined by histological evaluation on day
10 (Fig. 2.9d-e).
Additionally, we used periodic acid Schiff base (PAS) staining to identify mucin
positive goblet cells in the colon following DSS treatment as proxy for stem cell niche
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output. Although 4 days was sufficient time for WT mice to re-populate their colonic goblet
cells, Lingo3 KO mice had persistent defects, with few sparse patches of goblet cells (Fig.
2.9e-f). Consistent with a defect in stem cell output, mRNA expression for leucine-rich
repeat-containing G-protein coupled receptor 5 (Lgr5), an IEC stem cell gene necessary
for colonic recovery from DSS treatment (Koo and Clevers, 2014), was significantly lower
in Lingo3 KO mice as compared to WT under both basal and post-DSS treatment
conditions (Fig. 2.10b).
To address whether Lingo3 deficiency caused an intrinsic defect of intestinal stem
cell (ISC) activity apart from the collateral damage due to cell-cell adhesion defects,
enhanced inflammation, and Type 1 cytokines, we used an intestinal organoid in vitro
culture system (Sato et al., 2009). First, small intestinal organoids were grown over 7 days
and evaluated for budding and overall size as surrogate indicators of ISC activity (Fig.
2.11a). Both Lingo3 KO and Tff2 KO mice had a 2-4 fold defect in overall organoid
budding as well as a decrease in size (Fig. 2.11b-c, Fig. 2.10c-d). Congruent with this
interpretation, Lgr5 mRNA expression levels in Lingo3 KO and Tff2 KO organoids were
significantly lower than WT (Fig. 2.11d). Lingo3 KO organoids had decreased Tff2
expression levels, while Tff2 KO organoids had an additional decrease in Tff3 expression
(Fig. 2.10e). Second, when we evaluated colonic organoids grown over 7 days, we
observed that while Lingo3 KO organoids had increased budding compared to WT, Tff2
KO organoids had no difference relative to WT (Fig. 2.10f , Fig. 2.11e-f). Interestingly,
however, over 7 days of culture, both Lingo3 KO and Tff2 KO organoids had a loss in the
3D architecture and instead became flattened and 2D when compared to WT organoids
(Fig. 2.10g, Fig 2.11e, g). This flattened appearance is consistent with epithelial-
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mesenchymal transition (EMT) state and loss of organoid 3-D architecture (Bates and
Mercurio, 2003; Hahn et al., 2017; Onozato et al., 2018; Wendt et al., 2011). These data
demonstrate that both small intestinal and colonic organoids from Lingo3 KO and Tff2 KO
mice have a dysregulation in organoid budding and growth.
Therapeutic TFF2 administration promotes tissue recovery through LINGO3
Lastly, to establish whether TFF2 would heal damaged colonic mucosa in a manner
dependent upon LINGO3, we asked whether therapeutic administration of the TFF2-Fc
fusion protein would show any protective efficacy in DSS-treated WT and Lingo3 KO
mice. Cohorts of each strain were i.p administered 150 ng of TFF2-Fc or Fc alone on days
3, 6, and 9 following 2.5% DSS administration (Fig.2.10h). In WT DSS-treated mice,
TFF2-Fc accelerated weight recovery, reduced DAI scores and increased colon length
compared to Fc alone treatment, but none of these parameters were different between
TFF2-Fc vs. Fc alone-treated Lingo3 KO mice (Fig. 2.12a-c). Histological evaluation of
colon tissue at day 10 post-DSS administration revealed that TFF2-Fc treated WT mice
displayed goblet cell-rich, crypt architecture, reduced immune cell infiltration and reduced
ulcerative foci compared to WT-Fc, Lingo3 KO-TFF2-Fc or Lingo3 KO-Fc groups (Fig.
2.12d-g).
Lastly, we used immunohistochemistry to determine which, if any of the known
target proteins for TFF2-mediated signaling events were LINGO3 dependent. Since TFF2
induces MAPK signaling (Dubeykovskaya et al., 2009; Engevik et al., 2019; Orime et al.,
2013), we first assessed anti-pERK1/2 mAb staining in colon biopsies. TFF2-Fc treatment
significantly increased the numbers of pERK1/2 positive cells in DSS-treated colitic WT
mice. This response was blunted in Lingo3 KO mice treated with TFF2-Fc compared to
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their matched Fc alone controls (Fig. 2.12f-h). Second, phosphorylated STAT3 (p-STAT3)
levels were evaluated due to its role in TFF signaling (Le et al., 2016; Pickert et al., 2009;
Wu et al., 2016). WT mice treated with TFF2-Fc had statistically significantly decreased
p-STAT3 levels compared to WT-Fc treated mice within intestinal epithelial cells.
However, TFF2-Fc treatment did not change p-STAT3 levels in Lingo3 KO mice (Fig
2.13a-b). Interestingly, Lingo3 KO mice had significantly fewer p-STAT3+ IEC cells
compared to WT Fc-treated animals (Fig. 2.13a-b). Third, evaluation of another TFF target
protein, b-catenin, showed TFF2-Fc caused a statistically significant decrease in b -catenin
staining compared to WT-Fc and both Lingo3 KO groups, but TFF2 did not seem to have
an effect in Lingo3 KO mice (Fig. 2.13c-d). Consistent with this, staining for the S-phase
protein Ki-67 was also reduced by TFF2 treatment in a LINGO3-dependent manner (Fig
2.13e-f). Lastly, we used cleaved caspase 3 immunostaining to evaluate apoptotic cell
frequency among these groups. Data show TFF2 treatment did not change the number of
cleaved caspase 3+ cells in WT mice, but there was more cleaved caspase 3+ cells in Lingo3
KO tissues as compared to WT groups (Fig. 2.13g-h). Taken together, these data
demonstrate that TFF2 accelerated colonic tissue recovery and this was associated with
LINGO3 dependent MAPK activation, but LINGO3 dependent decrease in STAT3 and catenin activation was TFF2 independent. Lingo3 deficiency increased IEC apoptosis
irrespective of TFF2 treatment.
DISCUSSION
Our study provides evidence that the transmembrane protein LINGO3 serves a
critical role in IEC biology under homeostatic conditions and promotes repair during DSSinduced colitis. IEC selectively express LINGO3 in the vicinity of TFF2-expressing goblet
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cells and therapeutic administration of TFF2 heals the damaged colonic mucosa in a
mechanism dependent upon LINGO3. This finding is significant because it is the first
demonstration of a critical protein that functions downstream of TFF2, the latter of which
is known to promote epithelial cell proliferation, survival, and restitution at mucosal barrier
sites including the ocular, GI and respiratory tract (Hoffmann, 2005; Hung et al., 2018;
Judd et al., 2015; Kurt-Jones et al., 2007; Wills-Karp et al., 2012;

Xue et al., 2010).

LINGO3 has no other known function(s) reported to date, therefore our data provide a new
avenue for understanding how TFF2 mediates wound healing and epithelial cell barrier
function at the mucosal interface. In human tissues, LINGO3 was constitutively expressed
on mucosal epithelia lining the sigmoid colon and turbinate sinuses of the upper airway. In
mice, loss of function studies revealed basally increased inflammation, defective
expression of the cell adhesion molecule E-cadherin and defects in colonic tissue
regeneration post-acute tissue injury caused during DSS-colitis. Because the ability of
TFF2 to modulate the abundance of signal transduction proteins was only partially
LINGO3-dependent, it is likely that there are one or more receptor components necessary
for TFF2 responsiveness that remain un-identified.
Pursuit of novel candidate TFF receptor(s) led us to employ TRICEPs technology
created for identification of low-affinity protein interactions with glycosylated cell- surface
receptors (Frei et al., 2012; Frei et al., 2013). That initiative led us to investigate LINGO3.
LINGO3 is a 166 AA single pass transmembrane protein with 11 leucine repeats, 8 Nlinked glycosylation sites, a single disulfide bond, and a short cytoplasmic tail containing
2 serine’s and a single tyrosine (https://www.uniprot.org/uniprot/ Q6GQU6). Although
several reports have suggested that CXCR4, serves as a low affinity receptor for TFF2
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(Dubeykovskaya et al., 2009), those studies largely rely upon the CXCR4 antagonist
AMD3100. There are no data that have demonstrated direct binding between TFF2 and
CXCR4, CXCR4-dependent TFF2 signaling in vivo, or that Cxcr4 deficient mice
phenocopy any aspect of Tff2 deficiency such as impaired barrier integrity, basal Type 1
inflammation, or defects in the gastric compartment (Farrell et al., 2002; McBerry et al.,
2012). Although TFF2-LINGO3 only weakly interact as determined by flow cytometry
and immunoprecipitation assays, the Lingo3 KO mice that we generated clearly indicate
defects in IEC-expression of E- cadherin, basal endotoxemia, enhanced mucosal Type 1
inflammation, and disease exacerbation during DSS-colitis. Strikingly, these are the
reported features of Tff2 KO mice (Judd et al., 2015; McBerry et al., 2012). Further, TFF2mediated healing following DSS including weight recovery and ERK1/2 activation were
LINGO3 dependent. However, Lingo3 deficiency on its own resulted in other deficiencies
such as STAT3 activation and the number of IEC actively in S-phase during the wound
healing phase post-DSS colitis. Decreased p-STAT3 is consistent with our finding that
TFF2-Fc treatment decreases inflammation in WT DSS mice. Interestingly, both ERK1/2
and JAK/STAT3 signaling have been implicated in downstream of Trefoil signaling
(Dubeykovskaya et al., 2009; Engevik et al., 2019; Orime et al., 2013). While we cannot
rule out the possibility that TFF2 responsiveness additionally involves CXCR4 (or other
transmembrane signaling proteins), these data show that LINGO3 serves multiple roles
within the GI tract during homeostasis and tissue repair.
Tight junction complexes between epithelial cells at mucosal interfaces regulate
paracellular permeability (Campbell et al., 2017). EM photomicrographs show a striking
abnormal architecture in the Lingo3 KO IEC adherens junctional space, a region primarily
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comprised of E-cadherin-CD103 complexes (Campbell et al., 2017). Indeed, reduced Cdh1
and Itgae mRNA transcript levels as well as reduced protein levels of E-cadherin in Lingo3
KO mice suggest that these genes require LINGO3 activity through unknown mechanisms.
TFF2 administration did not induce Cdh1 or Itgae expression (data not shown), thus it is
likely that LINGO3 acts with other components to facilitate TFF2 responsiveness
biologically similar to LINGO1 signaling requirements that involve a tri-molecular
complex including TNFSF19/TROY and nogo-66 receptor/nogo receptor 1 (NgR) (Saha
et al., 2014; Satoh et al., 2007). LINGO1 is similar in structure to LGR4, a leucine rich
repeat type 2 family receptor, which binds to R-spondin and signals through WNT proteins,
a necessary signaling pathway for maintenance of intestinal stem cells (Xu et al., 2013).
Given the amino acid sequence homology between LINGO3 and LGR4, it is possible that
LGR4 may also be a component of the TFF2-LINGO3 signaling pathway. In fact, the
defective expression of Lgr5, coincident with the marked dysregulation of intestinal
organoid growth and delayed restoration of goblet cell expansion post-DSS mediated
injury, make it tempting to speculate that LINGO3 is somehow involved in regulation of
intestinal stem cell activity.
Although, we were unable to directly detect mouse LINGO3 in gut tissues due to
the lack of validated anti-mouse LINGO3 Ab, we did note that human LINGO3
immunostaining localized to enterocytes and cells within the crypt base where ISC
progenitors are found including Lgr5+ cells (Koo and Clevers, 2014; Sato et al., 2009).
Following crypt irradiation, Lgr5+ stem cells respond to intestinal damage by repopulating
the intestine (Andersson-Rolf et al., 2017; Chang et al., 2016; Koo and Clevers, 2014).
TFF2 administration promoted growth of gastric organoids through EGFR signaling
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(Engevik et al., 2019) making it possible that the defects observed in Tff2-and Lingo3
deficient intestinal organoids were somehow due to impaired EGFR activation.
Alternatively, tight junction complexes are necessary for crypt formation therefore it is also
possible that the defect in E-cadherin-CD103 complexes observed in Lingo3 KO and Tff2
KO organoids was responsible for the EMT phenotype resulting in the spontaneous
transition from 3D to 2D architecture (Onozato et al., 2018; Sato and Clevers, 2013).
Defects in EMT are linked to cancer metastasis (Wendt et al., 2011). Given the defect in
E-cadherin-CD103 complexes, the transition of Lingo3 KO and Tff2 KO organoids from
3D to 2D, and the increased inflammation in naïve Lingo3 KO and Tff2 KO mice implicates
a potential role of Lingo3-TFF2 colitis associated cancers and metastasis. This is further
supported by previous reports which have demonstrated that TFF2 could be a putative
colorectal cancer treatment (Dubeykovskaya et al., 2019).
Overall, this is the first report, to our knowledge demonstrating that the orphan
transmembrane type 1 receptor LINGO3, serves a critical role in GI homeostasis and
wound healing following DSS-mediated colitis. LINGO3 partially controls TFF2
responsiveness for MAPK signaling and mucosal tissue repair, and clearly deserves further
investigation as a potential therapeutic target in human patients with various forms of
inflammatory bowel disease.
Methods
Key Resource Table
Reagent Type
(Species of
Designation
resource)

Source
of reference

Identifiers

Additional
Information
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Genetic
reagent
(M. Lingo3 KO
musculus)

This Paper

C57Bl/6

Genetic reagent
Tff 2 KO
(M. Musculus)

This Paper

C57Bl/6

230-30028-10

1 ng/µL (DSS)
20µg (CO-IP)

Santa Cruz
Biotechnology

SC-247444

1:100

Peprotech

500-P312

1:100-1:250

e-bioscience

14-324982

1:250

Antibody

Anti-mouse
b-actin

Santa
Cruz
Biotechnology

47778

1:2000

Antibody

Recombinant
Murine TFF2

Peprotech

315-30

3 µg

Antibody

Antibody
Antibody
Antibody

Antibody
Primer
Primer

Recombinant mouse
Ray biotech
TFF2-Fc
Anti-human
LINGO3
Anti-human
TFF2
Anti-mouse
E-cadherin

Recombinant
mouse
CXCL12/SDF1a
TaqMan Probe
HPRT
TaqMan Probe
Lingo3

R & D Systems
ThermoFisher
ThermoFisher

460-SD-050
Mm00446968
Mm01178145

Primer
Primer

Reverse
mouse Lingo3

This Paper

FITC-Dextran

Sigma Aldrich

FD4

Origene

MR209193

Commercial
Reagent

Lingo3
Genetic reagent Mouse Tagged
ORF clone

1 µL
1 µL

5’ GCA CTT
GCT GCT GCT
1µL
GCC 3’
5’ CTC GGG
GAT GGC TGT
1 µL
CAG 3’

Forward
mouse Lingo3

This Paper

3 µg

44 mg/ 100g
24 µg

Mice. All animal procedures were approved by the Institutional Animal Care and
Use Committee at University of California, San Francisco. WT and Tff2 KO C57BL6 mice
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were bred in house. Super-ovulated female C57BL/6 mice (4 weeks old) were mated to
C57BL/6 stud males. Fertilized zygotes were collected from oviducts and injected with
Cas9 protein (30 ng/ul), sgRNA (15 ng/ul) into pronucleus of fertilized zygotes. Injected
zygotes were implanted into oviducts of pseudo pregnant CD1 female mice. Animals were
housed under specific-pathogen free barriers in vivarium at San Francisco General Hospital
or University of Pennsylvania. All procedures were reviewed and approved by IACUC at
University of California at San Francisco (protocol #AN109782-01) and University of
Pennsylvania (protocol #805911).
Single Nucleotide Polymorphism (SNP) analysis: SNP analysis was performed
using DARTmouse. Tails were cut from Lingo3 KO mice (1 male breeder, 1 female
breeder, 1 male pup, and 1 female pup) and sent to DARTmouse which performed analysis
on 5307 SNPs across all chromosomes in C57BL/6 WT mice and provided Lingo3 KO
mice.
Dextran sodium sulfate (DSS) model. All experiments used six to ten-week-old
wildtype (WT) or Lingo3 KO C57BL/6 female mice bred in house and cohoused for four
weeks. Colitis was induced using 2.5% Dextran Sulfate Sodium Salt (w/v, 0216011080,
MP-Biomedicals LLC Solon, OH) in autoclaved drinking water for 6 days. Fresh solution
was provided on day 3, on day 6 mice were returned to normal water and monitored until
necropsy. For TFF2 treatment, mice were administered either 150 ng of TFF2-Fc (1ng/µL)
or Fc (1 ng/µL) via intraperitoneal injection on Day 3, 6, 9 post 2.5% DSS treatment. Body
weight, appearance, fecal occult blood (Fisherbrand™ Sure-Vue™ Fecal Occult Blood
Slide Test System, ThermoFisher Scientific, Inc., Waltham, MA, USA), stool consistency,
and diarrhea were recorded daily from tattooed animals. Colon length was determined at
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necropsy. Disease activity index (DAI) a cumulative score with a maximum of 12, was
derived as follows: every mouse was assigned a score of 1 Vs 0 for each display of lack of
grooming, piloerection, awkward gait, hunched posture, and lack of mobility. Diarrhea
score (0 Normal stool, 1 soft stool, 2 loose formed stools, and 3 watery fecal matter), Rectal
Bleeding was scored as 0 no blood, 1 minor bleeding, and 2 gross rectal bleeding). Fecal
occult blood test was scored as 0 Negative, 1 Mild amount of blood, and 2 excessive
presence of blood. H&E were evaluated by a clinical pathologist at the veterinary
comparative pathothology core at the University of Pennsylvania following DSS
administration and following DSS administration +/- TFF2-Fc or Fc treatment.
Histopathological analysis has been focused on assessing the chronic mucosal changes
(inflammatory and proliferative) of the mid and distal colorectal tract present in each
sample. In some samples, the pathological picture was very heterogeneous combining
severe ulcerative lesions with nearly normal mucosal segments. This finding reflects the
typical multifocal nature of the ulcerative and inflammatory lesions induced by repeated
DSS administration. The extensive loss of mucosal glands observed in some of the samples
precluded in part the evaluation of pathological changes specifically affecting the mucosal
crypts including inflammation and hyperplasia. pERK1/2 (CST #4370), Caspase-3 (CST
#9661), p-STAT3 (CST #9145S), b-catenin (CST #9582), and Ki-67 (Thermo Scientific
RM-9106-S) immunohistochemistry staining was performed by the comparative pathology
core at the University of Pennsylvania. For quantification of b-catenin the region of interest
was outlined and % Threshold area was measured using MetaMorph microscopy
automation and image analysis software. All images were normalized using a standard set
for hue, saturation, and intensity (72,255,255, respectively).
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Co-immunoprecipitation. 2.4 × 106 CHO cells were transfected with 24

g

pCMV6:Lingo3: Flag (MR209193, Origene) or pCMV6 entry plasmids. After incubation
of the transfection mixture with the cells for 60 h, the cells were washed twice with PBS
and lysed with 300 µL digitonin extraction buffer [1% digitonin; 150 mM NaCl; 1 mM
MgCl2; 10 mM TrisHCl, pH 7.4, 1X Proteinase Inhibitor (Pierce), 1mM PMSF]. The
protein concentration was measured using BCA assay kit (Invitrogen). Around 0.6 mg total
protein was mixed with 20 µg purified TFF2-Fc (Ray Biotech) or Fc (Ray Biotech) and
precleared with control agarose resin for 1 hr at 4°C. The lysate samples were then
precipitated with 40 µl protein A/G agarose (Invitrogen) overnight at 4°C. The
immunoprecipitation (IP) complex was washed with TBS for 5 times and eluted with 4×
SDS loading buffer at 95°C. The IP elutes along with whole cell lysates were
immunoblotted with rabbit anti-FLAG (1:400) followed by incubation with goat anti-rabbit
IgG Cy5 (1:1000). TFF2-Fc and Fc were generated by transfecting HEK293 cells (500 mL)
with MaxiPrep extracted plasmid DNA. After 3 days post transfection, the cell culture
medium was collected for protein G affinity purification.
Human tissue and immunostaining. Archived rectosigmoid biopsy samples were
from the SCOPE cohort at the University of California, San Francisco (UCSF). The UCSF
Committee on Human Research reviewed and approved the SCOPE study (IRB# 1001218), all participants provided written informed consent. Using this cohort, archived gut
biopsies and plasma samples were selected from HIV-negative participants. Prior to
sigmoidoscopy and gastrointestinal biopsy, study participants underwent a blood draw and
received a Fleet enema. Rectosigmoid biopsies were obtained by sigmoidoscopy 10-30 cm
from the anal verge. Human sinonasal polyp samples were obtained from patients
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undergoing sinonasal surgery for the management of their chronic rhinosinusitis with
informed consent and full approval of the University of Pennsylvania Institutional Review
Board (Protocol #800614). Tissue sections from Human sinonasal polyps and Human
Rectosigmoid (normal) were fixed in formalin and paraffin embedded. The sections were
then deparaffinized and antigen was retrieved using an electric pressure cooker (Nesco
PC6-25P) in a low-pH Citrate Buffer. The slides were then incubated and stained with the
following primary Antibodies: anti-LINGO3 Ab was raised against Goat (Santa Cruz sc247444) and anti-TFF2 raised against Rabbit (Peprotech: 500-P312) were used to detect
the LINGO3 and TFF2 interactions in situ. Primary antibodies were then followed by
incubation with the Alexa Fluor series of secondary antibodies (AffiniPure F(ab')₂
Fragment Donkey Anti-Mouse IgG, AffiniPure F(ab')₂ Fragment Donkey Anti-Rabbit IgG,
AffiniPure

F(ab')₂

Fragment

Donkey

Anti-Goat

IgG)

supplied

by

Jackson

ImmunoResearch. Detection of fluorescence was observed under Cy2, Cy3, and Cy5 filters
on a Leica Inverted Microscope DMi8 S Platform and a Leica DM6000B microscope with
an automated stage coupled with a Leica DFC350FX camera. We normalized exposure
times and fluorescence intensities to appropriate control images. We photographed
fluorescent channels separately, merged them together and overlaid them atop the
corresponding images.
Western Blotting. Distal colon tissue was isolated from WT and Lingo3 KO
C57BL6 mice and lysed in Schlessing buffer (50 mM HEPES, 50 mM NaCl, 10% glycerol,
1% Triton X-100, 1mM EDTA, 10 nM sodium pyrophosphate, Roche proteinase inhibitor
(1 tablet in 7mL buffer), Roche phosphatase inhibitor (1:1000 dilution). Tissue was
homogenized and centrifuged at full speed for 5 minutes, lysates were collected. Protein
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concentration was measured using Pierce BCA protein Assay Kit (ThermoFisher #23225)
and absorbance was read at 562 nm using Synergy 2 microplate reader and the Gen 5.0
Software (BioTek). 10µg of protein lysates + 5µL of 5X protein sample buffer (125 mM
Tris, pH6.8, 10% SDS, 50% Glycerol, Water, 0.06% Bromophenol blue, 1% bmercaptoethanol) + H20, for a final volume of 25µl was added to a Nupage 4-12% bis-tris
PAGE protein gel. The gel was run for 40 minutes at 200v in 1X Nupage MOPS SDS
running buffer. The gel was then transferred using a PVDF membrane and Transfer buffer
(2.42 g Tris Base, 10.80 g Glycine, 100 mL Methanol, 900 mL Deionized H20) for 1 hour
and 10 minutes at 30v. Post transfer, membranes were blocked using 5% TBS-T for 1 hour.
Primary antibodies were stained overnight at 4C. E-cadherin (ebioscience #14-324982)
was used at a 1:250 dilution and -actin (Santa Cruz 47778) was used at a 1:2000 dilution.
The following day membranes were washed 3X in TBST for 5 minutes and then stained
with secondary antibodies (a-rat IgG 1:2000 (Jackson Immunoresearch #112-036-068),
and (a-mouse IgG 1:2000 (CST #7076s)). Pierce ECL western blotting substrate
(ThermoFisher #32106) was used to develop the membranes. Image Lab Software 6.0.1
was used to take a picture of the membranes.
Soluble ligand binding assay. Purified murine IgG (Ray Biotech), murine recombinant
TFF2 (Peprotech) and SDF1a (R&D systems) were labeled with Alexa Fluor 647 dye using
the Alexa Fluor 647 protein labeling kit (A30009, Molecular Probes) per manufacturer’s
directions. HEK293 cells were maintained in DMEM medium (Invitrogen) supplemented
with 10% fetal bovine serum (Invitrogen) and 1% penicillin- streptomycin (Invitrogen) at
37ºC with 5% CO2. HEK293 cells were seeded at 1 x 106/well and incubated at 37ºC with
5% CO2 overnight before transfection with 3ug of plasmids pCMV3-mLINGO3-GFP,
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pCMV3-mLINGO2-GFP or 6ug of pCMV3- mCXCR4-GFP using FuGENE HD DNA
transfection reagent (Promega) based on manufacturer’s instructions. 24h post transfection,
cells were incubated with either PBS or 3µg of Alexa Fluor 647 labeled soluble ligands for
3h at 4ºC. Cells expressing GFP and Alexa Fluor 647 positive were identified by flow
cytometry.
Transmission electron microscopy. 2-mm length mouse distal colon and jejunum
was dissected and immersed in the primary fixative buffer (2% Paraformaldehyde, 2.5%
Glutaraldehyde, and 0.05% Ruthenium Red in a 0.2M Cacodylate Buffer) overnight at 4
°C and then washed with 0.1M Cacodylate Buffer. Then, the sample was post fixed with
2% aqueous OsO4, 0.05% Ruthenium Red in 0.2 M Cacodylate Buffer for 2 hours and
washed 0.1 M Cacodylate Buffer wash. The sample was dehydrated with 50%, 70%, 80%,
90%, 95% and 100% ethanol sequentially. After that, the sample was embedded with Epon
812 and cured for 48 hours in a 60°C oven.
Finally, ultra-thin sections (~70nm) of the sample was taken and stained with uranyl acetate
for 4 min and lead citrate for 2 min. The sample was studied by using JEOL USA
Transmission Electron Microscope.
16S rRNA gene sequencing. Genomic DNA was extracted from fecal pellets of
mice using Qiagen DNeasy PowerSoil Kit. The V4 region of the 16S rRNA gene was
amplified using barcoded primers for use on the Illumina platform (Jasarevic et al., 2018;
Kozich et al., 2013). Sequencing was performed using 250-base paired-end chemistry on
an Illumina MiSeq instrument. QIIME v. 1.8 (Caporaso et al., 2010) was used to process
paired-end reads and to perform downstream analyses including taxonomy assignment and
heat map generation.
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Histological staining. Colon tissue was either opened longitudinally, flushed with
ice-cold PBS to remove feces and formalin fixed as “swiss rolls” or 1-2 cm of the distal
colon. Colon tissues were stained with hematoxylin and eosin (H&E), periodic acid Schiff
stain (PAS). 1-2 cm of Jejunum tissue was formalin fixed. Jejunum was stained with PAS.
A Leica widefield microscope was used for imaging. A clinical pathologist evaluated H&E
colon slides.
Quantitative RT-PCR. For intestinal epithelial cell isolation, colons and small
intestines were dissected from WT and Lingo3 KO mice and cut open longitudinally.
Intestines were washed 3X in Hank’s Buffered Saline Solution (HBSS) containing 5mM
EDTA+ 2.5mM DTT for 10 mins shaking at 37C. Following 10min incubation intestines
were vigorously shaken by hand using forceps, epithelial cell fraction was collected.
Following 3X washes epithelial fractions were spun down at 1500 RPM for 5 min, and
supernatants were aspirated. Cell pellets were then resuspended in 10 mL HBSS and
filtered through a 70 micron strainer and centrifuged for 5 minutes at 1500 RPM. Cells
pellets were resuspended in 1 mL HBSS and filtered through a 40 micron strainer
centrifuged at 1500 RPM for 10 mins. For CD4+ cells, B220+ cells, CD11b+CD11c+ cell
isolation spleens and MLN were pooled and homogenized from WT and Lingo3 KO mice.
Cells were positively selected for CD4, B220, or a pool of CD11b/CD11c using
Microbeads sorts (Miltenyi Biotec #130-108-338, 130-049-601, 130-049-201, 130-049501). For bone marrow isolation, isolated femurs from WT and Lingo3 KO mice were
crushed using mortar and pestle and passed through a cellular strainer to separate cells from
bone and muscle debris. Cells were then centrifuged at 2000 rpm for 5 min. at 4C.
Supernatant was removed, and cells were resuspended in 7 mL of DMEM media and
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layered on top of Histopaque. Cells were then centrifuged at 2000 RPM for 20 min. at low
breaking. Following centrifugation, the cell layer was collected and resuspended in equal
volume of media and centrifuged at 1500 RPM for 5 min. Following centrifugation RNA
was purified from cell subsets. RNA was purified from cell subsets (intestinal epithelial
cells, CD4+ cells, B220+ cells, CD11b+ cells), whole colon ileum, lung, bone marrow,
spleen , liver, heart, kidney, and brain, homogenized tissue, or organoid cultures (at day 7
of culture) using nucleospin RNA plus kit (clontech # 740984.25). cDNA was prepared
using 1µL of 100 ng Random primers (Invitrogen), 1 µg of RNA, 10 mM dNTP
(Invitrogen), and 1 µL of Maxima H Reverse Transcriptase (ThermoFisher #EP0752).
PCRs were set up in a final volume of 20 µL using 2uL DNA, 1 µL 20 µM Forward and
reverse primer, and 2X Sybr Green I Master Mix (Bio-Rad #172-5274). Gene expression
was measured using Bio-Rad CFX machine and data normalized to GAPDH and presented
as MEAN ± SEM from the replicates. For the TaqMan hybridization assays 4 µL of 300
ng cDNA was added to a master mix containing to 10 µL 2X TaqMan gene expression
master mix (Thermofisher catalog #4369016), 5µL RNase free water, and 1 µL of Lingo3
TaqMan MGB 20x probe (ThermoFisher #Mm01178145) or 1 µL of HPRT TaqMan MGB
20x probe (ThermoFisher #Mm00446968), for a final volume of 20 µL. Data was
normalized to HPRT. For the SYBR green assays 2µL of 300 ng cDNA was added to a
master mix containing of 10 µL SYBR green assays SsoAdvanced SYBR Green (Bio-Rad
#172-5274), 1µL Lingo3 forward primer (5’ GCA CTT GCT GCT GCT GCC 3’), 1µL
Lingo3 Reverse primer (5’ CTC GGG GAT GGC TGT CAG 3’), 6µL RNase Free water,
for a final volume of 20 µL. Data was normalized to GAPDH. All real-time PCR reactions
were carried out on Bio-Rad CFX96 system and data were analyzed using the ΔΔCt method
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as recommended in the manual.
Flow Cytometry. MLN was dissected from WT and Lingo3 KO mice,
homogenized, and resuspended in 1mL of RPMI. A 5 cm portion of colon was washed
three times for 10 minutes each at 37°C in 5mM EDTA+ 2.5mM DTT for removal of
epithelial cells and mucus. In between every wash colons were washed with HBSS
containing 25mM HEPES and 2% FCS. Following epithelial and mucus removal,
intestines were minced and incubated at 37°C for 25 minutes in 7mL digestion buffer
(DMEM+2%FBS +0.05mg/mL Liberase TM +0.02 mg/mL DNase (Sigma #5401127001,
#11284932001, respectively). Post-incubation tissues were extruded through a 16-gauge
needle 10 times, further 3 mL of fresh digestion buffer was added to the digested tissue
suspension and incubated for another 20 minutes at 37°C. Post-incubation, tissues were
extruded through an 18-gauge needle ten times. 10 mL of digested tissue was spun down
1600 RPM with low brake for 7 minutes. Supernatant was removed, cells were resuspended
in 5 mL of RPMI containing 10% FBS (cRPMI) and filtered through a 40-micron strainer.
Cells were re-centrifuged at 1600 RPM for 7 minutes. Supernatant was removed and cells
were resuspended in 1 mL of cRPMI. Cell concentration was determined using the Muse
cell counter (EMD Millipore). For intracellular cytokine staining mesenteric lymph node
(MLN) cells and Lamina propria cells were stimulated (Stim) in RPMI containing
100ng/mL PMA + 1µg/mL ionomycin + 10 µg/mL brefeldin A (BFA) + monesin (1:1500
dilution) or media (Med) containing 10 µg/mL brefeldin A (BFA) + monesin (1:1500
dilution) for four hours at 37°C. Following stimulation cells were washed in PBS and
stained with the following surface markers: LiveDead Aqua CD4 APC-cy7 (Clone Gk1.5,
Biolegend #100414), CD8 PE-TexasRed (clone 5H10 ThermoFisher#MCD0817), CD44
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AF700 (clone IM7, Thermofisher 56044182) , CD62L PE-cy5 (clone MEL-14, Biolegend
104418), CD19 FITC (clone MB19-1, Thermofisher 11-0191-85), CD11b FITC (clone
M1/70,Biolegend 101206) CD11c FITC(clone N418, Thermofisher 11-0114-85, diluted in
Fc block. After surface stain, cells were washed with FACs buffer and fixed for 20 minutes.
Post fixation cells were washed with permeabilization buffer and stained overnight with
the following markers: TNF APC (Clone MP6-XT22, ThermoFisher 17- 7321-81), IFNg
PE (clone XMG1.2, Biolegend 505808). For the myeloid flow cytometry panel the
following surface markers were used: LiveDead Aqua, CD11c PE-Texas Red (Clone N418,
Thermofisher MCD11c17), CD103 BV605 (Clone 2E7, Biolegend 121433), CD64 PE/Cy7
(clone Fc RI, Biolegend 139314), Ly6c APC-Cy7 (CloneHK1.4, Biolegend #128026),
MHCII AF700 (Clone M5/114.15.2, Biolegend #107622), CX3CR1 BV785 (Clone
SA011F11, Biolegend #149029), XCR1 BV650 (clone ZET, Biolegend #148225), SIRPa
PerCP-Cy5.5 (Clone P84, Biolegend #144010), NK1.1 FITC (Clone PK136, Biolegend
#108706), CD3 FITC (Clone 17A2, Biolegend #100204), CD19 FITC(Clone MB19-1,
ThermoFisher #11-0191-82)
Evaluation of intestinal permeability. WT and Lingo3 KO C57BL6 cohoused (4
weeks) mice were fasted for 16 hours and orally gavaged with 200 µL of 44mg/100g of
4kDA fluorescein isothiocyanate dextran (FITC-dextran) (Sigma, FD4). 4hrs post
administration, mice were euthanized, and blood was collected. A standard curve was
generated from 0.1-1 mg/mL of FITC-dextran and fluorescence was measured at a
wavelength of 520 nm using Synergy 2 microplate reader and the Gen 5.0 software
(BioTek). Limulus Amebocyte Lysate (LAL) assay was performed on serum from WT and
Lingo3 KO C57BL6 cohoused (4 weeks) mice using Pierce LAL chromogenic endotoxin
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quantification kit (ThermoFisher #88282). Endotoxin levels was measured using
absorbance at 405-410 nm using Synergy 2 microplate reader and the Gen 5.0 Software
(BioTek).
Nasal ALI and intestinal organoid cultures. Primary murine nasal epithelial cells
were grown for 7 days as submerged cultures and for 2 weeks at air liquid interface in trans
wells. On day 21, monolayers were wounded in a cross pattern with a sterile pipet tip (1mm
width) and treated daily on the apical side with 10 ng/ml recombinant human TFF2
(Peprotech) or 1xPBS (Mock). Cultures were rinsed with 1X PBS prior to TEER
measurement. Serial measurements of TEER (Ohms-cm2) were taken using an EVOM
(World precision instruments) and the cup/trans well insert adapter. Crypts were isolated
from mouse small intestinal jejunum with modifications indicated (Mahe et al., 2013; Sato
et al., 2009). Briefly, the small intestines and colons of WT and Lingo3 KO mice were
removed, opened longitudinally and washed with Ca2+-Mg2+-free Hank’s balanced salt
solution (HBSS). Villi were scraped off using a coverslip under a dissecting microscope
then tissue incubated in 5mM EDTA in HBSS for 30 mins at 4ºC on an orbital shaker.
Residual villi were removed with further washing. The crypts were separated from the
basal membrane by vigorous pipetting in 0.5% BSA in HBSS and then filtered through a
70-µm cell strainer. Crypts were pelleted at 250 x g (5 min, 4ºC) and resuspended in
complete crypt culture medium (Advanced DMEM/F12 [Thermo, 12634-010], 10 mM
HEPES [IVT, 15630-080], 1x penicillin/streptomycin [IVT, 15140-122], 1x gentamycin
[Gibco, 15750-500], 1x N2 Supplement [IVT, 17502-048] , 1x B27 Supplement [IVT
17504-044], 1mM N-Acetyl-cysteine [Sigma, A9165-5g], 50ng/mL recombinant mouse
epidermal grown factor [IVT, PMG8041], 100ng/mL mNOGGIN [peprotech, 250-38],
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1µg/mL R-spondin 1 [R&D, 3474-RS-050], 5mM CHIR99021 [Stemgent 04-0004], to a
final volume of 2%). Approximately 100-300 crypts per well were then embedded in 80%
Matrigel/20% complete crypt culture media in pre-warmed 48-well flat bottom plates and
incubated for 15 min at 37ºC. Embedded enteroids were cultured in 200 µL of complete
crypt culture media added at 37ºC and 5% CO2 with media changed every 2-3 days.
Organoids were imaged using an inverted Nikon eclipse (TE2000-U) widefield microscope
at 4x, 10x, and 20 x on day 3, 5, and 7 of growth.
Statistics. Statistical analyses were performed using GraphPad Prism version 7.0
(GraphPad). A two-tailed Student’s T test or ANOVA was used where appropriate.
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Fig 2.1 LINGO3 is an orphan leucine rich repeat and Ig domain containing
receptor expressed on mucosal epithelia of mice and humans. (a) Cartoon
image of LINGO3 protein (b) Lingo3 mRNA expression in mucosal tissues at the
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Chapter 3: Lingo3 deficiency does not confer susceptibility to the enteropathogenic
bacterium, Citrobacter rodentium
Abstract
The intestinal epithelium is a complex network of cells and proteins that work in
conjunction with one another to protect against pathogenic insult or chemical injury.
However, during a pathogenic invasion, whether that be viral or bacterial, the intestinal
epithelium can become injured allowing entry of pathogens into the lamina propria, leading
to inflammatory immune responses. Citrobacter rodentium (C. rodentium) is a Gramnegative attaching and effacing bacterium that infects rodents through attachment to
intestinal epithelial cells. Although much is known about how C. rodentium infects host
cells and the immune response it induces within the host, it is not well understood the
necessary signaling pathways and proteins required to prevent infection. Herein, we have
identified a novel receptor, LINGO3, which regulates barrier integrity and tissue repair
during colitis. Because of LINGO3’s role in protection against colitis, we assessed if
LINGO3 was also necessary during control of bacterial infection. We demonstrate that
Lingo3 deficiency does not confer susceptibility to C. rodentium, albeit, Lingo3 deficiency
does lead to enhanced Type 1 immune responses during C. rodentium infection. Combined
we propose that LINGO3 is a novel protein that is not necessary for controlling bacterial
burden but is necessary for controlling immune responses during C. rodentium infection.
Introduction
Escherichia coli (E. coli) is a commensal bacterium that colonizes the GI tract and
lives in symbiosis with the host. However, there of a variety of E. coli strains that can lead
to GI diseases (Tenaillon et al., 2010). Enterohaemorrhagic E. coli (EHEC) and
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Enteropathogenic E. coli (EPEC) are two strains that can cause fatal diarrhea (Kaper et al.,
2004). Within the United States alone, the Center for Disease and Control estimates
265,000

E.

coli

cases

a

year

occur,

causing

severe

food

poisoning

(https://www.who.int/news-room/fact-sheets/detail/e-coli). The number of these cases
increases in developing countries, leading to severe illness, and sometimes death
(Agbodaze et al., 1988; Haghi et al., 2014; Okeke, 2009). Therefore, a better understanding
of how these strains of E. coli evade the hosts immune system is crucial for development
of vaccines and new treatments.
EPEC and EHEC are a part of a family of bacteria that form attachment and
effacement (A/E) lesions on intestinal epithelial cells (Hartland and Leong, 2013; Jerse et
al., 1990). Following attachment, these bacteria use their pathogenicity island known as
the locus of enterocyte effacement (LEE) which encodes a Type III secretion system that
can translocate bacterial proteins into the cytoplasm of the host cell (Deng et al., 2004;
McDaniel et al., 1995). To better understand the pathogenicity of EPEC and EHEC and
how these bacteria evade the host immune response, the murine pathogen Citrobacter
rodentium (C. rodentium), has been used as a model (Schauer and Falkow, 1993a).
In chapter 1, the pathogenesis and immune responses induced by C. rodentium were
discussed briefly. Important to note is upon secretion of the Type III secretion system, Tir,
a Type III secretion system effector, is inserted into the host plasma membrane, where it
binds to its receptor, Intimin, and triggers actin polymerization.
Without Tir, Intimin, or the Type III secretion system C. rodentium is aviral (Deng et al.,
2003; Petty et al., 2010; Schauer and Falkow, 1993b). Interestingly, IL-22 is crucial for
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the clearance of this bacteria (Zheng et al., 2008). Work from Tsai et al has demonstrated
that IL-22 can upregulate the tight junction protein claudin 2, which limits tissue damage
and promotes clearance (Tsai et al., 2017). Furthermore, leucine rich repeat proteins, such
as toll like receptor 2 (TLR2) have been shown to be necessary for induction of
inflammatory responses against enteric pathogens (Gibson et al., 2008b). The TLR adaptor
protein myeloid differentiation factor (Myd) 88 can control pathogen burden through
promotion of epithelial proliferation, induction of neutrophils, and maintenance of tight
junction proteins (Gibson et al., 2008a; Gibson et al., 2008b; Lebeis et al., 2007), however
whether or not other leucine rich repeat proteins play a protective role in C. rodentium
pathogenesis is not well understood.
LINGO3 is a 64 kDa leucine rich repeat protein expressed in intestinal epithelial
cells (Fig 2.1c). Upon gene deletion, mice have a barrier defect, disruption of tight junction
proteins, enhanced Type 1 immune responses, and fail to recover from DSS- induced colitis
(discussed in chapter 2). C. rodentium is also used as a model of colitis since infection
induces colonic hyperplasia, and microbiota dysbiosis (Lupp et al., 2007; Mundy et al.,
2005); therefore, we evaluated the role of Lingo3 deficiency during C. rodentium infection.
Herein we demonstrate that Lingo3 deficient mice do not confer susceptibility or resistance
to C. rodentium infection regardless of a stronger Type 1 immune responses during C.
rodentium infection compared to WT mice. Together, these data demonstrate that LINGO3
is an epithelial protein that does not control bacterial burdens against a Type 1 inducing
enteropathogenic bacterium.
Results
Lingo3 deficiency leads to increased TLR mRNA levels but does not confer resistance
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to C. rodentium infection
WT C57Bl/6 mice clear C. rodentium infection within three weeks of infection
(Schauer and Falkow, 1993a; Wiles et al., 2004). However, during the course of C.
rodentium infection mice have diarrhea, can lose weight, and have colonic hyperplasia
(Schauer and Falkow, 1993a; Wiles et al., 2004). C. rodentium infection requires a Type 1
immune response as well as TLR signaling for clearance (Gibson et al., 2008a; Gibson et
al., 2008b; Simmons et al., 2003; Simmons et al., 2002). In chapter 2 we have discussed
that Lingo3 deficiency confers enhanced Type 1 immune responses at steady- state.
Because Lingo3 KO mice have a gut permeability defect, and commensals such as
E. coli can enter into the lamina propria, we reasoned that TLR expression may be
increased. TLR2 is a toll like receptor that specifically recognizes acylated bacteria while
TLR4 recognizes lipopolysaccharides, a polysaccharide commonly found in both Grampositive and Gram-negative bacteria (Cario et al., 2000; Lien et al., 1999). Using RT- PCR,
we evaluated the mRNA levels of Tlr2 and Tlr4 within IEC fraction of the colon and small
intestine. Not surprisingly, mRNA levels for Tlr2 were increased in Lingo3 deficient IECs
compared to WT (Fig 3.1a). We did not observe any difference in mRNA levels of Tlr4
between genotypes (Fig 3.1b). Because TLR2 is critical for control of C. rodentium we
reasoned that together with enhanced Type 1 immune responses as well as enhanced
mRNA levels of TLR2, Lingo3 KO mice would be resistant to C. rodentium infection. To
this end, we orally infected WT and Lingo3 KO mice with 10^8 colony forming units
(colony forming units), a moderate dose, of C. rodentium. Following infection, mice were
weighed, and bacteria burden assessed within feces every three days for twelve days of
infection. Interestingly, following infection both WT and Lingo3 KO mice had similar fecal
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burdens (Fig 3.2a). To confirm that C. rodentium was in fact the bacteria that was growing
from feces on Difco MacConkey agar plates, a PCR was performed for the C. rodentium
protein espB. All purple colonies that grew on Difco MacConkey agar plates were positive
for espB (Fig 3.2b). Because C. rodentium infection can cause weight loss, we next
assessed weight change over the course of infection. Neither Lingo3 KO nor WT mice lost
weight during 12 days of C. rodentium infection (Fig 3.3). C. rodentium is shed within
feces during infection, however, high C. rodentium fecal burden could be demonstrative of
mice clearing C. rodentium faster. To better assess whether or not Lingo3 KO mice were
clearing C. rodentium infection as efficiently as WT mice we next assessed dissemination
of C. rodentium in peripheral organs. We observed no differences in C. rodentium bacterial
burden in colon, cecum, MLN, Peyer’s patches (PP), or spleen (Fig 3.4). Together, these
data demonstrate, despite enhanced Type 1 immune responses and mRNA levels of Tlr2 at
steady-state, Lingo3 KO mice do not confer resistance to C. rodentium infection.
Lingo3 deficiency does not confer resistance to high dose C. rodentium infection
Although Lingo3 KO mice did not confer resistance to C. rodentium infection when
orally infected with a moderate dose of bacteria, we reasoned that it is possible Lingo3
deficiency could confer resistance in a dose dependent manner. To assess this, we infected
WT and Lingo3 KO mice with a high dose of C. rodentium infection (1011 CFU).
Following infection with 1011 CFU, Lingo3 KO mice had similar fecal bacterial burdens
as compared to WT mice (Fig 3.5a). Furthermore, neither weight loss nor organ
dissemination was changed between genotypes (Fig 3.5b-c). Together, these data
demonstrate regardless of C. rodentium inoculum dose, Lingo3 deficiency does not confer
resistance to C. rodentium infection.
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Lingo3 KO mice have enhanced Type 1 immunes responses during C. rodentium
infection
Control and clearance of C. rodentium infection requires CD4+ T cells (Shiomi et
al., 2010; Simmons et al., 2003). Since Lingo3 KO mice have enhanced Type 1 immune
responses at steady state, we reasoned that these immune responses help to control C.
rodentium burdens within Lingo3 KO mice. Using enzyme linked immunosorbent assay
(ELISA), we assessed Type 1 immune responses from MLN of infected WT and Lingo3
KO mice. Following high dose of C. rodentium infection, IL-17A, IL-22, and IFNg protein
levels were increased in Lingo3 KO mice as compared to WT mice (Fig 3.6a-c). Together,
these data show that despite C. rodentium burdens being similar between WT and Lingo3
KO mice, Lingo3 deficiency leads to enhanced Type 1 immune responses during C.
rodentium infection.
Discussion
Citrobacter rodentium is a Gram-negative bacterium that is used as a model system
to study E. coli infections as well as colitis. Although C. rodentium causes colonic
hyperplasia, colonic shortening, and a Type 1 immune response, similar to DSS-induced
colitis, it does not cause intestinal epithelial damage that is commonly found in DSSinduced colitis as well as IBD patients (Chassaing et al., 2014; Fakhoury et al., 2014;
Luperchio and Schauer, 2001). Therefore, the use of C. rodentium along with DSS can
begin to distinguish roles of proteins and signaling pathways within inflammation induced
during colitis as well as repair mechanisms necessary to prevent colitis, respectively.
The work shown in this study demonstrate that despite enhanced Type 1 immune
responses at steady -state, Lingo3 KO mice are not resistant to C. rodentium infection

80

regardless of inoculum dose. Interestingly, despite not having lower C. rodentium burdens
compared to WT mice, Lingo3 KO mice maintain a statistically significant increase in Type
1 immune responses compared to WT mice during C. rodentium infection. These findings
suggest that although Lingo3 KO mice have similar levels of fecal bacterial burden and
dissemination as compared to WT, the enhanced Type 1 immune response could in part be
responsible for maintaining control of C. rodentium.
In chapter 2 we have demonstrated that Lingo3 KO mice have a gut permeability
defect associated with dysregulated adherens junction formation. Additionally, C.
rodentium infection can disrupt tight junction complexes such that deficiency in these
protein complexes allows for increased bacterial burdens (Guttman et al., 2006; Tsai et al.,
2017). Given these data, one alternative hypothesis for the findings in this chapter could
be that Lingo3 KO mice would be more susceptible to C. rodentium, since a permeability
defect can allow C. rodentium infection to enter into the lamina propria more efficiently.
However, since Lingo3 KO mice have enhanced mRNA levels of Tlr2 along with enhanced
Type 1 immune responses, it is possible that these signaling pathways are in part
responsible for controlling C. rodentium burdens to similar levels as WT mice.
Interestingly, enhanced mRNA expression of TLR2 at steady-state suggest that there is, to
some extent, microbial dysbiosis within the Lingo3 KO mice.
TLRs are leucine rich repeat proteins and members of the pattern recognition
receptor family (Hug et al., 2018). These receptors sense pathogenic insults and induce an
immune response to pathogens (Hug et al., 2018). Additionally, during bacterial infection
TLRs, specifically TLR2 and TLR4 become upregulated (Davey et al., 2008; Dessein et
al., 2009; Rosenstiel et al., 2007). The enhanced mRNA expression of Tlr2 but not Tlr4 in
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IECs isolated from Lingo3 KO mice is surprising because during inflammatory conditions
within the GI tract, typically Tlr2 and Tlr4 expression is increased (Cario and Podolsky,
2000; Hausmann et al., 2002). We have demonstrated that Tlr2 mRNA levels are increased
within IECs isolated from Lingo3 KO mice further support inflammatory conditions within
these mice at steady-state despite comparable histology within the GI tract (Fig 2.2b, Fig
2.5b-c). Because the enhanced Tlr2 mRNA expression levels could be a secondary effect
to the gut permeability defect observed within these Lingo3 KO mice, it will be important
in future studies to understand if Lingo3 KO mice become more susceptible to C. rodentium
following antibiotic treatment. Prophylaxis treatment with antibiotics is well known to
eradicate commensal bacterium within the GI tract (Brandl et al., 2008; Buffie et al., 2012;
Lewis et al., 2015). Furthermore, eradication of commensal bacteria can lead to
susceptibility of bacterial infections such as Clostridium difficile (Buffie et al., 2012).
Therefore, it is possible Lingo3 KO mice have enhanced Type 1 immune responses at
steady-state due to the permeability defect discussed in Chapter 2, therefore treatment of
Lingo3 KO mice with antibiotics prior to C. rodentium infection would decrease enhanced
Type 1 immune responses and render Lingo3 KO mice susceptible to C. rodentium
infection.
Importantly, the work shown here does not demonstrate that Lingo3 KO mice clear
infection. It is well known that WT C57Bl/6 mice with normal immune systems (functional
CD4+ T cell and B cells) can clear C. rodentium infection within three weeks (Maaser et
al., 2004; Shiomi et al., 2010; Simmons et al., 2003; Simmons et al., 2002). Previous
reports have demonstrated that during early C. rodentium infection (day 0- day 6) the innate
immune response, specifically, IL-22 secretion from ILC3 and LTis are critical for early
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control (Sonnenberg et al., 2011; Zheng et al., 2008). Additionally, during late control of
C. rodentium infection (post day 6-8), that adaptive immune response including IFNg is
critical for control of C. rodentium burden (Shiomi et al., 2010; Simmons et al., 2002). To
date, C. rodentium burden has only been evaluated within Lingo3 KO mice through day 12
post infection and whether or not Lingo3 KO mice can clear C. rodentium infection faster
than WT mice has not been evaluated. It is possible that Lingo3 KO mice can clear C.
rodentium infection faster than WT mice, however, prophylactic administration of
antibiotics prior to C. rodentium may ablate this effect. Therefore, future work will evaluate
the implications of LINGO3 during clearance of C. rodentium infection.
Colonic hyperplasia is described as the thickening and increased rate of epithelial
proliferation within the colon (Barthold and Jonas, 1977). Colonic hyperplasia is a
hallmark histological pathology associated with C. rodentium infection (Mundy et al.,
2005). Along with colonic hyperplasia, C. rodentium infection is associated with a decrease
in goblet cell numbers (Bergstrom et al., 2008). Bergstrom et al demonstrated that C.
rodentium directly interacts with goblet cells and during the peak of C. rodentium infection
there is a decrease in goblet cells and expression levels of goblet cell-derived MUC2 and
TFF3 (Bergstrom et al., 2008). Follow up studies, demonstrated that reconstitution of Rag1
KO mice with CD4+ T cells led to the depletion of goblet cells and worsened pathology
during C. rodentium infection (Chan et al., 2013). Additionally, Rag1 KO mice had similar
C. rodentium burdens as compared to Rag1 KO mice reconstituted with either CD4+ or
CD8+ T cells, despite being more susceptible to mortality (Bergstrom et al., 2008; Chan et
al., 2013). These data suggest that the presence of T cells reduces mortality, however,
increases pathology during C. rodentium infection (Chan et al., 2013). We have
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demonstrated that Lingo3 KO and WT mice have comparable fecal and peripheral organ
C. rodentium bacteria burdens; however, we do not know whether or not pathology is
different between the two genotypes. Given the enhanced Type 1 immune responses within
Lingo3 KO mice at steady-state (Chapter 2) and during C. rodentium infection it is possible
that Lingo3 KO mice have worsened pathology. To further investigate this hypothesis,
evaluating colonic hyperplasia, goblet cell numbers via PAS-stained tissues, as well as
colon length during 21 days of C. rodentium infection will provide insight into the role of
LINGO3 during inflammation- induced pathology.
Together the work shown here, demonstrate the Lingo3 deficiency does not affect
bacterial burdens or dissemination of C. rodentium during 12 days of moderate and high
dose infection. Similar to the steady-state findings, Lingo3 KO mice maintain a statistically
significant increased Type 1 immune response during C. rodentium infection as compared
to WT mice. Importantly, these data do not evaluate the role of LINGO3 on worsened
pathology during C. rodentium infection, a phenotype associated with persistent Type 1
immune responses. Although these findings suggest that LINGO3 does not have a
functional role in controlling bacteria burden, these studies cannot yet rule out whether
LINGO3 is important for clearance of C. rodentium. Future studies will be undergone to
better understand if LINGO3 controls inflammation-induced pathology and the effects of
Lingo3 deficiency on goblet cell depletion.
Methods
Mice. All animal procedures were approved by the Institutional Animal Care and
Use Committee at University of California, San Francisco. WT C57BL6 mice were bred
in house. Super-ovulated female C57BL/6 mice (4 weeks old) were mated to C57BL/6 stud
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males. Fertilized zygotes were collected from oviducts and injected with Cas9 protein (30
ng/µl), sgRNA (15 ng/µl) into pronucleus of fertilized zygotes. Injected zygotes were
implanted into oviducts of pseudo pregnant CD1 female mice. Animals were housed under
specific-pathogen free barriers in vivarium at San Francisco General Hospital or University
of Pennsylvania. All procedures were reviewed and approved by IACUC at University of
California at San Francisco (protocol #AN109782-01) and University of Pennsylvania
(protocol #805911).
Quantitative RT-PCR. For intestinal epithelial cell isolation, small intestines were
dissected from WT and Lingo3 KO mice and cut open longitudinally. Intestines were
washed 3X in Hank’s Buffered Saline Solution (HBSS) containing 5mM EDTA+ 2.5mM
DTT for 10 mins shaking at 37ºC. Following 10min incubation intestines were vigorously
shaken by hand using forceps, epithelial cell fraction was collected. Following 3X washes
epithelial fractions were spun down at 1500 RPM for 5 min, and supernatants were
aspirated. Cell pellets were then resuspended in 10 mL HBSS and filtered through a 70
micron strainer and centrifuged for 5 minutes at 1500 RPM. Cells pellets were resuspended
in 1 mL HBSS and filtered through a 40 micron strainer centrifuged at 1500 RPM for 10
mins. Following centrifugation RNA was purified from cell subsets using nucleospin RNA
plus kit (clontech # 740984.25). cDNA was prepared using 1µL of 100 ng Random primers
(Invitrogen), 1 µg of RNA, 10 mM dNTP (Invitrogen), and 1 µL of Maxima H Reverse
Transcriptase (ThermoFisher #EP0752). PCRs were set up in a final volume of 20 µL using
2uL DNA, 1 µL 20 µM Forward and reverse primer, and 2X Sybr Green I Master Mix
(Bio-Rad #172-5274). Gene expression was measured using BIO- RAD CFX machine and
data normalized to GAPDH and presented as MEAN ± SEM from the replicates. The
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primer sequences are as follows: espB Forward primer (5’
ATGCCGCAGATGAGACAGTTG3’),
espB Reverse primer (5’CGTCAGCAGCCTTTTCAGCTA 3’),
TLR2 Forward primer (5’CACTTTATTCAGAGCCGTTGG 3’),
TLR2 Reverse primer (5’ TCTCCAGAAGATGTGCCTCC 3’),
TLR4 Forward primer (5’ CACTTTATTCAGAGCCGTTGG 3’),
TLR4 Reverse primer (5’ TCTCCAGAAGATGTGCCTCC 3’). All real-time PCR
reactions were carried out on Bio-Rad CFX96 system and data were analyzed using the CT
method as recommended in the manual.
C. rodentium infection. WT and Lingo3 KO male mice (2-3 months old) were
cohoused for 4 weeks prior to infection. Mice were fasted for 16-18 hours prior to infection.
Mice were weighed and fecals collected every 3 days throughout the course of infection.
C. rodentium strain DBS100 was provided by the Wu lab (University of Pennsylvania).
Prior to infections, a C. rodentium colony was grown overnight for 16 hours. The following
morning a 1:10 dilution of overnight C. rodentium was performed in LB broth Miller
(Fisher Scientific #244620). Using a spectrometer, an OD600 reading was performed on
the diluted C. rodentium to get an OD600 of 1 mL of overnight culture. This value was
then used as a conversion factor for subsequent experiments. For infections: two days prior
to infection, a glycerol stock of C. rodentium was thawed and streaked on a Difco
MacConkey agar plate (Fischer Scientific #DF0075-17-1) and incubated overnight at 37C.
one day prior to infection 1 C. rodentium colony was picked and inoculated into 3 mLs of
LB Broth miller overnight at 37C in a shaking incubator. 16 hours post shaking at 37C, a
1:10 dilution of 16hr grown C. rodentium was measured using a Spectrometer. Mice were
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orally infected 200 µL of either 108 or 1011 C. rodentium. To calculate the volume of C.
rodentium needed for each infection the total CFU (desired CFU X number of mice) was
divided by the CFU of 16 hr culture. The volume of C. rodentium required for infection
was centrifuged at 10,000 RPM for 10 minutes and resuspended in appropriate volume of
1X Sterile PBS. Following oral infection, excess of 16hr C. rodentium was serially diluted
and plated on Difco MacConkey agar filled Bi-plates (Fisher Scientific #FB08757150). 50
µL of serially diluted C. rodentium was plated on each side of bi-plate petri dish and spread
using a bacterial spreader. Plates were then incubated upside down at 37C for 24 hours.
Purple colonies were counted the following days and multiplied by serial dilution X 2 (to
account for the 1:10 dilution) which gave the amount of CFU. For fecal burdens, 2-3 fecal
pellets were collected every three days and weighed. 1 mL of sterile 1x PBS was added to
each fecal tube and made into a fecal slurry. For organ bacterial burden, spleen, colon,
cecum, liver, kidney, MLN, Peyer’s patch was weighed and homogenized by hand using a
plastic sterilized mortal. Serial dilutions of fecals as well as organs were performed in LB
broth Miller. Following serial dilutions, each dilution was plated as discussed above. 24hrs
post plating colonies were counted, multiplied by the serial dilution X 2 and divided by
weight of either fecal or organ to calculate the CFU/g.
ELISA. Following 12 days of C. rodentium infection, mice were euthanized, and
MLNs were isolated and homogenized. 0.25X 106 cells/mL were plated on a CD3:CD28
coated 96 well plate or a non-aCD3:CD28 coated 96 well plate. Plates were incubated for
72hrs at 37C. Following incubation, plate was centrifuged at 1500 RPM for 3 minutes and
supernatants were collected. All ELISAs were performed according to manufacturer’s
instructions. IFNg ELISA kit (ebioscience #88-7314-88), IL-22 ELISA kit (#88-7422-88),
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and IL-17A ELISA kit (ThermoFisher #88-7371-77).
Statistics. Statistical analyses were performed using GraphPad Prism version 7.0
(GraphPad). A two-tailed Student’s T test or ANOVA was used where appropriate.
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Fig 3.1 Lingo3 KO intestinal epithelial cells have increased Tlr2 mRNA levels.
Intestinal epithelial cells were isolated from small intestine (a) Tlr2 mRNA expression
(b) Tlr4 mRNA expression. Representative of oneindependent experiment.
Mean ± SEM, n=4-5 cohoused mice/ genotype. **** p-value 0.0001
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Fig 3.2 WT and Lingo3 KO mice have equivalent C. rodentium burdens.
WT and Lingo3 KO mice were orally infected with 108 colony forming units (CFU)
of C. rodentium. (a) CFU/g of feces in WT and Lingo3 KO 12 days post
C. rodentium infection (b) PCR for espB expression within purple colony from
overnight fecal Difco MacConkey agar plate. Lane 1 is non template control
(NTC), Lane 2 is expected C. rodentium (CR) colony from fecal plate,
Lane 3 is E. coli, a negative control. Data represented is pooled from two
experiments. Mean±SEM, n=5-9 cohoused mice/ genotype.
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Fig 3.3 WT and Lingo3 KO mice have no weight loss following infection
with 108 CFU of C. rodentium. (a) Body weight percentage (%) during
C. rodentium infection.Data represented is pooled from two experiments.
Mean ± SEM, N=5-9 cohoused mice/ genotype.
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Fig 3.4 WT and Lingo3 KO mice have similar C. rodentium burden in
peripheral organs following oral infection with 108 CFU.
(a) Bacterial burden (CFU/g) in colon, cecum, mesenteric lymph node (MLN),
peyer’s patch (PP), Spleen during C. rodentium infection.Data represented is
pooled from two experiments. Mean ± SEM, N=5-9 cohoused mice/ genotype.
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Fig 3.5 WT and Lingo3 KO mice have equivalent C. rodentium burdens
following high dose infection. WT and Lingo3 KO mice were orally infected with
1011 CFU of C. rodentium. (a) C. rodentium fecal burden over 12 days of infection
(b) Body weight percentage (Body weight (%)) over 12 days of infection
(c) Dissemination of C. rodentium in Liver, Spleen, and Cecum day 12
post infection. Data represented is from individual experiment.
n=5-7 cohoused mice/genotype
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Fig 3.6 Lingo3 KO mice have enhanced Type 1 immune responses
following C. rodentium infection. Whole MLN lysates were stimulated
with aCD3:CD28 for 72hrs following 12 days of C. rodentium infection
(a) IL17A protein concentration (pg/mL) in supernatants (b) IL22 protein
concentration in supernatants (c) IFN protein concentration in supernatants.
Mean±SEM, n=5-7 cohoused mice/ genotype.
* p-value 0.5. Data is representative of individual experiment.
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Chapter 4 Discussion
Overview
This dissertation focused on gaining a better understanding of the cellular and
molecular pathways underlying mucosal tissue repair. Specifically, it was designed to
identify and characterize novel proteins that interacted with Trefoil factor proteins (TFFs),
particularly TFF2. TFFs were first identified in the 1990s as small glycoproteins expressed
at mucosal sites that serve functionally important roles in tissue repair (Buda et al., 2012;
Podolsky et al., 1993; Suemori et al., 1991; Thim, 1989). Interestingly, although these
proteins have been studied for over 20 years, exactly how these proteins promote tissue
repair is not well understood. This lack of knowledge was due to largely the lack of
understanding of how TFFs signal and the identity of transmembrane TFF-binding proteins
that could confer the tissue reparative functions of these secreted factors. Recent work from
my dissertation laboratory has begun to elucidate novel TFF binding partners through the
use of TRICEPS, which is a chemoproteomics-based screen that is designed to identify
low-affinity interactions reliant upon glycoproteins (Frei et al., 2012; Frei et al., 2013).
LINGO family of proteins were identified through this screen. Recently published work
from Belle et al. has demonstrated that LINGO2 interacts with TFF3 and EGFR to protect
against colitis (Belle et al., 2019). However, the understanding of whether any of the other
remaining LINGO family members serve roles in TFF signaling and mucosal tissue repair
was unknown prior to my thesis work.
The work presented herein has identified that LINGO3 is expressed within the GI
tract as well as the lung which are two locations in which TFF2 is also expressed.
Furthermore, we have found that LINGO3 is expressed on intestinal epithelial cells and
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not on any of the immune cell subsets isolated and evaluated from the MLN or spleen of
mice. Interestingly, within human rectosigmoid tissue, LINGO3 is expressed within two
distinct locations; apically where enterocytes are found and also at the base of the colonic
crypts where intestinal stem cells (ISCs) are found.
In mice lacking Lingo3, we found a basal defect in gut permeability and
dysregulated adherens junction architecture, which is a phenotype that resembles Tff2
deficient mice. It is well established that deficiency in the AJC within the GI tract can lead
to entry of commensals and/or pathogenic bacteria into the lamina propria that
subsequently drives an inflammatory immune response (Chan et al., 2013). Given the
steady-state increase in gut permeability observed in Lingo3 deficient mice, we next
evaluated the nature of the ongoing inflammatory response leading to find that Lingo3
deficient mice have an increase in the overall number of intestinal DCs as well as an
accumulation of TH1 immune cells within the lamina propria and MLN all at steady-state
naïve specific pathogen free (SPF) conditions.
Defects in AJC function and resultant enhanced Type 1 inflammation are conserved
features of IBD, which are a spectrum of diseases in which defects in TFF biology have
been implicated (Fakhoury et al., 2014). Tff2 deficient mice are more susceptible to acute
and chronic forms of DSS-induced colitis (Judd et al., 2015). We demonstrate that similar
to mice with Tff2 deficiency, Lingo3 deficient mice have increased susceptibility to DSSinduced tissue damage and immunopathology as measured by increased DAI scores,
decreased body weight, and decreased colon lengths compared to cohoused WT mice.
Interestingly, Lingo3 KO mice are particularly more susceptible to DSS during the tissue
recovery phase, which is also when TFF responsiveness is most important to promote
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healing. Additionally, work in this thesis demonstrates that LINGO3 is required for TFF2
treatment to promote a faster recovery during DSS-induced colitis than mock-treated
animals. We found that TFF2 requires LINGO3 to promote MAPK activation , but that
conversely STAT3 signaling is driven through a TFF2 independent pathway that is
dysregulated within Lingo3 KO mice during DSS-induced colitis. Although Lingo3
deficiency leads to susceptibility during DSS- induced colitis it does not alter the outcome
of susceptibility or resistance to the rodent enteropathogenic bacterium C. rodentium,
which is used to model human infection with attaching effacing strains of E. coli.
Collectively, the body of work completed for this thesis supports a hypothesis that
LINGO3 is a novel Type 1 transmembrane protein that is a critical for basal maintenance
of the AJC structure, promotes tissue repair during DSS-induced colitis and partially
confers TFF2 signaling. Future studies should be targeted to further define LINGO3
expression patterns in the mucosa of humans and mice, define the mechanisms responsible
for how LINGO3 regulates distinct proteins of the AJC, and whether augmenting LINGO3
activity can directly repress Type 1 inflammation. Further investigation of these
outstanding questions may shed light on whether LINGO3 activity can be a therapeutic
target of IBD therapy as well as other injury models within mucosal sites that LINGO3 is
expressed. In this chapter, the functional role for LINGO3 within the ISC niche, the
potential implication for LINGO3 as a putative treatment for IBD, as well as broader
implications of LINGO3 in other immune related diseases such as asthma will be
discussed.
4.1 The role of Lingo3 in the intestinal stem cell niche
As discussed in chapter 1, the ISC niche is comprised of a variety of epithelial
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subtypes that each have a specific role in the maintenance of homeostasis and tissue repair.
The Lgr5+ cell is a bona-fide stem cell found at the bottom of the intestinal crypt within the
small and large intestine (Barker et al., 2007; Koo and Clevers, 2014). Work from the
Clever’s laboratory first identified these cells from working on a hypothesis that because
WNT signaling is the essential for crypt development that Wnt target genes would be
specifically expressed within distinct cells of the stem cell niche (Barker et al., 2007; Sato
et al., 2009). Since the establishment of this idea in 2007, much work has been done to
better understand the key signaling pathways necessary for maintenance and regulation of
the Lgr5+ cells. Demonstration that WNT3a, EGF, NOGGIN, and R- SPONDIN1 are key
proteins required for growing intestinal organoids has greatly advanced the overall
understanding of Lgr5+ cells (de Lau et al., 2011; Nozaki et al., 2016; Wang et al., 2017).
In vitro organoid culture is a method that not only allows the ability to study the number
of stem cells within a crypt, but also how the crypt can be manipulated in real time, and the
effects that these manipulations have on the regenerative properties of the ISC niche (de
Lau et al., 2011; Nozaki et al., 2016; Wang et al., 2017).
Although the Lgr5 gene has been well studied, its homologues such as Lgr4 have
received as much attention. LGR4 is also necessary for WNT signaling within intestinal
crypts (Kinzel et al., 2014; Xu et al., 2013). When Lgr5 and Lgr4 are simultaneously
deleted in vivo, intestinal crypt structure is lost, and epithelial cell proliferation is decreased
(de Lau et al., 2011). Additionally, each of the four R-SPONDIN proteins,
which are known agonists for WNT signaling, can bind to LGR4, LGR5, and LGR6,
suggesting that in addition to LGR5, both LGR4 and LGR6 also have functional roles
within the ISC niche (de Lau et al., 2011). The ability of LGR4-6 to bind to R- SPONDINs,
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is accompanied by high sequence conservation, high sequence homology and similar
structure amongst the LGR family members (Barker and Clevers, 2010; Hauser et al., 1997;
Herpin et al., 2004; Kudo et al., 2000; Nishi et al., 2000; Nothacker and Grimmelikhuijzen,
1993; Tensen et al., 1994). Because of the high sequence homology and conservation of
the LGR proteins, one can hypothesize that the LGR family of proteins have compensatory
roles in maintenance of the ISC niche. To this end, work from Liu et al demonstrates that
Lgr4 deficient mice have reduced Paneth and Lgr5+ cells. Furthermore, Lgr4 deficient mice
have worsened DSS-induced colitis and a defect in cellular proliferation (Liu et al., 2013).
Curiously, the phenotype of Lgr4 deficient mice is quite similar to the phenotype of Lingo3
KO mice during DSS-induced colitis. It is therefore possible that there is some degree of
overlap in the function of LGR4 and LINGO3. Interestingly, LINGO1 bears some degree
of structural similarity to LGR4 (Xu et al., 2013). This finding is extremely noteworthy
because the LINGO family members, like LGR family members, share sequence homology
amongst one another (Mi et al., 2004). More importantly, because LINGO1 is known to
form a receptor signaling complex with two other proteins, Nogo-66 receptor and p-75
signaling complex, it is plausible that other LINGO family members similarly form
receptor complexes, perhaps even with receptors in the LGR family of proteins (Inoue et
al., 2007; Mi et al., 2004; Pepinsky et al., 2014).
In chapter 2, I discuss the expression pattern of LINGO3 in human rectosigmoid
tissue samples. We find expression of this protein in two anatomically distinct locations,
apically where enterocytes are found, and at the base of the crypt where Lgr5+ stem cells
are found. Additionally, we observe that both small and large intestinal organoids grown
from Lingo3 KO and Tff2 KO mice have marked developmental abnormalities. Small
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intestinal organoids from Lingo3 KO and Tff2 KO mice do not develop buds as efficiently
as WT organoids over the days of growth evaluated. Colonic organoids from Lingo3 KO
and Tff2 KO mice do not have obvious defects in budding but do display defects in
maintaining their 3D architecture. These differences in budding, growth and architecture
within Lingo3 KO small intestinal and colonic organoids could be in part because colonic
organoids require more WNT signaling as compared to small intestinal organoids (Mahe
et al., 2013). Since Tff2 KO organoids have a similar defective phenotype as compared to
Lingo3 KO organoids further supports a hypothesis that LINGO3 and TFF2 have important
functions in the maintenance of the ISC niche.
To date, there have been no publications implicating TFFs in the maintenance or
development of the ISC niche. Interestingly, the Tumor necrosis factor receptor
superfamily member 19 (TROY), a p75-neurotropin receptor family member that is a part
of the LINGO1 complex, can interact with LGR5 to inhibit WNT signaling (Fafilek et al.,
2013; Mi et al., 2004; Satoh et al., 2007). Fafilek et al demonstrated that Troy deficient
organoids maintained cellular proliferation in the absence of R-SPONDIN 1, while WT
organoids did not (Fafilek et al., 2013). Moreover, if Troy deficient organoids are
supplemented with 15 ng/mL of R-SPONDIN 1, which is a concentration that is sixty-six
times lower than the normal concentration of R-SPONDIN1 used in organoid cultures,
these organoids could then proliferate for weeks, while WT organoids arrested (Fafilek et
al., 2013). These data suggest that TROY is a negative regulator of WNT signaling.
Although the crystal structure of LINGO3 is currently not known, given the
conservation among the LINGO proteins, combined with the known interaction between
LINGO1 and TROY, it is possible that the LINGO proteins can interact with LGR4, LGR5
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and/or LGR6 and modulate WNT signaling and maintenance of the ISC niche (Fig. 4.1).
In support of this model, preliminary bulk RNA sequencing data demonstrate that IECs
isolated from Lingo3 KO mice have dysregulated Wnt target genes (data not shown).
Understanding the role of these Wnt target genes within the ISC niche may help to better
understand whether or not LINGO3 regulates WNT signaling similar to TROY. The ability
to control the on/off switch of Wnt signaling transcriptionally and translationally is
necessary for maintenance of the ISC niche. Given these preliminary results, future work
should focus on biochemical assays that assess whether LINGO3 can form a protein
complex with any of the LGRs. Because both Tff2 KO and Lingo3 KO organoids have
similar defects, it is possible that a LINGO3-TFF2 signaling pathway is required for normal
WNT signaling. Future experiments should test if the addition of recombinant TFF2 can
promote normal organoid architecture and growth within Lingo3 KO and/or Tff2 KO small
or large intestinal organoids. Finally, based on the data within this dissertation, we have
hypothesized that WNT signaling is dysregulated, but we do not know whether or not WNT
signaling is upregulated or downregulated; therefore, assessing protein concentrations of
different WNT ligands within organoid cultures and changing the concentration of WNT3a
added to organoid cultures should further our understanding of how LINGO3 and TFF2
regulate WNT signaling. Given the dysregulation within Lingo3 deficient organoids one
model prediction is that LINGO3 expression can potentially regulate the secretion of WNT
ligands, leading to dysregulation of WNT when Lingo3 is genetically deleted (Fig 4.1).
Beyond ISCs themselves, work from the Regev lab has demonstrated that Lingo3
is expressed on transit amplifying (TA) cells (Lauber et al., 1989). These are cells that are
found within the ISC niche but instead of sitting at the base of the crypt they are typically
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found at the start of the villus, closer to +4 quiescent cells (Lauber et al., 1989). Recent
work has demonstrated that these cells promote proliferation of previously primed stem
cells as well as quiescent stem cells and require the Sonic Hedgehog signaling pathway
(Hsu et al., 2014). To date, there have not been studies of TA cells functional role in tissue
regeneration or repair during IBD. There is one study that demonstrates the IL22 receptor
A1 is expressed on TA cells (Zwarycz et al., 2019). This study demonstrates that increased
levels of IL22 in vivo can increase proliferation of TA cells but has no proliferative effects
on the Lgr5+ population (Zwarycz et al., 2019). Work shown in chapter 3 demonstrates that
Lingo3 KO mice have enhanced IL22 cytokine secretion following 72 hours of stimulation
with aCD3:CD28 post C. rodentium infection. Given the data known about TA cells and
the increase in IL-22 secretion within Lingo3 KO mice, it is possible that there is a
dysregulation in the TA cell compartment within Lingo3 deficient mice. Paneth cells have
been implicated in providing compensatory role to Lgr5+ cells during the recovery phase
of DSS-induced injury (Schmitt et al., 2018). Therefore, it is possible that TA cells act in
a similar fashion. One hypothesis is that if LINGO3 is expressed within the TA cell subset
and functions in a similar manner to TROY that inhibits WNT signaling, then it is possible
that Lingo3 deficient mice also have a dysregulated TA cell compartment as well as
dysregulation of WNT signaling (Fig 4.1).
The impact of Lingo3 deficiency on the ISC niche within the small and large
intestine remains to be fully characterized. Future experiments should assess whether there
are differences within epithelial cell subtypes present in this location such as Paneth cells,
Lgr5+ cells, and TA cells. Based on the work completed for this thesis, it is likely one or
more of these epithelial cell progenitor populations are dysregulated within the Lingo3 KO
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mice compared to WT mice. Both Paneth cells and Lgr5+ cells have been shown to be
necessary during the tissue regenerative stage of DSS-induced colitis, therefore, a defect
in one or both of these populations could explain at least in part, the abnormal phenotypes
observed within the Lingo3 KO mice (Davidson et al., 2012; Schmitt et al., 2018). It is
unlikely that there is a severe defect in ISC biology such as the complete loss of one or
more of these populations, because the loss of Lgr5 expression is incompatible with life. A
more likely scenario is that there is an alteration in some aspect of the biology of the cells,
perhaps a moderate reduction in overall number or position of cells within the ISC niche
of Lingo3 KO mice (Fig 4.1) (Kinzel et al., 2014).
4.2 The functional role of Lingo3 in AJC and cellular motility
In chapter 2, we demonstrate that colonic organoids from Lingo3 KO and Tff2 KO
mice have a defect in 3-dimensional (3D) architecture which manifests as a conversion to
a flattened 2-dimensional (2D) appearance. This defect in architecture could be caused by
the identified AJC defects leading to the overall increase in gut permeability that occurs in
both Lingo3 KO and Tff2 KO mice. Additional research needs to be performed to
understand which proteins of the AJC are dysregulated within the Tff2 KO mice; however;
we show using electron microscopy that within the jejunum and colon of Lingo3 KO mice
this region of the apical junction is dysregulated. This data is further supported by the
decrease in E-cadherin both at the mRNA and protein level. It has previously been
established that polymorphisms within E-cadherin can lead to IBD (Bates and Mercurio,
2003; Grill et al., 2015; Hahn et al., 2017; Muise et al., 2009; Wendt et al., 2011).
Additionally, defects in the epithelial-mesenchymal transition promote a 2D architecture
within organoids (Bates and Mercurio, 2003; Grill et al., 2015; Hahn et al., 2017; Muise et
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al., 2009; Wendt et al., 2011). Our RNA sequencing data comparing WT and Lingo3 KO
mice under steady-state conditions demonstrates that IECs isolated from the GI tract of
Lingo3 KO mice have a decrease in expression of genes associated with the epithelialmesenchymal transition (data not shown). Given these data, it is possible that the defect in
colonic organoids is in part due to dysregulated function (s) of the adherens junction.
Therefore, it is possible that LINGO3 can indirectly or directly regulate the formation of
the apical junction complex (Fig 4.2).
E-cadherin can form a complex with CD103 and b-catenin to form the adherens
junction (Coopman and Djiane, 2016; Van den Bossche et al., 2012). In Chapter 1, the role
of b-catenin within WNT signaling was discussed. In short, the binding of WNT to its
receptors, Frizzled and LRP5/6 turns off the b -catenin degradation complex which allows
for b -catenin to accumulate within the nucleus and associate with LEF/TCF complex
inducing the transcription of Wnt responsive genes (Behrens et al., 1996; Molenaar et al.,
1996; Moparthi and Koch, 2019). In addition to b -catenin’s role in WNT signaling,
following complex formation with E-cadherin and integrins, b -catenin binds to a-catenin
which can bind actin (Adhikari et al., 2018; Campbell et al., 2017). Therefore, our model
predicts that any dysregulation in one of these signaling complexes/mechanisms could lead
to disrupted adherens junction, intestinal permeability, and defects in organoid
architecture/growth (Fig 4.2).
In chapter 2 , we demonstrate that Lingo3 deficiency dysregulates adherens
junction architecture via electron microscopy (EM) (Fig 2.7). Interestingly, within both
Lingo3 KO colon and jejunum EM images, a looped-like structure could be observed in
place of a more linear adherens junction configuration seen within EM images of WT mice.
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One potential hypothesis for the formation of looped-like adherens junction could be
dysregulation of actin filaments and actin cytoskeleton. The AJC has been well known to
form and bind to actin through a -catenin (Campbell et al., 2017). Mutations within either
b-catenin or a- catenin can disrupt cell adhesion as well as polarization of the actin
cytoskeleton (Orsulic and Peifer, 1996). Consequently, a potential dysregulation of the
Wnt- b-catenin signaling pathway could also have a role in dysregulation of actin
polarization in addition to adherens junctions.
Polymerization of actin requires actin-related proteins 2 and 3 (ARP2/3) complex
and nucleation-promoting factors, namely Wiskott-Aldrich syndrome protein (WASP),
which can bind actin monomers and the ARP 2/3 complex (Marchand et al., 2001;
Rodnick-Smith et al., 2016). Upon binding, the Arp 2/3 complex becomes activated and
can form new actin filaments leading to branched actin networks (Marchand et al., 2001;
Rodnick-Smith et al., 2016). Interestingly a-catenin can regulate actin polymerization by
suppression of the ARP 2/3 complex (Drees et al., 2005). Therefore, a normal adherens
junction formation is necessary for regulated actin polymerization. One hypothesis is that
dysregulation in either the Wnt- b-catenin signaling, or the E-cadherin- b-catenin complex
can lead to aberrant formation of actin polymerization (Fig 4.2). Moreover, actin
polymerization is necessary for cell motility (Carlier and Pantaloni, 1997; Carlier et al.,
1999).
During tissue injury, the process of cellular restitution is critical for successful
tissue repair. Restitution is defined as the movement of cells over areas of denuded
basement membrane at the site of injury (Aihara et al., 2018). This cellular restitution is
initiated by actin polymerization (Aihara et al., 2018). To date TFFs have not been shown
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to regulate actin polymerization, but instead have been shown to promote cellular
restitution during injury (Xue et al., 2010). Taken together, one potential explanation for
the loop-like structures within adherens junction of Lingo3 KO colon and jejunum could
be dysregulated Wnt- b-catenin signaling, leading to the disruption of the E-cadherin- b
catenin complex and subsequent binding of a-catenin to actin filaments. Alternatively,
LINGO3 signaling could indirectly promote formation of the E-cadherin- b-catenin
complex, therefore Lingo3 deficiency results in a defective complex. Although we have no
evidence that LINGO3 can directly bind to b-catenin or E-cadherin, published data within
the Herbert laboratory demonstrates that Lingo2 deficient mice also have a gut permeability
defect implying a similar phenotypic alteration as observed with Lingo3 deficiency (Belle
et al., 2019). Because either Lingo2 or Lingo3 deficiency leads to increased gut
permeability, it is possible that the LINGO family of proteins can bind to and regulate the
AJC proteins necessary for maintenance of this complex. A defect within b-catenin could
lead to dysregulation of actin polymerization and in part lead to a defect in cellular
restitution during tissue injury as observed during DSS-induced colitis. In chapter 2 we
demonstrate that TFF2 requires LINGO3 for MAPK activation during DSS- induced
injury. It is possible that TFF2 also requires LINGO3 for cellular restitution, and that a
defect in either Lingo3 or Tff2 can cause dysregulated E-cadherin- b-catenin complex.
Previous reports have demonstrated that administration of TFF3 can promote
expression of tight junction proteins such as claudins while reducing protein levels of
cadherin, a-and b-catenin, as well as a decrease in actin ring formation (as measured by

phalloidin staining) (Buda et al., 2012; Meyer zum Buschenfelde et al., 2004). There are
no reports implicating TFF2 signaling on the formation of the AJC or actin polymerization.
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A potential scenario that could be possible is that TFF2 and TFF3 can act in a compensatory
mechanism such that TFF2 signaling promotes actin polymerization while TFF3 acts as a
switch to downregulate polymerization and promote tight junction formation. Therefore, I
propose to investigate whether LINGO3 downstream signaling and AJC formation is
TFF2-dependent, future experiments should be carried out that employ biochemical and
functional assays that can parse out: 1) if LINGO3 is directly or indirectly bound to or
signaling through b-catenin and 2) whether LINGO3 directly or indirectly acts on different
proteins within the AJC to promote formation (Fig 4.2).
4.3 The role of Lingo3 on regulating Type 1 immune responses
Prior to the work completed for this thesis, there were no publications on LINGO3.
There is no data on the basic biology of LINGO3 signaling or potential signaling pathways
that may regulate Lingo3 either transcriptionally or translationally. It is known is that the
cytoplasmic tail of LINGO3 contains both serine and tyrosine residues that kinase binding
software predicts to be phosphorylated by kinases such as MAPK and AKT, two kinases
that are strongly implicated in TFF2 signaling and tissue regeneration (Engevik et al., 2019;
Orime et al., 2013). Additionally, within the locus of human Lingo3 there are
transcriptional binding sites for the Aryl hydrocarbon receptor nuclear translocator (Arnt).
The transcriptional binding site for Arnt is interesting given the role of AHR in regulation
of Th17 responses and Type 1 immune responses (Yu et al., 2018).
Arnt forms a dimer with the Aryl hydrocarbon receptor (Ahr) within the nucleus.
Upon dimerization, transcription occurs (Sakurai et al., 2017). AHR is a part of the basic
helix loop helix (bHLH)/ PerARNT-Sim (PAS) superfamily of proteins (Yu et al., 2018).
Previous work has demonstrated that upon activation of AHR by its ligand, 6- formylindolo
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(3,2-b) carbazole (FICZ), there is downregulation of inflammatory cytokines, an increase
in transepithelial resistance as well as localization of ZO-1, Occludin, and Claudin-1 (Yu
et al., 2018). Furthermore, Ahr can regulate Rnf43 and Znrf3, two E3 ubiquitin ligases that
target Wnt receptors for degradation to control ISC proliferation (Metidji et al., 2019). The
regulatory role of Ahr on decreased expression of inflammatory cytokines, promotion of
AJC barrier function, and ISC proliferation makes it tempting to speculate that LINGO3 is
part of a novel regulatory signaling complex that controls cellular adhesion.
It is possible that Lingo3 can interact with the Ahr complex and regulate Type 17
responses and/or repress Type 1 inflammatory cytokines. Understanding how the
transcriptional binding sites within the Lingo3 locus represses or promotes transcription
will be important in future work to better understand the signaling pathways that Lingo3 is
regulated by and pathways in which Lingo3 may regulate. We do not know whether or not
Lingo3 deficiency directly leads to enhanced Type 1 immune responses or whether
enhanced Type 1 immune responses is secondary to the adherens junction defect observed
within deficient mice (Fig 4.2). To begin to parse out this finding, future work will
investigate if treatment with IFNg and TNF blocking antibodies leads to an increase in GI
barrier function within Lingo3 KO mice .
4.4 The implications of LINGO3 in IBD
Inflammatory bowel disease (IBD) constitute a spectrum of detrimental diseases of
the GI tract that affects children, adults, third world countries, and the United States.
Although this disease has been around since the 1930s, there have been limited efforts to
better understand the pathobiology and factors that drive this disease (Feuerstein and
Cheifetz, 2017). Understanding the causes and environmental triggers of IBD is essential
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for the development of new treatments as well as curative therapies. At the onset of IBD,
patients present with bloody stool, diarrhea, weight loss, cramping, and sometimes fever
and fatigue (Burgmann et al., 2006; Cheifetz, 2013; Dahlhamer et al., 2016). In order to be
diagnosed with IBD, patients need to undergo a colonoscopy, where samples of the small
and large intestine are taken and evaluated for inflammation and tissue damage (Burgmann
et al., 2006; Cheifetz, 2013; Dahlhamer et al., 2016). The current treatment options for IBD
are anti-inflammatory drugs, TNF inhibitors, immune-suppressants, and sometimes
surgery to remove the damaged portion of the intestine (Chateau and Peyrin- Biroulet,
2019; Feuerstein and Cheifetz, 2017; Ribaldone et al., 2019; Sands et al., 2019). Although
the innovation of TNF inhibitors for IBD has been a huge leap forward in the quality of
life and general outcomes for patients, not all patients respond to this treatment. Therefore,
identifying new putative therapies for refractory patients is important.
The TFFs have been implicated in tissue repair and regeneration during DSSinduced colitis (Judd et al., 2015; Kjellev et al., 2007; Kurt-Jones et al., 2007). Recent work
has demonstrated that patients with IBD have increased serum levels of all TFFs, and
following treatment with prednisolone, there is a reduction in TFF protein concentrations
(Gronbaek et al., 2006). To this end, the TFFs have become in part a diagnostic marker of
an ongoing flare during IBD. Furthermore, TFFs have been implicated as putative
treatments for IBD. Recent work has demonstrated that TNF and NFkB can inhibit
transcription of TFF3, which is part of why TNF inhibition has been such a promising new
therapy for these patients (Loncar et al., 2003). To date, there have been no clinical studies
evaluating TFF2 as a putative therapy for IBD; however, there have been a number of
reports demonstrating that treatment with recombinant TFF2 is protective in rats and dogs
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during experimental colitis (Tran et al., 1999). This protective role of TFF2 is in part due
to a reduction of leukocyte recruitment in inflamed tissues (Soriano-Izquierdo et al., 2004).
Understanding how TFFs signal and promote epithelial restitution as well as inhibition of
apoptosis is critical for developing these proteins as putative treatments for IBD. Because
recent work has demonstrated that TNF can inhibit TFF3 there is potential that addition of
TFF3 to TNF blockade treatment will be synergistic, and an alternative therapy for these
patients (Loncar et al., 2003). Based on the work presented in this thesis, it is also possible
that a similar treatment can be designed for the use of recombinant TFF2.
The data presented within Chapter 2 suggests that the addition of TFF2-Fc during
DSS-induced colitis enhances recovery of weight and drives a reduction in disease activity
dependent upon LINGO3. This study supports a model wherein LINGO3 drives MAPK
activation in local IECs to promote cellular proliferation. Because proliferation occurs
downstream of MAPK signaling, future work will need to evaluate whether downstream
of p-ERK, goblet cells are driven to proliferate, which would, in turn, lead to an increase
in TFF2 secretion or alternatively, test if p-ERK leads to the proliferation of all intestinal
epithelial cell types (Fig 4.3). Interestingly, Lingo3 deficiency also affected STAT3, but
in a TFF2-independent manner. This data further suggests that LINGO3, independent of
TFF2, could promote reparative signaling pathways. Interestingly, in Chapter 3 we
demonstrate no phenotype in Lingo3 deficient mice during C. rodentium infection. This
could be because of early control of C. rodentium through enhanced IL-22 and Type 1
cytokine production as discussed in Chapter 3, however, it could also because C. rodentium
infection does not cause epithelial damage like that associated with IBD. There have been
no studies implicating TFFs during C. rodentium infection. In fact, there have been no
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studies investigating if Tff deficient mice have any defects in controlling C. rodentium
infection or if these mice have worsened pathology during infection. To date, TFF signaling
has only been implicated in diseases or infection models that cause severe epithelial
damage like IBD, helminth infection, and asthma (Hung et al., 2018; Hung et al., 2019).
Given these findings, it is not surprisingly that LINGO3, which signals in part in a TFF2
dependent manner, has no role in a non-epithelial damaging bacterial infections.
To date, there have been no polymorphisms identified for Lingo3 that are associated
with the development of IBD. Ongoing work within the Herbert laboratory is beginning to
identify if there are polymorphisms associated with IBD risk; however, LINGO3 is the
only LINGO family member that has not been associated with any polymorphisms,
suggestive that defects within Lingo3 are incompatible with human life. Interestingly, using
NCBI Geoprofile database, we have found that Lingo3 is expressed during IBD and is
differentially expressed during a time-course of DSS-induced colitis (Fang et al., 2011;
Moehle et al., 2006; Olsen et al., 2009; Zahn et al., 2007). To better understand if these
trends follow the same trends as TFF expression during colitis additional research needs to
be performed. Given these data, it is possible that manipulating LINGO3 signaling pathway
in combination with administration of recombinant TFF2, can be a potential therapy for
IBD patients.
The work in this thesis has focused on the expression pattern and signaling of
LINGO3 in mice. Because this work has not fully evaluated LINGO3 expression within
humans it is possible that LINGO3 expression in humans is in a different cellular
expression pattern from mice. In mice, TFF2 has been shown to be expressed in
macrophages in addition to epithelial cells (Hung et al., 2019). Furthermore, the Herbert
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laboratory identified the LINGOs using a human differentiated monocyte cell line;
therefore, it is possible that within humans, immune cell subsets in addition to epithelial
cells can express LINGO3. Based on the data presented in Chapter 2, it is possible that
LINGO3 dependent TFF2 signaling can promote anti-inflammatory responses such as
induction of Tregs or secretion of IL-10 from macrophages as a potential mechanism to
control inflammation during IBD. Therefore, future work evaluating LINGO3 expression
patterns within humans during homeostasis as well as during IBD will be necessary. Single
cell RNA sequencing revealed that Lingo3, albeit low expressing, was expressed on DC
subsets as well as monocytes within humans (Villani et al., 2017). Given this data,
understanding how LINGO3 signals within immune cells subsets and the potential role
LINGO3 signaling has on inflammatory immune responses will be important for future
studies.
4.5 The implications of Lingo3 outside of the gastrointestinal tract
This thesis has focused on the role of LINGO3 within the GI tract. However, we
have also noted in Chapter 2 that both in humans as well as mice express Lingo3 within
the lung and upper airways. The general architecture and composition of the lung is
comparable to the GI tract in that the lung contains a mucus membrane, a variety of
epithelial and immune cell subsets, as well as tight junctions that form between epithelial
cells (Itoh et al., 2004; Wittekindt, 2017). Furthermore, there are lung specific diseases
such as asthma and the pulmonary phase of Nippostrongylus brasiliensis (N. brasiliensis)
infection that are inflammatory and require tissue repair and regeneration (Hung et al.,
2018; Hung et al., 2019).
Asthma is a chronic inflammatory disorder that involves a number of immune cells
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such as macrophages and T cells as well as epithelial cells (Mims, 2015). Although the
exact cause of asthma is not known and likely pleiotropic, environmental factors such as
air pollution and smoking as well as genetic factors have been associated with risk and
development of asthma (Mims, 2015; Toskala and Kennedy, 2015). Type 2 inflammation
is strongly associated to an asthmatic response. This immune infiltration within the
bronchioles of the lung involve TH2 cells, granulocytes such as eosinophils and mast cells,
as well as ILC2 (Huang et al., 2019; Mims, 2015; Toskala and Kennedy, 2015).
Additionally, airway epithelial cells and alveolar macrophages infiltrate the damaged tissue
(Mims, 2015). Similar to IBD, asthma causes epithelial hyperplasia as well as an increase
in mucus production from goblet cells (Mims, 2015). Furthermore, TFFs, specifically
TFF2, are known to be upregulated during asthma (Viby et al., 2015; Wills- Karp et al.,
2012). Work from the Herbert laboratory has demonstrated that TFF2 treatment can induce
IL33, a Type 2 cytokine that is associated with inflammation during allergic response
(Hung et al., 2018). Although TFF2 has been shown to induce IL-33 and subsequent
inflammation, there have also been reports demonstrating treatment of recombinant TFF2
is beneficial for controlling bronchial epithelial apoptosis and epithelial thickening during
asthma (Royce et al., 2013). These data suggest that recombinant TFF2 could be a putative
treatment for airway diseases (Royce et al., 2013). Interestingly, this work further
demonstrates that TFF2 treatment does not reduce inflammation within the lung in support
of the hypothesis that TFF2 promotes IL-33 and Type 2 inflammation (Hung et al., 2018;
Royce et al., 2013).
In support of the role of TFF2 within the lung during infection, following N.
brasiliensis infection, Tff2 mRNA expression is induced (Wills-Karp et al., 2012).
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Nippostrongylus brasiliensis is a hookworm infection that travels to the lungs during early
time of infection, approximately day 2, where it then migrates to the intestines (Hung et
al., 2019; Nair and Herbert, 2016). While in the lungs, N. brasiliensis causes a massive
amount of epithelial tissue damage leading to the induction of TFF2 (Hung et al., 2018;
Wills-Karp et al., 2012). Furthermore, in the absence of Tff2, mice are more susceptible to
lung damage and have increased amount of hemorrhage at day 1 post infection as compared
to Tff2 deficient mice at steady state or WT mice during infection (Wills-Karp et al., 2012).
Additionally, post N. brasiliensis infection, Tff2 deficient mice had a reduction in lung
collagen, suggestive of a lack a lung repair (Wills-Karp et al., 2012). Given these data and
the role of TFF2 during asthma infection, it suggests that the TFF2 signaling pathway is
required for lung repair in two lung injury models. Because of the expression of LINGO3
within the lung and the implications LINGO3 has on TFF2 mediated signaling during DSSinduced colitis, it is possible that LINGO3 is also necessary during repair of lung injury.
Preliminary data demonstrates that similar to the GI tract, there is increased lung
permeability within Lingo3 deficient mice at the steady-state (Fig 4.4). These data suggest
that there could be an apical junction defect within different epithelial cell populations of
the lung. Interestingly, during asthma, IL-13, a known Type 2 cytokine has been shown to
drive changes within claudin expression as well as enhanced permeability (Schmidt et al.,
2019). Given these data it is possible that defects within tight junctions can lead to
worsened severity of asthma infection. Furthermore, mice infected with N. brasiliensis
demonstrated enhanced endotoxin levels, demonstrating that
N. brasiliensis infection disrupts tight junctions and leads to epithelial denudation (Farid
et al., 2008). Although LINGO3 has not yet been studied in disease models of asthma, there
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has been datasets that have identified differential expression of Lingo3 during asthma (Lu
et al., 2007; Subrata et al., 2009) (https://www.ncbi.nlm.nih.gov/geoprofiles/8523063).
However, based on the available data there is no consistent trends of Lingo3 expression
being dysregulated during asthma infection. Therefore, future work will need to be
performed to understand the expression of Lingo3 during various periods and onsets of
asthmatic disease. Understanding the role of LINGO3 signaling within the lung will be
important to elucidate novel repair mechanisms during lung injury. Future work will focus
on the implications of Lingo3 deficiency on asthma and whether or not LINGO3 can
regulate Type 2 immune responses in a similar fashion to TFF2 (Hung et al., 2018; Hung
et al., 2019; Wills-Karp et al., 2012).
Conclusions
Taken together, the work presented in this thesis has identified LINGO3, a novel
leucine rich repeat transmembrane receptor, as an important protein expressed within
mucosal sites that functions to control tight junctions and tissue repair during DSS- induced
colitis. Given the expression patterns of LINGO3 in human gastrointestinal tissue it is
possible that LINGO3 is expressed on ISCs as well as other cell subsets
outside of intestinal epithelial cells. Additionally, this thesis provides evidence that
LINGO3 is an important reparative protein that is involved within the TFF2 signaling
pathway but does not directly interact with TFF2. This leads to an open-ended question of
what LINGO3 is a receptor for and whether or not it forms a complex with other proteins
similar to what has been shown with LINGO1 and LINGO2. This work has laid the
foundation for future studies involving LINGO3. Understanding how LINGO3 signals,
other putative binding proteins for LINGO3, as well as if LINGO3 directly functions within
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the ISC niche or on the AJC will be important for elucidating the mechanisms that LINGO3
utilizes to promote tissue repair during human diseases such as IBD and asthma.
Methods
FITC-Dextran assay. WT and Lingo3 KO mice were fasted for 16 hours prior to
4 kDa FITC-Dextran (Sigma, FD4) administration. Mice were anesthetized using
isoflurane prior to intratracheal challenge. For intratracheal challenge, mice are placed on
a plexiglass inclined plane and hung by the incisors. The tongue is gently held with forceps
and 50 µL of 4 kDa FITC-Dextran was placed on the back of the tongue. The mouth was
then closed for aspiration of the droplet. Mice were euthanized following 4 hours of
administration. Blood was collected from the heart using a cardiac puncture and
centrifuged at 10,000 RPM for 10 minutes at 4C to isolate sera. FITC-Dextran assay was
performed in the same manner as described in the methods section of Chapter 2: Evaluation
of intestinal permeability.
Geo-Profile

data

search:

The

NCBI

website

geo-profile

(https://www.ncbi.nlm.nih.gov/geoprofiles/) was used to search datasets on the
expression of Lingo3 during IBD and asthma. The terms used for these searches were as
follows “Lingo3 and colitis” and “Lingo3 and asthma”. ID numbers were referenced for
all datasets cited within this thesis .

116

Figures

Fig. 4.1 LINGO3 may have a functional role in the intestinal stem cell niche.
1) LINGO3 may be expressed on Lgr5+ intestinal stem cell, and downstream signaling
leads to cellular differentiation, repopulating the intestinal villus with mature epithelial
cells. 2) Alternatively, LINGO3 may be expressed on either a transit amplifying cell or
paneth cell and downstream signaling leads to the secretion of WNT ligands which can
then bind to LGR5 leading to cellular differentiation
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Figure 4.2 LINGO3 may have a functional role within the apical junction complex. 1)
LINGO3 may indirectly regulate the formation or protein expression of tight junction
proteins (claudins, occludens, or ZO proteins). 2) LINGO3 may indirectly regulate the
protein expression of junctional adhesion molecules (JAMs). 3) LINGO3 regulates the
formation of the adherens junction complex either indirectly through downstream signaling
or directly through binding to b-catenin.
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Figure 4.3 Potential functional role of a LINGO3-TFF2 axis in inflammatory
bowel disease. During DSS-induced injury, goblet cells secrete TFF2. TFF2 can indirectly
signal through LINGO3, expressed on enterocytes, leading to downstream signaling of
MAPK, specifically activation of ERK via phosphorylation. P-ERK can lead to cellular
proliferation either 1) directly on goblet cells leading to further TFF2 secretion or 2)
indirectly on epithelial cells along the villus.
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Fig 4.4 Lingo 3 deficient mice have a lung permeability defect.
(a) FITC-Dextran concentration within sera following intratracheal
administration of 44mg/100g of 4kDA of FITC-Dextran. N= 6 cohoused mice/genotype
*** p 0.005

120

Bibliography
References
Aberle, H., Butz, S., Stappert, J., Weissig, H., Kemler, R., and Hoschuetzky, H. (1994).
Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J Cell Sci
107 ( Pt 12), 3655-3663.
Adhikari, S., Moran, J., Weddle, C., and Hinczewski, M. (2018). Unraveling the
mechanism of the cadherin-catenin-actin catch bond. PLoS Comput Biol 14, e1006399.
Agbodaze, D., Abrahams, C.A., and Arai, S. (1988). Enteropathogenic and enterotoxigenic
Escherichia coli as aetiological factors of infantile diarrhoea in rural and urban Ghana.
Trans R Soc Trop Med Hyg 82, 489-491.
Ahmad, R., Chaturvedi, R., Olivares-Villagomez, D., Habib, T., Asim, M., Shivesh, P.,
Polk, D.B., Wilson, K.T., Washington, M.K., Van Kaer, L., et al. (2014). Targeted colonic
claudin- 2 expression renders resistance to epithelial injury, induces immune suppression,
and protects from colitis. Mucosal Immunol 7, 1340-1353.
Aihara, E., Engevik, K.A., and Montrose, M.H. (2017). Trefoil Factor Peptides and
Gastrointestinal Function. Annu Rev Physiol 79, 357-380.
Aihara, E., Medina-Candelaria, N.M., Hanyu, H., Matthis, A.L., Engevik, K.A., Gurniak,
C.B., Witke, W., Turner, J.R., Zhang, T., and Montrose, M.H. (2018). Cell injury triggers
actin polymerization to initiate epithelial restitution. J Cell Sci 131.
Al-Sadi, R., Khatib, K., Guo, S., Ye, D., Youssef, M., and Ma, T. (2011). Occludin
regulates macromolecule flux across the intestinal epithelial tight junction barrier. Am J
Physiol Gastrointest Liver Physiol 300, G1054-1064.
Amasheh, S., Meiri, N., Gitter, A.H., Schoneberg, T., Mankertz, J., Schulzke, J.D., and

121

Fromm, M. (2002). Claudin-2 expression induces cation-selective channels in tight
junctions of epithelial cells. J Cell Sci 115, 4969-4976.
Andersson-Rolf, A., Zilbauer, M., Koo, B.K., and Clevers, H. (2017). Stem Cells in Repair
of Gastrointestinal Epithelia. Physiology (Bethesda) 32, 278-289.
Angelow, S., Kim, K.J., and Yu, A.S. (2006). Claudin-8 modulates paracellular
permeability to acidic and basic ions in MDCK II cells. J Physiol 571, 15-26.
Apter, F.M., Lencer, W.I., Finkelstein, R.A., Mekalanos, J.J., and Neutra, M.R. (1993).
Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxininduced chloride secretory response and block toxin binding to intestinal epithelial cells in
vitro. Infect Immun 61, 5271-5278.
Artis, D., and Spits, H. (2015). The biology of innate lymphoid cells. Nature 517, 293-301.
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G.,
Yamasaki, S., Saito, T., Ohba, Y., et al. (2011). Induction of colonic regulatory T cells by
indigenous Clostridium species. Science 331, 337-341.
Bachmann, M., Horn, K., Rudloff, I., Goren, I., Holdener, M., Christen, U., Darsow, N.,
Hunfeld, K.P., Koehl, U., Kind, P., et al. (2010). Early production of IL-22 but not IL-17
by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of
monocytes and interleukin-1. PLoS Pathog 6, e1001144.
Baker, J.W., Thubrikar, M.J., Parekh, J.S., Forbes, M.S., and Nolan, S.P. (1991). Change
in endothelial cell morphology at arterial branch sites caused by a reduction of intramural
stress. Atherosclerosis 89, 209-221.
Balda, M.S., Whitney, J.A., Flores, C., Gonzalez, S., Cereijido, M., and Matter, K. (1996).
Functional dissociation of paracellular permeability and transepithelial electrical resistance

122

and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a
mutant tight junction membrane protein. J Cell Biol 134, 1031-1049.
Barker, N., and Clevers, H. (2010). Leucine-rich repeat-containing G-protein-coupled
receptors as markers of adult stem cells. Gastroenterology 138, 1681-1696.
Barker, N., van Es, J.H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M.,
Haegebarth, A., Korving, J., Begthel, H., Peters, P.J., and Clevers, H. (2007). Identification
of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003-1007.
Barthold, S.W., and Jonas, A.M. (1977). Morphogenesis of early 1, 2-dimethylhydrazineinduced lesions and latent period reduction of colon carcinogenesis in mice by a variant of
Citrobacter freundii. Cancer Res 37, 4352-4360.
Basuroy, S., Seth, A., Elias, B., Naren, A.P., and Rao, R. (2006). MAPK interacts with
occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen
peroxide. Biochem J 393, 69-77.
Bates, R.C., and Mercurio, A.M. (2003). Tumor necrosis factor-alpha stimulates the
epithelial-to-mesenchymal transition of human colonic organoids. Mol Biol Cell 14, 17901800.
Behrens, J., von Kries, J.P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and
Birchmeier, W. (1996). Functional interaction of beta-catenin with the transcription factor
LEF-1. Nature 382, 638-642.
Belle, N.M., Ji, Y., Herbine, K., Wei, Y., Park, J., Zullo, K., Hung, L.Y., Srivatsa, S.,
Young, T., Oniskey, T., et al. (2019). TFF3 interacts with LINGO2 to regulate EGFR
activation for protection against colitis and gastrointestinal helminths. Nat Commun 10,
4408.

123

Bergstrom, K.S., Guttman, J.A., Rumi, M., Ma, C., Bouzari, S., Khan, M.A., Gibson, D.L.,
Vogl, A.W., and Vallance, B.A. (2008). Modulation of intestinal goblet cell function
during infection by an attaching and effacing bacterial pathogen. Infect Immun 76, 796811.
Berkley, J.A., Lowe, B.S., Mwangi, I., Williams, T., Bauni, E., Mwarumba, S., Ngetsa, C.,
Slack, M.P., Njenga, S., Hart, C.A., et al. (2005). Bacteremia among children admitted to
a rural hospital in Kenya. N Engl J Med 352, 39-47.
Bjerknes, M., and Cheng, H. (1999). Clonal analysis of mouse intestinal epithelial
progenitors. Gastroenterology 116, 7-14.
Black, K.P., Cummins, J.E., Jr., and Jackson, S. (1996). Serum and secretory IgA from
HIV- infected individuals mediate antibody-dependent cellular cytotoxicity. Clin Immunol
Immunopathol 81, 182-190.
Brandl, K., Plitas, G., Mihu, C.N., Ubeda, C., Jia, T., Fleisher, M., Schnabl, B., DeMatteo,
R.P., and Pamer, E.G. (2008). Vancomycin-resistant enterococci exploit antibioticinduced innate immune deficits. Nature 455, 804-807.
Buda, A., Jepson, M.A., and Pignatelli, M. (2012). Regulatory function of trefoil peptides
(TFF) on intestinal cell junctional complexes. Cell Commun Adhes 19, 63-68.
Buffie, C.G., Jarchum, I., Equinda, M., Lipuma, L., Gobourne, A., Viale, A., Ubeda, C.,
Xavier, J., and Pamer, E.G. (2012). Profound alterations of intestinal microbiota following
a single dose of clindamycin results in sustained susceptibility to Clostridium difficileinduced colitis. Infect Immun 80, 62-73.
Burgmann, T., Clara, I., Graff, L., Walker, J., Lix, L., Rawsthorne, P., McPhail, C., Rogala,
L., Miller, N., and Bernstein, C.N. (2006). The Manitoba Inflammatory Bowel Disease

124

Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel
syndrome?
Clin Gastroenterol Hepatol 4, 614-620. Cai, Y., Yi, M., Chen, D., Liu, J., Guleng, B., Ren,
J., and Shi, H. (2016). Trefoil factor family 2 expression inhibits gastric cancer cell growth
and invasion in vitro via interactions with the transcription factor Sp3. Int J Mol Med 38,
1474-1480.
Campbell, H.K., Maiers, J.L., and DeMali, K.A. (2017). Interplay between tight junctions
& adherens junctions. Exp Cell Res 358, 39-44.
Capaldo, C.T., Farkas, A.E., Hilgarth, R.S., Krug, S.M., Wolf, M.F., Benedik, J.K.,
Fromm, M., Koval, M., Parkos, C., and Nusrat, A. (2014). Proinflammatory cytokineinduced tight junction remodeling through dynamic self-assembly of claudins. Mol Biol
Cell 25, 2710- 2719.
Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K.,
Fierer, N., Pena, A.G., Goodrich, J.K., Gordon, J.I., et al. (2010). QIIME allows analysis
of high-throughput community sequencing data. Nat Methods 7, 335-336.
Cardenas, M., Elofsson, U., and Lindh, L. (2007). Salivary mucin MUC5B could be an
important component of in vitro pellicles of human saliva: an in situ ellipsometry and
atomic force microscopy study. Biomacromolecules 8, 1149-1156.
Cario, E., and Podolsky, D.K. (2000). Differential alteration in intestinal epithelial cell
expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect
Immun 68, 7010-7017.
Cario, E., Rosenberg, I.M., Brandwein, S.L., Beck, P.L., Reinecker, H.C., and Podolsky,
D.K. (2000). Lipopolysaccharide activates distinct signaling pathways in intestinal

125

epithelial cell lines expressing Toll-like receptors. J Immunol 164, 966-972.
Carlier, M.F., and Pantaloni, D. (1997). Control of actin dynamics in cell motility. J Mol
Biol 269, 459-467.
Carlier, M.F., Ressad, F., and Pantaloni, D. (1999). Control of actin dynamics in cell
motility. Role of ADF/cofilin. J Biol Chem 274, 33827-33830.
Carmon, K.S., Lin, Q., Gong, X., Thomas, A., and Liu, Q. (2012). LGR5 interacts and
cointernalizes with Wnt receptors to modulate Wnt/beta-catenin signaling. Mol Cell Biol
32, 2054-2064.
Cash, H.L., Whitham, C.V., Behrendt, C.L., and Hooper, L.V. (2006). Symbiotic bacteria
direct expression of an intestinal bactericidal lectin. Science 313, 1126-1130.
Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., and
Colonna, M. (1999). Plasmacytoid monocytes migrate to inflamed lymph nodes and
produce large amounts of type I interferon. Nat Med 5, 919-923.
Chan, J.M., Bhinder, G., Sham, H.P., Ryz, N., Huang, T., Bergstrom, K.S., and Vallance,
B.A. (2013). CD4+ T cells drive goblet cell depletion during Citrobacter rodentium
infection. Infect Immun 81, 4649-4658.
Chandrakesan, P., Roy, B., Jakkula, L.U., Ahmed, I., Ramamoorthy, P., Tawfik, O.,
Papineni, R., Houchen, C., Anant, S., and Umar, S. (2014). Utility of a bacterial infection
model to study epithelial-mesenchymal transition, mesenchymal-epithelial transition or
tumorigenesis. Oncogene 33, 2639-2654.
Chang, P.Y., Jin, X., Jiang, Y.Y., Wang, L.X., Liu, Y.J., and Wang, J. (2016).
Mensenchymal stem cells can delay radiation-induced crypt death: impact on intestinal
CD44(+) fragments. Cell Tissue Res 364, 331-344.

126

Chassaing, B., Aitken, J.D., Malleshappa, M., and Vijay-Kumar, M. (2014). Dextran
sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol 104, 15 25 11-15 25
14.
Chateau, T., and Peyrin-Biroulet, L. (2019). Two Cases of Inflammatory Bowel Disease
Patients Treated With Ustekinumab 90 mg Every 3 Weeks. Inflamm Bowel Dis.
Chattopadhyay, P.K., Betts, M.R., Price, D.A., Gostick, E., Horton, H., Roederer, M., and
De Rosa, S.C. (2009). The cytolytic enzymes granyzme A, granzyme B, and perforin:
expression patterns, cell distribution, and their relationship to cell maturity and bright
CD57 expression. J Leukoc Biol 85, 88-97.
Cheifetz, A.S. (2013). Management of active Crohn disease. JAMA 309, 2150-2158.
Chinery, R., and Cox, H.M. (1995). Immunoprecipitation and characterization of a binding
protein specific for the peptide, intestinal trefoil factor. Peptides 16, 749-755.
Chinery, R., Poulsom, R., Elia, G., Hanby, A.M., and Wright, N.A. (1993). Expression and
purification of a trefoil peptide motif in a beta-galactosidase fusion protein and its use to
search for trefoil-binding sites. Eur J Biochem 212, 557-563.
Cleynen, I., Boucher, G., Jostins, L., Schumm, L.P., Zeissig, S., Ahmad, T., Andersen, V.,
Andrews, J.M., Annese, V., Brand, S., et al. (2016). Inherited determinants of Crohn's
disease and ulcerative colitis phenotypes: a genetic association study. Lancet 387, 156167.
Cohen, H.B., Ward, A., Hamidzadeh, K., Ravid, K., and Mosser, D.M. (2015). IFN-gamma
Prevents Adenosine Receptor (A2bR) Upregulation To Sustain the Macrophage Activation
Response. J Immunol 195, 3828-3837.
Cong, X., Zhang, Y., Li, J., Mei, M., Ding, C., Xiang, R.L., Zhang, L.W., Wang, Y., Wu,

127

L.L., and Yu, G.Y. (2015). Claudin-4 is required for modulation of paracellular
permeability by muscarinic acetylcholine receptor in epithelial cells. J Cell Sci 128, 22712286.
Coopman, P., and Djiane, A. (2016). Adherens Junction and E-Cadherin complex
regulation by epithelial polarity. Cell Mol Life Sci 73, 3535-3553.
Corfield, A.P. (2015). Mucins: a biologically relevant glycan barrier in mucosal protection.
Biochim Biophys Acta 1850, 236-252.
Dahlhamer, J.M., Zammitti, E.P., Ward, B.W., Wheaton, A.G., and Croft, J.B. (2016).
Prevalence of Inflammatory Bowel Disease Among Adults Aged >/=18 Years - United
States, 2015. MMWR Morb Mortal Wkly Rep 65, 1166-1169.
Davey, M., Liu, X., Ukai, T., Jain, V., Gudino, C., Gibson, F.C., 3rd, Golenbock, D.,
Visintin, A., and Genco, C.A. (2008). Bacterial fimbriae stimulate proinflammatory
activation in the endothelium through distinct TLRs. J Immunol 180, 2187-2195.
Davidson, L.A., Goldsby, J.S., Callaway, E.S., Shah, M.S., Barker, N., and Chapkin, R.S.
(2012). Alteration of colonic stem cell gene signatures during the regenerative response to
injury. Biochim Biophys Acta 1822, 1600-1607.
de Lau, W., Barker, N., Low, T.Y., Koo, B.K., Li, V.S., Teunissen, H., Kujala, P.,
Haegebarth, A., Peters, P.J., van de Wetering, M., et al. (2011). Lgr5 homologues associate
with Wnt receptors and mediate R-spondin signalling. Nature 476, 293-297.
Deng, W., Li, Y., Vallance, B.A., and Finlay, B.B. (2001). Locus of enterocyte effacement
from Citrobacter rodentium: sequence analysis and evidence for horizontal transfer among
attaching and effacing pathogens. Infect Immun 69, 6323-6335.
Deng, W., Puente, J.L., Gruenheid, S., Li, Y., Vallance, B.A., Vazquez, A., Barba, J.,

128

Ibarra, J.A., O'Donnell, P., Metalnikov, P., et al. (2004). Dissecting virulence: systematic
and functional analyses of a pathogenicity island. Proc Natl Acad Sci U S A 101, 35973602. Deng, W., Vallance, B.A., Li, Y., Puente, J.L., and Finlay, B.B. (2003). Citrobacter
rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for
actin condensation, intestinal colonization and colonic hyperplasia in mice. Mol Microbiol
48, 95-115.
DePoortere, D., Chen, B., and Cohen, N.A. (2013). Polyhydrated ionogen with MgBr2
accelerates in vitro respiratory epithelial healing. Am J Rhinol Allergy 27, 333-337.
Dessein, R., Gironella, M., Vignal, C., Peyrin-Biroulet, L., Sokol, H., Secher, T., LacasGervais, S., Gratadoux, J.J., Lafont, F., Dagorn, J.C., et al. (2009). Toll-like receptor 2 is
critical for induction of Reg3 beta expression and intestinal clearance of Yersinia
pseudotuberculosis. Gut 58, 771-776.
Drees, F., Pokutta, S., Yamada, S., Nelson, W.J., and Weis, W.I. (2005). Alpha-catenin is
a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament
assembly. Cell 123, 903-915.
Drescher, D.G., Selvakumar, D., and Drescher, M.J. (2018). Analysis of Protein
Interactions by Surface Plasmon Resonance. Adv Protein Chem Struct Biol 110, 1-30.
Dubeykovskaya, Z., Dubeykovskiy, A., Solal-Cohen, J., and Wang, T.C. (2009). Secreted
trefoil factor 2 activates the CXCR4 receptor in epithelial and lymphocytic cancer cell
lines. J Biol Chem 284, 3650-3662.
Dubeykovskaya, Z.A., Duddempudi, P.K., Deng, H., Valenti, G., Cuti, K.L., Nagar, K.,
Tailor, Y., Guha, C., Kitajewski, J., and Wang, T.C. (2019). Therapeutic potential of
adenovirus- mediated TFF2-CTP-Flag peptide for treatment of colorectal cancer. Cancer

129

Gene Ther 26, 48-57.
Duraivelan, K., Basak, A.J., Ghosh, A., and Samanta, D. (2018). Molecular and structural
bases of interaction between extracellular domains of nectin-2 and N-cadherin. Proteins
86, 1157-1164.
Earle, K.A., Billings, G., Sigal, M., Lichtman, J.S., Hansson, G.C., Elias, J.E., Amieva,
M.R., Huang, K.C., and Sonnenburg, J.L. (2015). Quantitative Imaging of Gut Microbiota
Spatial Organization. Cell Host Microbe 18, 478-488.
Engevik, K.A., Hanyu, H., Matthis, A.L., Zhang, T., Frey, M.R., Oshima, Y., Aihara, E.,
and Montrose, M.H. (2019). Trefoil factor 2 activation of CXCR4 requires calcium
mobilization to drive epithelial repair in gastric organoids. J Physiol 597, 2673-2690.
Fafilek, B., Krausova, M., Vojtechova, M., Pospichalova, V., Tumova, L., Sloncova, E.,
Huranova, M., Stancikova, J., Hlavata, A., Svec, J., et al. (2013). Troy, a tumor necrosis
factor receptor family member, interacts with lgr5 to inhibit wnt signaling in intestinal stem
cells. Gastroenterology 144, 381-391.
Fakhoury, M., Negrulj, R., Mooranian, A., and Al-Salami, H. (2014). Inflammatory bowel
disease: clinical aspects and treatments. J Inflamm Res 7, 113-120.
Fang, K., Bruce, M., Pattillo, C.B., Zhang, S., Stone, R., 2nd, Clifford, J., and Kevil, C.G.
(2011). Temporal genomewide expression profiling of DSS colitis reveals novel
inflammatory and angiogenesis genes similar to ulcerative colitis. Physiol Genomics 43,
43-56.
Farhadi, A., Keshavarzian, A., Ranjbaran, Z., Fields, J.Z., and Banan, A. (2006). The role
of protein kinase C isoforms in modulating injury and repair of the intestinal barrier. J
Pharmacol Exp Ther 316, 1-7.

130

Farid, A.S., Jimi, F., Inagaki-Ohara, K., and Horii, Y. (2008). Increased intestinal
endotoxin absorption during enteric nematode but not protozoal infections through a mast
cell- mediated mechanism. Shock 29, 709-716.
Farquhar, M.G., and Palade, G.E. (1963). Junctional complexes in various epithelia. J Cell
Biol 17, 375-412.
Farrell, J.J., Taupin, D., Koh, T.J., Chen, D., Zhao, C.M., Podolsky, D.K., and Wang, T.C.
(2002). TFF2/SP-deficient mice show decreased gastric proliferation, increased acid
secretion, and increased susceptibility to NSAID injury. J Clin Invest 109, 193-204.
Feuerstein, J.D., and Cheifetz, A.S. (2017). Crohn Disease: Epidemiology, Diagnosis, and
Management. Mayo Clin Proc 92, 1088-1103.
Flynn, A.N., and Buret, A.G. (2008). Tight junctional disruption and apoptosis in an in
vitro model of Citrobacter rodentium infection. Microb Pathog 45, 98-104.
Forbes, S.J., Eschmann, M., and Mantis, N.J. (2008). Inhibition of Salmonella enterica
serovar typhimurium motility and entry into epithelial cells by a protective
antilipopolysaccharide monoclonal immunoglobulin A antibody. Infect Immun 76, 41374144.
Frei, A.P., Jeon, O.Y., Kilcher, S., Moest, H., Henning, L.M., Jost, C., Pluckthun, A.,
Mercer, J., Aebersold, R., Carreira, E.M., and Wollscheid, B. (2012). Direct identification
of ligand- receptor interactions on living cells and tissues. Nat Biotechnol 30, 997-1001.
Frei, A.P., Moest, H., Novy, K., and Wollscheid, B. (2013). Ligand-based receptor
identification on living cells and tissues using TRICEPS. Nat Protoc 8, 1321-1336. Frenkel,
E.S., and Ribbeck, K. (2015). Salivary mucins protect surfaces from colonization by
cariogenic bacteria. Appl Environ Microbiol 81, 332-338.

131

Furuse, M., Hata, M., Furuse, K., Yoshida, Y., Haratake, A., Sugitani, Y., Noda, T., Kubo,
A., and Tsukita, S. (2002). Claudin-based tight junctions are crucial for the mammalian
epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 156, 1099-1111.
Gajhede, M., Petersen, T.N., Henriksen, A., Petersen, J.F., Dauter, Z., Wilson, K.S., and
Thim, L. (1993). Pancreatic spasmolytic polypeptide: first three-dimensional structure of a
member of the mammalian trefoil family of peptides. Structure 1, 253-262.
Garber, J.J., Mallick, E.M., Scanlon, K.M., Turner, J.R., Donnenberg, M.S., Leong, J.M.,
and Snapper, S.B. (2018). Attaching-and-Effacing Pathogens Exploit Junction Regulatory
Activities of N-WASP and SNX9 to Disrupt the Intestinal Barrier. Cell Mol Gastroenterol
Hepatol 5, 273-288.
Gauberg, J., Wu, N., Cramp, R.L., Kelly, S.P., and Franklin, C.E. (2019). A lethal fungal
pathogen directly alters tight junction proteins in the skin of a susceptible amphibian. J Exp
Biol 222.
Geier, M.S., Smith, C.L., Butler, R.N., and Howarth, G.S. (2009). Small-intestinal
manifestations of dextran sulfate sodium consumption in rats and assessment of the effects
of Lactobacillus fermentum BR11. Dig Dis Sci 54, 1222-1228.
Geremia, A., Arancibia-Carcamo, C.V., Fleming, M.P., Rust, N., Singh, B., Mortensen,
N.J., Travis, S.P., and Powrie, F. (2011). IL-23-responsive innate lymphoid cells are
increased in inflammatory bowel disease. J Exp Med 208, 1127-1133.
Gibson, D.L., Ma, C., Bergstrom, K.S., Huang, J.T., Man, C., and Vallance, B.A. (2008a).
MyD88 signalling plays a critical role in host defence by controlling pathogen burden and
promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis. Cell
Microbiol 10, 618-631.

132

Gibson, D.L., Ma, C., Rosenberger, C.M., Bergstrom, K.S., Valdez, Y., Huang, J.T., Khan,
M.A., and Vallance, B.A. (2008b). Toll-like receptor 2 plays a critical role in maintaining
mucosal integrity during Citrobacter rodentium-induced colitis. Cell Microbiol 10, 388403.
Glover, L.E., Lee, J.S., and Colgan, S.P. (2016). Oxygen metabolism and barrier regulation
in the intestinal mucosa. J Clin Invest 126, 3680-3688.
Grill, J.I., Neumann, J., Hiltwein, F., Kolligs, F.T., and Schneider, M.R. (2015). Intestinal
E- cadherin Deficiency Aggravates Dextran Sodium Sulfate-Induced Colitis. Dig Dis Sci
60, 895-902.
Gronbaek, H., Vestergaard, E.M., Hey, H., Nielsen, J.N., and Nexo, E. (2006). Serum
trefoil factors in patients with inflammatory bowel disease. Digestion 74, 33-39.
Guan, H., Nagarkatti, P.S., and Nagarkatti, M. (2009). Role of CD44 in the differentiation
of Th1 and Th2 cells: CD44-deficiency enhances the development of Th2 effectors in
response to sheep RBC and chicken ovalbumin. J Immunol 183, 172-180.
Guilliams, M., Dutertre, C.A., Scott, C.L., McGovern, N., Sichien, D., Chakarov, S., Van
Gassen, S., Chen, J., Poidinger, M., De Prijck, S., et al. (2016). Unsupervised HighDimensional Analysis Aligns Dendritic Cells across Tissues and Species. Immunity 45,
669-684.
Guo, D., Liu, X., Zeng, C., Cheng, L., Song, G., Hou, X., Zhu, L., and Zou, K. (2019).
Estrogen receptor beta activation ameliorates DSS-induced chronic colitis by inhibiting
inflammation and promoting Treg differentiation. Int Immunopharmacol 77, 105971.
Guttman, J.A., Samji, F.N., Li, Y., Vogl, A.W., and Finlay, B.B. (2006). Evidence that
tight junctions are disrupted due to intimate bacterial contact and not inflammation during

133

attaching and effacing pathogen infection in vivo. Infect Immun 74, 6075-6084.
Haber, A.L., Biton, M., Rogel, N., Herbst, R.H., Shekhar, K., Smillie, C., Burgin, G.,
Delorey, T.M., Howitt, M.R., Katz, Y., et al. (2017). A single-cell survey of the small
intestinal epithelium. Nature 551, 333-339.
Haghi, F., Zeighami, H., Hajiahmadi, F., Khoshvaght, H., and Bayat, M. (2014). Frequency
and antimicrobial resistance of diarrhoeagenic Escherichia coli from young children in
Iran. J Med Microbiol 63, 427-432.
Hahn, S., Nam, M.O., Noh, J.H., Lee, D.H., Han, H.W., Kim, D.H., Hahm, K.B., Hong,
S.P.,
Yoo, J.H., and Yoo, J. (2017). Organoid-based epithelial to mesenchymal transition
(OEMT) model: from an intestinal fibrosis perspective. Sci Rep 7, 2435.
Haines, B.P., and Rigby, P.W. (2008). Expression of the Lingo/LERN gene family during
mouse embryogenesis. Gene Expr Patterns 8, 79-86.
Hanash, A.M., Dudakov, J.A., Hua, G., O'Connor, M.H., Young, L.F., Singer, N.V., West,
M.L., Jenq, R.R., Holland, A.M., Kappel, L.W., et al. (2012). Interleukin-22 protects
intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft
versus host disease. Immunity 37, 339-350.
Hand, T.W., Dos Santos, L.M., Bouladoux, N., Molloy, M.J., Pagan, A.J., Pepper, M.,
Maynard, C.L., Elson, C.O., 3rd, and Belkaid, Y. (2012). Acute gastrointestinal infection
induces long-lived microbiota-specific T cell responses. Science 337, 1553-1556.
Hanisch, C., Sharbati, J., Kutz-Lohroff, B., Huber, O., Einspanier, R., and Sharbati, S.
(2017). Trefoil factor 3 mediates resistance to apoptosis in colon carcinoma cells by a
regulatory RNA axis. Cell Death Dis 8, e2660.

134

Harpur, C.M., Kato, Y., Dewi, S.T., Stankovic, S., Johnson, D.N., Bedoui, S., Whitney,
P.G., Lahoud, M.H., Caminschi, I., Heath, W.R., et al. (2019). Classical Type 1 Dendritic
Cells Dominate Priming of Th1 Responses to Herpes Simplex Virus Type 1 Skin Infection.
J Immunol 202, 653-663.
Harrison, O.J., Srinivasan, N., Pott, J., Schiering, C., Krausgruber, T., Ilott, N.E., and
Maloy, K.J. (2015). Epithelial-derived IL-18 regulates Th17 cell differentiation and
Foxp3(+) Treg cell function in the intestine. Mucosal Immunol 8, 1226-1236.
Hartland, E.L., and Leong, J.M. (2013). Enteropathogenic and enterohemorrhagic E. coli:
ecology, pathogenesis, and evolution. Front Cell Infect Microbiol 3, 15.
Hauser, F., Nothacker, H.P., and Grimmelikhuijzen, C.J. (1997). Molecular cloning,
genomic organization, and developmental regulation of a novel receptor from Drosophila
melanogaster structurally related to members of the thyroid-stimulating hormone, folliclestimulating hormone, luteinizing hormone/choriogonadotropin receptor family from
mammals. J Biol Chem 272, 1002-1010.
Hausmann, M., Kiessling, S., Mestermann, S., Webb, G., Spottl, T., Andus, T.,
Scholmerich, J., Herfarth, H., Ray, K., Falk, W., and Rogler, G. (2002). Toll-like receptors
2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122, 1987- 2000.
He, R., Yin, H., Yuan, B., Liu, T., Luo, L., Huang, P., Dai, L., and Zeng, K. (2017). IL-33
improves wound healing through enhanced M2 macrophage polarization in diabetic mice.
Mol Immunol 90, 42-49.
Herpin, A., Badariotti, F., Rodet, F., and Favrel, P. (2004). Molecular characterization of a
new leucine-rich repeat-containing G protein-coupled receptor from a bivalve mollusc:
evolutionary implications. Biochim Biophys Acta 1680, 137-144.

135

Hershberg, R.M., and Mayer, L.F. (2000). Antigen processing and presentation by
intestinal epithelial cells - polarity and complexity. Immunol Today 21, 123-128. Higgins,
L.M., Frankel, G., Douce, G., Dougan, G., and MacDonald, T.T. (1999).
Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and
lesions similar to those in murine inflammatory bowel disease. Infect Immun 67, 30313039.
Hiippala, K., Jouhten, H., Ronkainen, A., Hartikainen, A., Kainulainen, V., Jalanka, J., and
Satokari, R. (2018). The Potential of Gut Commensals in Reinforcing Intestinal Barrier
Function and Alleviating Inflammation. Nutrients 10.
Hoffmann, W. (2005). Trefoil factors TFF (trefoil factor family) peptide-triggered signals
promoting mucosal restitution. Cell Mol Life Sci 62, 2932-2938.
Hsu, Y.C., Li, L., and Fuchs, E. (2014). Transit-amplifying cells orchestrate stem cell
activity and tissue regeneration. Cell 157, 935-949.
Huang, C., Li, F., Wang, J., and Tian, Z. (2019). Innate-like Lymphocytes and Innate
Lymphoid Cells in Asthma. Clin Rev Allergy Immunol.
Hug, H., Mohajeri, M.H., and La Fata, G. (2018). Toll-Like Receptors: Regulators of the
Immune Response in the Human Gut. Nutrients 10.
Hugot, J.P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J.P., Belaiche, J., Almer, S.,
Tysk, C., O'Morain, C.A., Gassull, M., et al. (2001). Association of NOD2 leucine-rich
repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603.
Hung, L.Y., Oniskey, T.K., Sen, D., Krummel, M.F., Vaughan, A.E., Cohen, N.A., and
Herbert, D.R. (2018). Trefoil Factor 2 Promotes Type 2 Immunity and Lung Repair through
Intrinsic Roles in Hematopoietic and Nonhematopoietic Cells. Am J Pathol 188, 1161-

136

1170.
Hung, L.Y., Sen, D., Oniskey, T.K., Katzen, J., Cohen, N.A., Vaughan, A.E., Nieves, W.,
Urisman, A., Beers, M.F., Krummel, M.F., and Herbert, D.R. (2019). Macrophages
promote epithelial proliferation following infectious and non-infectious lung injury
through a Trefoil factor 2-dependent mechanism. Mucosal Immunol 12, 64-76.
Inoue, H., Lin, L., Lee, X., Shao, Z., Mendes, S., Snodgrass-Belt, P., Sweigard, H., Engber,
T., Pepinsky, B., Yang, L., et al. (2007). Inhibition of the leucine-rich repeat protein
LINGO-1 enhances survival, structure, and function of dopaminergic neurons in
Parkinson's disease models. Proc Natl Acad Sci U S A 104, 14430-14435.
Itoh, H., Nishino, M., and Hatabu, H. (2004). Architecture of the lung: morphology and
function. J Thorac Imaging 19, 221-227.
Itoh, M., Furuse, M., Morita, K., Kubota, K., Saitou, M., and Tsukita, S. (1999). Direct
binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the
COOH termini of claudins. J Cell Biol 147, 1351-1363.
Ivanov, II, Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D., Goldfarb,
K.C., Santee, C.A., Lynch, S.V., et al. (2009). Induction of intestinal Th17 cells by
segmented filamentous bacteria. Cell 139, 485-498.
Jasarevic, E., Howard, C.D., Morrison, K., Misic, A., Weinkopff, T., Scott, P., Hunter, C.,
Beiting, D., and Bale, T.L. (2018). The maternal vaginal microbiome partially mediates the
effects of prenatal stress on offspring gut and hypothalamus. Nat Neurosci.
Jerse, A.E., Yu, J., Tall, B.D., and Kaper, J.B. (1990). A genetic locus of enteropathogenic
Escherichia coli necessary for the production of attaching and effacing lesions on tissue
culture cells. Proc Natl Acad Sci U S A 87, 7839-7843.

137

Jiang, J., Zenewicz, L.A., San Mateo, L.R., Lau, L.L., and Shen, H. (2003). Activation of
antigen-specific CD8 T cells results in minimal killing of bystander bacteria. J Immunol
171, 6032-6038.
Jit, I. (1953). The development of the goblet cells in the human gut. Indian J Med Res 41,
479-482.
Johansson, M.E., Phillipson, M., Petersson, J., Velcich, A., Holm, L., and Hansson, G.C.
(2008). The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of
bacteria. Proc Natl Acad Sci U S A 105, 15064-15069.
Joly Condette, C., Khorsi-Cauet, H., Morliere, P., Zabijak, L., Reygner, J., Bach, V., and
Gay-Queheillard, J. (2014). Increased gut permeability and bacterial translocation after
chronic chlorpyrifos exposure in rats. PLoS One 9, e102217.
Judd, L.M., Chalinor, H.V., Walduck, A., Pavlic, D.I., Dabritz, J., Dubeykovskaya, Z.,
Wang, T.C., Menheniott, T.R., and Giraud, A.S. (2015). TFF2 deficiency exacerbates
weight loss and alters immune cell and cytokine profiles in DSS colitis, and this cannot be
rescued by wild-type bone marrow. Am J Physiol Gastrointest Liver Physiol 308, G12-24.
Kaboord, B., and Perr, M. (2008). Isolation of proteins and protein complexes by
immunoprecipitation. Methods Mol Biol 424, 349-364.
Kaper, J.B., Nataro, J.P., and Mobley, H.L. (2004). Pathogenic Escherichia coli. Nat Rev
Microbiol 2, 123-140.
Kara, E.E., Comerford, I., Fenix, K.A., Bastow, C.R., Gregor, C.E., McKenzie, D.R., and
McColl, S.R. (2014). Tailored immune responses: novel effector helper T cell subsets in
protective immunity. PLoS Pathog 10, e1003905.
Kiela, P.R., and Ghishan, F.K. (2016). Physiology of Intestinal Absorption and Secretion.

138

Best Pract Res Clin Gastroenterol 30, 145-159.
Kim, B.S., Siracusa, M.C., Saenz, S.A., Noti, M., Monticelli, L.A., Sonnenberg, G.F.,
Hepworth, M.R., Van Voorhees, A.S., Comeau, M.R., and Artis, D. (2013). TSLP elicits
IL- 33-independent innate lymphoid cell responses to promote skin inflammation. Sci
Transl Med 5, 170ra116.
Kim, K.A., Wagle, M., Tran, K., Zhan, X., Dixon, M.A., Liu, S., Gros, D., Korver, W.,
Yonkovich, S., Tomasevic, N., et al. (2008). R-Spondin family members regulate the Wnt
pathway by a common mechanism. Mol Biol Cell 19, 2588-2596.
Kim, T.W., Seo, J.N., Suh, Y.H., Park, H.J., Kim, J.H., Kim, J.Y., and Oh, K.I. (2006).
Involvement of lymphocytes in dextran sulfate sodium-induced experimental colitis.
World J Gastroenterol 12, 302-305.
Kimura, K., Ito, M., Amano, M., Chihara, K., Fukata, Y., Nakafuku, M., Yamamori, B.,
Feng, J., Nakano, T., Okawa, K., et al. (1996). Regulation of myosin phosphatase by Rho
and Rho-associated kinase (Rho-kinase). Science 273, 245-248.
Kinzel, B., Pikiolek, M., Orsini, V., Sprunger, J., Isken, A., Zietzling, S., Desplanches, M.,
Dubost, V., Breustedt, D., Valdez, R., et al. (2014). Functional roles of Lgr4 and Lgr5 in
embryonic gut, kidney and skin development in mice. Dev Biol 390, 181-190.
Kirchberger, S., Royston, D.J., Boulard, O., Thornton, E., Franchini, F., Szabady, R.L.,
Harrison, O., and Powrie, F. (2013). Innate lymphoid cells sustain colon cancer through
production of interleukin-22 in a mouse model. J Exp Med 210, 917-931.
Kjellev, S., Thim, L., Pyke, C., and Poulsen, S.S. (2007). Cellular localization, binding
sites, and pharmacologic effects of TFF3 in experimental colitis in mice. Dig Dis Sci 52,
1050- 1059.

139

Kjetland, E.F., Hegertun, I.E., Baay, M.F., Onsrud, M., Ndhlovu, P.D., and Taylor, M.
(2014). Genital schistosomiasis and its unacknowledged role on HIV transmission in the
STD intervention studies. Int J STD AIDS 25, 705-715.
Kohanski, M.A., Workman, A.D., Patel, N.N., Hung, L.Y., Shtraks, J.P., Chen, B., Blasetti,
M., Doghramji, L., Kennedy, D.W., Adappa, N.D., et al. (2018). Solitary chemosensory
cells are a primary epithelial source of IL-25 in patients with chronic rhinosinusitis with
nasal polyps. J Allergy Clin Immunol 142, 460-469 e467.
Koo, B.K., and Clevers, H. (2014). Stem cells marked by the R-spondin receptor LGR5.
Gastroenterology 147, 289-302.
Kozar, S., Morrissey, E., Nicholson, A.M., van der Heijden, M., Zecchini, H.I., Kemp, R.,
Tavare, S., Vermeulen, L., and Winton, D.J. (2013). Continuous clonal labeling reveals
small numbers of functional stem cells in intestinal crypts and adenomas. Cell Stem Cell
13, 626-633.
Kozich, J.J., Westcott, S.L., Baxter, N.T., Highlander, S.K., and Schloss, P.D. (2013).
Development of a dual-index sequencing strategy and curation pipeline for analyzing
amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ
Microbiol 79, 5112-5120.
Kramer, B., Goeser, F., Lutz, P., Glassner, A., Boesecke, C., Schwarze-Zander, C.,
Kaczmarek, D., Nischalke, H.D., Branchi, V., Manekeller, S., et al. (2017). Compartmentspecific distribution of human intestinal innate lymphoid cells is altered in HIV patients
under effective therapy. PLoS Pathog 13, e1006373.
Krndija, D., El Marjou, F., Guirao, B., Richon, S., Leroy, O., Bellaiche, Y., Hannezo, E.,
and Matic Vignjevic, D. (2019). Active cell migration is critical for steady-state epithelial

140

turnover in the gut. Science 365, 705-710.
Kruse, K., Lee, Q.S., Sun, Y., Klomp, J., Yang, X., Huang, F., Sun, M.Y., Zhao, S., Hong,
Z., Vogel, S.M., et al. (2019). N-cadherin signaling via Trio assembles adherens junctions
to restrict endothelial permeability. J Cell Biol 218, 299-316.
Kudo, M., Chen, T., Nakabayashi, K., Hsu, S.Y., and Hsueh, A.J. (2000). The nematode
leucine-rich repeat-containing, G protein-coupled receptor (LGR) protein homologous to
vertebrate gonadotropin and thyrotropin receptors is constitutively active in mammalian
cells. Mol Endocrinol 14, 272-284.
Kurt-Jones, E.A., Cao, L., Sandor, F., Rogers, A.B., Whary, M.T., Nambiar, P.R., Cerny,
A., Bowen, G., Yan, J., Takaishi, S., et al. (2007). Trefoil family factor 2 is expressed in
murine gastric and immune cells and controls both gastrointestinal inflammation and
systemic immune responses. Infect Immun 75, 471-480.
Lauber, J.S., Abrams, H.L., and Ray, M.C. (1989). Silent bowel perforation occurring
during corticosteroid treatment for pemphigus vulgaris. Cutis 43, 27-28.
Le, J., Zhang, D.Y., Zhao, Y., Qiu, W., Wang, P., and Sun, Y. (2016). ITF promotes
migration of intestinal epithelial cells through crosstalk between the ERK and JAK/STAT3
pathways. Sci Rep 6, 33014.
Lebeis, S.L., Bommarius, B., Parkos, C.A., Sherman, M.A., and Kalman, D. (2007). TLR
signaling mediated by MyD88 is required for a protective innate immune response by
neutrophils to Citrobacter rodentium. J Immunol 179, 566-577.
Lee, K.A., Kim, S.H., Kim, E.K., Ha, E.M., You, H., Kim, B., Kim, M.J., Kwon, Y., Ryu,
J.H., and Lee, W.J. (2013). Bacterial-derived uracil as a modulator of mucosal immunity
and gut-microbe homeostasis in Drosophila. Cell 153, 797-811.

141

Lee, R.J., Chen, B., Redding, K.M., Margolskee, R.F., and Cohen, N.A. (2014). Mouse
nasal epithelial innate immune responses to Pseudomonas aeruginosa quorum-sensing
molecules require taste signaling components. Innate Immun 20, 606-617.
Lewis, B.B., Buffie, C.G., Carter, R.A., Leiner, I., Toussaint, N.C., Miller, L.C., Gobourne,
A., Ling, L., and Pamer, E.G. (2015). Loss of Microbiota-Mediated Colonization
Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With
Metronidazole. J Infect Dis 212, 1656-1665.
Lien, E., Sellati, T.J., Yoshimura, A., Flo, T.H., Rawadi, G., Finberg, R.W., Carroll, J.D.,
Espevik, T., Ingalls, R.R., Radolf, J.D., and Golenbock, D.T. (1999). Toll-like receptor 2
functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 274,
33419-33425.
Lindemans, C.A., Calafiore, M., Mertelsmann, A.M., O'Connor, M.H., Dudakov, J.A.,
Jenq, R.R., Velardi, E., Young, L.F., Smith, O.M., Lawrence, G., et al. (2015). Interleukin22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature 528, 560-564.
Liu, H., Magoun, L., Luperchio, S., Schauer, D.B., and Leong, J.M. (1999). The Tirbinding region of enterohaemorrhagic Escherichia coli intimin is sufficient to trigger actin
condensation after bacterial-induced host cell signalling. Mol Microbiol 34, 67-81.
Liu, S., Qian, Y., Li, L., Wei, G., Guan, Y., Pan, H., Guan, X., Zhang, L., Lu, X., Zhao,
Y., et al. (2013). Lgr4 gene deficiency increases susceptibility and severity of dextran
sodium sulfate-induced inflammatory bowel disease in mice. J Biol Chem 288, 8794-8803;
discussion 8804.
Liu, Y., Nusrat, A., Schnell, F.J., Reaves, T.A., Walsh, S., Pochet, M., and Parkos, C.A.
(2000). Human junction adhesion molecule regulates tight junction resealing in epithelia.

142

J Cell Sci 113 ( Pt 13), 2363-2374.
Loftus, E.V., Jr. (2004). Clinical epidemiology of inflammatory bowel disease: Incidence,
prevalence, and environmental influences. Gastroenterology 126, 1504-1517.
Loncar, M.B., Al-azzeh, E.D., Sommer, P.S., Marinovic, M., Schmehl, K., Kruschewski,
M., Blin, N., Stohwasser, R., Gott, P., and Kayademir, T. (2003). Tumour necrosis factor
alpha and nuclear factor kappaB inhibit transcription of human TFF3 encoding a
gastrointestinal healing peptide. Gut 52, 1297-1303.
Lopetuso, L.R., De Salvo, C., Pastorelli, L., Rana, N., Senkfor, H.N., Petito, V., Di
Martino, L., Scaldaferri, F., Gasbarrini, A., Cominelli, F., et al. (2018). IL-33 promotes
recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and
repair. Proc Natl Acad Sci U S A 115, E9362-E9370.
Lu, X., Jain, V.V., Finn, P.W., and Perkins, D.L. (2007). Hubs in biological interaction
networks exhibit low changes in expression in experimental asthma. Mol Syst Biol 3, 98.
Luperchio, S.A., and Schauer, D.B. (2001). Molecular pathogenesis of Citrobacter
rodentium and transmissible murine colonic hyperplasia. Microbes Infect 3, 333-340.
Lupp, C., Robertson, M.L., Wickham, M.E., Sekirov, I., Champion, O.L., Gaynor, E.C.,
and Finlay, B.B. (2007). Host-mediated inflammation disrupts the intestinal microbiota and
promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2, 119-129.
Lykens, J.E., Terrell, C.E., Zoller, E.E., Risma, K., and Jordan, M.B. (2011). Perforin is a
critical physiologic regulator of T-cell activation. Blood 118, 618-626.
Maaser, C., Housley, M.P., Iimura, M., Smith, J.R., Vallance, B.A., Finlay, B.B.,
Schreiber, J.R., Varki, N.M., Kagnoff, M.F., and Eckmann, L. (2004). Clearance of
Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM

143

antibodies. Infect Immun 72, 3315-3324.
Madsen, K., Cornish, A., Soper, P., McKaigney, C., Jijon, H., Yachimec, C., Doyle, J.,
Jewell, L., and De Simone, C. (2001). Probiotic bacteria enhance murine and human
intestinal epithelial barrier function. Gastroenterology 121, 580-591.
Mahe, M.M., Aihara, E., Schumacher, M.A., Zavros, Y., Montrose, M.H., Helmrath, M.A.,
Sato, T., and Shroyer, N.F. (2013). Establishment of Gastrointestinal Epithelial Organoids.
Curr Protoc Mouse Biol 3, 217-240.
Mandell, K.J., Babbin, B.A., Nusrat, A., and Parkos, C.A. (2005). Junctional adhesion
molecule 1 regulates epithelial cell morphology through effects on beta1 integrins and
Rap1 activity. J Biol Chem 280, 11665-11674.
Mantis, N.J., McGuinness, C.R., Sonuyi, O., Edwards, G., and Farrant, S.A. (2006).
Immunoglobulin A antibodies against ricin A and B subunits protect epithelial cells from
ricin intoxication. Infect Immun 74, 3455-3462.
Marchand, J.B., Kaiser, D.A., Pollard, T.D., and Higgs, H.N. (2001). Interaction of
WASP/Scar proteins with actin and vertebrate Arp2/3 complex. Nat Cell Biol 3, 76-82.
Marshman, E., Booth, C., and Potten, C.S. (2002). The intestinal epithelial stem cell.
Bioessays 24, 91-98.
Martin-Gallausiaux, C., Larraufie, P., Jarry, A., Beguet-Crespel, F., Marinelli, L., Ledue,
F., Reimann, F., Blottiere, H.M., and Lapaque, N. (2018). Butyrate Produced by
Commensal Bacteria Down-Regulates Indolamine 2,3-Dioxygenase 1 (IDO-1) Expression
via a Dual Mechanism in Human Intestinal Epithelial Cells. Front Immunol 9, 2838.
Maseda, D., Zackular, J.P., Trindade, B., Kirk, L., Roxas, J.L., Rogers, L.M., Washington,
M.K., Du, L., Koyama, T., Viswanathan, V.K., et al. (2019). Nonsteroidal Anti-

144

inflammatory Drugs Alter the Microbiota and Exacerbate Clostridium difficile Colitis
while Dysregulating the Inflammatory Response. MBio 10.
Mashimo, H., Wu, D.C., Podolsky, D.K., and Fishman, M.C. (1996). Impaired defense of
intestinal mucosa in mice lacking intestinal trefoil factor. Science 274, 262-265.
Massey-Harroche, D. (2000). Epithelial cell polarity as reflected in enterocytes. Microsc
Res Tech 49, 353-362.
Maxwell, J.R., Yadav, R., Rossi, R.J., Ruby, C.E., Weinberg, A.D., Aguila, H.L., and
Vella,
A.T. (2006). IL-18 bridges innate and adaptive immunity through IFN-gamma and the
CD134 pathway. J Immunol 177, 234-245.
McBerry, C., Egan, C.E., Rani, R., Yang, Y., Wu, D., Boespflug, N., Boon, L., Butcher,
B., Mirpuri, J., Hogan, S.P., et al. (2012). Trefoil factor 2 negatively regulates type 1
immunity against Toxoplasma gondii. J Immunol 189, 3078-3084.
McCauley, H.A., and Guasch, G. (2015). Three cheers for the goblet cell: maintaining
homeostasis in mucosal epithelia. Trends Mol Med 21, 492-503.
McDaniel, T.K., Jarvis, K.G., Donnenberg, M.S., and Kaper, J.B. (1995). A genetic locus
of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc Natl
Acad Sci U S A 92, 1664-1668.
Metidji, A., Omenetti, S., Crotta, S., Li, Y., Nye, E., Ross, E., Li, V., Maradana, M.R.,
Schiering, C., and Stockinger, B. (2019). The Environmental Sensor AHR Protects from
Inflammatory Damage by Maintaining Intestinal Stem Cell Homeostasis and Barrier
Integrity. Immunity 50, 1542.
Meyer zum Buschenfelde, D., Hoschutzky, H., Tauber, R., and Huber, O. (2004).

145

Molecular mechanisms involved in TFF3 peptide-mediated modulation of the Ecadherin/catenin cell adhesion complex. Peptides 25, 873-883.
Meyer zum Buschenfelde, D., Tauber, R., and Huber, O. (2006). TFF3-peptide increases
transepithelial resistance in epithelial cells by modulating claudin-1 and -2 expression.
Peptides 27, 3383-3390.
Mi, S., Lee, X., Shao, Z., Thill, G., Ji, B., Relton, J., Levesque, M., Allaire, N., Perrin, S.,
Sands, B., et al. (2004). LINGO-1 is a component of the Nogo-66 receptor/p75 signaling
complex. Nat Neurosci 7, 221-228.
Mills, C.D., Kincaid, K., Alt, J.M., Heilman, M.J., and Hill, A.M. (2000). M-1/M-2
macrophages and the Th1/Th2 paradigm. J Immunol 164, 6166-6173.
Mims, J.W. (2015). Asthma: definitions and pathophysiology. Int Forum Allergy Rhinol 5
Suppl 1, S2-6.
Moe, H. (1953). Mucus-producing goblet cells of the small intestine. Nature 172, 309.
Moehle, C., Ackermann, N., Langmann, T., Aslanidis, C., Kel, A., Kel-Margoulis, O.,
Schmitz-Madry, A., Zahn, A., Stremmel, W., and Schmitz, G. (2006). Aberrant intestinal
expression and allelic variants of mucin genes associated with inflammatory bowel disease.
J Mol Med (Berl) 84, 1055-1066.
Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S.,
Korinek, V., Roose, J., Destree, O., and Clevers, H. (1996). XTcf-3 transcription factor
mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86, 391-399.
Moparthi, L., and Koch, S. (2019). Wnt signaling in intestinal inflammation.
Differentiation 108, 24-32.
Mouchacca, P., Chasson, L., Frick, M., Foray, C., Schmitt-Verhulst, A.M., and Boyer, C.

146

(2015). Visualization of granzyme B-expressing CD8 T cells during primary and secondary
immune responses to Listeria monocytogenes. Immunology 145, 24-33.
Muise, A.M., Walters, T.D., Glowacka, W.K., Griffiths, A.M., Ngan, B.Y., Lan, H., Xu,
W., Silverberg, M.S., and Rotin, D. (2009). Polymorphisms in E-cadherin (CDH1) result
in a mis-localised cytoplasmic protein that is associated with Crohn's disease. Gut 58, 11211127.
Mundy, R., MacDonald, T.T., Dougan, G., Frankel, G., and Wiles, S. (2005). Citrobacter
rodentium of mice and man. Cell Microbiol 7, 1697-1706.
Nair, M.G., and Herbert, D.R. (2016). Immune polarization by hookworms: taking cues
from T helper type 2, type 2 innate lymphoid cells and alternatively activated macrophages.
Immunology 148, 115-124.
Nathan, C.F., Murray, H.W., Wiebe, M.E., and Rubin, B.Y. (1983). Identification of
interferon-gamma as the lymphokine that activates human macrophage oxidative
metabolism and antimicrobial activity. J Exp Med 158, 670-689.
Newman, J.V., Zabel, B.A., Jha, S.S., and Schauer, D.B. (1999). Citrobacter rodentium
espB is necessary for signal transduction and for infection of laboratory mice. Infect
Immun 67, 6019-6025.
Ng, S.C., Bernstein, C.N., Vatn, M.H., Lakatos, P.L., Loftus, E.V., Jr., Tysk, C., O'Morain,
C., Moum, B., Colombel, J.F., Epidemiology, and Natural History Task Force of the
International Organization of Inflammatory Bowel, D. (2013). Geographical variability
and environmental risk factors in inflammatory bowel disease. Gut 62, 630-649.
Nieman, D.C., Henson, D.A., Dumke, C.L., Oley, K., McAnulty, S.R., Davis, J.M.,
Murphy, E.A., Utter, A.C., Lind, R.H., McAnulty, L.S., and Morrow, J.D. (2006).

147

Ibuprofen use, endotoxemia, inflammation, and plasma cytokines during ultramarathon
competition. Brain Behav Immun 20, 578-584.
Niess, J.H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B.A., Vyas, J.M., Boes,
M., Ploegh, H.L., Fox, J.G., et al. (2005). CX3CR1-mediated dendritic cell access to the
intestinal lumen and bacterial clearance. Science 307, 254-258.
Nishi, S., Hsu, S.Y., Zell, K., and Hsueh, A.J. (2000). Characterization of two fly LGR
(leucine-rich repeat-containing, G protein-coupled receptor) proteins homologous to
vertebrate glycoprotein hormone receptors: constitutive activation of wild-type fly LGR1
but not LGR2 in transfected mammalian cells. Endocrinology 141, 4081-4090.
Nishida, M., Yoshida, M., Nishiumi, S., Furuse, M., and Azuma, T. (2013). Claudin-2
regulates colorectal inflammation via myosin light chain kinase-dependent signaling. Dig
Dis Sci 58, 1546-1559.
Nothacker, H.P., and Grimmelikhuijzen, C.J. (1993). Molecular cloning of a novel,
putative G protein-coupled receptor from sea anemones structurally related to members of
the FSH, TSH, LH/CG receptor family from mammals. Biochem Biophys Res Commun
197, 1062-1069.
Nowarski, R., Jackson, R., Gagliani, N., de Zoete, M.R., Palm, N.W., Bailis, W., Low, J.S.,
Harman, C.C., Graham, M., Elinav, E., and Flavell, R.A. (2015). Epithelial IL-18
Equilibrium Controls Barrier Function in Colitis. Cell 163, 1444-1456.
Nozaki, K., Mochizuki, W., Matsumoto, Y., Matsumoto, T., Fukuda, M., Mizutani, T.,
Watanabe, M., and Nakamura, T. (2016). Co-culture with intestinal epithelial organoids
allows efficient expansion and motility analysis of intraepithelial lymphocytes. J
Gastroenterol 51, 206-213.

148

Nusrat, A., Giry, M., Turner, J.R., Colgan, S.P., Parkos, C.A., Carnes, D., Lemichez, E.,
Boquet, P., and Madara, J.L. (1995). Rho protein regulates tight junctions and
perijunctional actin organization in polarized epithelia. Proc Natl Acad Sci U S A 92,
10629-10633.
Ogura, Y., Bonen, D.K., Inohara, N., Nicolae, D.L., Chen, F.F., Ramos, R., Britton, H.,
Moran, T., Karaliuskas, R., Duerr, R.H., et al. (2001). A frameshift mutation in NOD2
associated with susceptibility to Crohn's disease. Nature 411, 603-606.
Ohue, R., Hashimoto, K., Nakamoto, M., Furukawa, Y., Masuda, T., Kitabatake, N., and
Tani, F. (2011). Bacterial heat shock protein 60, GroEL, can induce the conversion of naive
T cells into a CD4 CD25(+) Foxp3-expressing phenotype. J Innate Immun 3, 605- 613.
Okeke, I.N. (2009). Diarrheagenic Escherichia coli in sub-Saharan Africa: status,
uncertainties and necessities. J Infect Dev Ctries 3, 817-842.
Olsen, J., Gerds, T.A., Seidelin, J.B., Csillag, C., Bjerrum, J.T., Troelsen, J.T., and Nielsen,
O.H. (2009). Diagnosis of ulcerative colitis before onset of inflammation by multivariate
modeling of genome-wide gene expression data. Inflamm Bowel Dis 15, 1032-1038.
Onozato, D., Yamashita, M., Nakanishi, A., Akagawa, T., Kida, Y., Ogawa, I., Hashita, T.,
Iwao, T., and Matsunaga, T. (2018). Generation of Intestinal Organoids Suitable for
Pharmacokinetic Studies from Human Induced Pluripotent Stem Cells. Drug Metab Dispos
46, 1572-1580.
Orime, K., Shirakawa, J., Togashi, Y., Tajima, K., Inoue, H., Ito, Y., Sato, K., Nakamura,
A., Aoki, K., Goshima, Y., and Terauchi, Y. (2013). Trefoil factor 2 promotes cell
proliferation in pancreatic beta-cells through CXCR-4-mediated ERK1/2 phosphorylation.
Endocrinology 154, 54-64.

149

Orsulic, S., and Peifer, M. (1996). An in vivo structure-function study of armadillo, the
beta-catenin homologue, reveals both separate and overlapping regions of the protein
required for cell adhesion and for wingless signaling. J Cell Biol 134, 1283-1300.
Ortiz-Masia, D., Hernandez, C., Quintana, E., Velazquez, M., Cebrian, S., Riano, A.,
Calatayud, S., Esplugues, J.V., and Barrachina, M.D. (2010). iNOS-derived nitric oxide
mediates the increase in TFF2 expression associated with gastric damage: role of HIF-1.
FASEB J 24, 136-145.
Oshima, T., and Miwa, H. (2016). Gastrointestinal mucosal barrier function and diseases.
J Gastroenterol 51, 768-778.
Otto, W.R., and Thim, L. (2005). Trefoil factor family-interacting proteins. Cell Mol Life
Sci 62, 2939-2946.
Patel, N.N., Kohanski, M.A., Maina, I.W., Triantafillou, V., Workman, A.D., Tong,
C.C.L., Kuan, E.C., Bosso, J.V., Adappa, N.D., Palmer, J.N., et al. (2018). Solitary
chemosensory cells producing interleukin-25 and group-2 innate lymphoid cells are
enriched in chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol.
Patel, R.M., Myers, L.S., Kurundkar, A.R., Maheshwari, A., Nusrat, A., and Lin, P.W.
(2012). Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier
function. Am J Pathol 180, 626-635.
Payne, C.M., Fass, R., Bernstein, H., Giron, J., Bernstein, C., Dvorak, K., and Garewal, H.
(2006). Pathogenesis of diarrhea in the adult: diagnostic challenges and life-threatening
conditions. Eur J Gastroenterol Hepatol 18, 1047-1051.
Pepinsky, R.B., Arndt, J.W., Quan, C., Gao, Y., Quintero-Monzon, O., Lee, X., and Mi, S.
(2014). Structure of the LINGO-1-anti-LINGO-1 Li81 antibody complex provides insights

150

into the biology of LINGO-1 and the mechanism of action of the antibody therapy. J
Pharmacol Exp Ther 350, 110-123.
Peterson, L.W., and Artis, D. (2014). Intestinal epithelial cells: regulators of barrier
function and immune homeostasis. Nat Rev Immunol 14, 141-153.
Petty, N.K., Bulgin, R., Crepin, V.F., Cerdeno-Tarraga, A.M., Schroeder, G.N., Quail,
M.A., Lennard, N., Corton, C., Barron, A., Clark, L., et al. (2010). The Citrobacter
rodentium genome sequence reveals convergent evolution with human pathogenic
Escherichia coli. J Bacteriol 192, 525-538.
Pichery, M., Mirey, E., Mercier, P., Lefrancais, E., Dujardin, A., Ortega, N., and Girard,
J.P. (2012). Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues,
lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il33-LacZ gene trap reporter strain. J Immunol 188, 3488-3495.
Pickert, G., Neufert, C., Leppkes, M., Zheng, Y., Wittkopf, N., Warntjen, M., Lehr, H.A.,
Hirth, S., Weigmann, B., Wirtz, S., et al. (2009). STAT3 links IL-22 signaling in intestinal
epithelial cells to mucosal wound healing. J Exp Med 206, 1465-1472.
Piontek, J., Winkler, L., Wolburg, H., Muller, S.L., Zuleger, N., Piehl, C., Wiesner, B.,
Krause, G., and Blasig, I.E. (2008). Formation of tight junction: determinants of
homophilic interaction between classic claudins. FASEB J 22, 146-158.
Piqueras, B., Connolly, J., Freitas, H., Palucka, A.K., and Banchereau, J. (2006). Upon
viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct
chemokines to recruit immune effectors. Blood 107, 2613-2618.
Playford, R.J., Marchbank, T., Chinery, R., Evison, R., Pignatelli, M., Boulton, R.A., Thim,
L., and Hanby, A.M. (1995). Human spasmolytic polypeptide is a cytoprotective agent that

151

stimulates cell migration. Gastroenterology 108, 108-116.
Podolsky, D.K., Gerken, G., Eyking, A., and Cario, E. (2009). Colitis-associated variant of
TLR2 causes impaired mucosal repair because of TFF3 deficiency. Gastroenterology 137,
209-220.
Podolsky, D.K., Lynch-Devaney, K., Stow, J.L., Oates, P., Murgue, B., De-Beaumont, M.,
Sands, B.E., and Mahida, Y.R. (1993). Identification of human intestinal trefoil factor.
Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 268,
12230.
Poritz, L.S., Garver, K.I., Green, C., Fitzpatrick, L., Ruggiero, F., and Koltun, W.A. (2007).
Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. J Surg
Res 140, 12-19.
Potten, C.S., Kovacs, L., and Hamilton, E. (1974). Continuous labelling studies on mouse
skin and intestine. Cell Tissue Kinet 7, 271-283.
Poulsen, S.S., Thulesen, J., Hartmann, B., Kissow, H.L., Nexo, E., and Thim, L. (2003).
Injected TFF1 and TFF3 bind to TFF2-immunoreactive cells in the gastrointestinal tract in
rats. Regul Pept 115, 91-99.
Poulsen, S.S., Thulesen, J., Nexo, E., and Thim, L. (1998). Distribution and metabolism of
intravenously administered trefoil factor 2/porcine spasmolytic polypeptide in the rat. Gut
43, 240-247.
Pound, L.D., Patrick, C., Eberhard, C.E., Mottawea, W., Wang, G.S., Abujamel, T.,
Vandenbeek, R., Stintzi, A., and Scott, F.W. (2015). Cathelicidin Antimicrobial Peptide:
A Novel Regulator of Islet Function, Islet Regeneration, and Selected Gut Bacteria.
Diabetes 64, 4135-4147.

152

Purohit, V., Bode, J.C., Bode, C., Brenner, D.A., Choudhry, M.A., Hamilton, F., Kang,
Y.J., Keshavarzian, A., Rao, R., Sartor, R.B., et al. (2008). Alcohol, intestinal bacterial
growth, intestinal permeability to endotoxin, and medical consequences: summary of a
symposium. Alcohol 42, 349-361.
Rajasekaran, S.A., Beyenbach, K.W., and Rajasekaran, A.K. (2008). Interactions of tight
junctions with membrane channels and transporters. Biochim Biophys Acta 1778, 757769.
Raleigh, D.R., Boe, D.M., Yu, D., Weber, C.R., Marchiando, A.M., Bradford, E.M., Wang,
Y., Wu, L., Schneeberger, E.E., Shen, L., and Turner, J.R. (2011). Occludin S408
phosphorylation regulates tight junction protein interactions and barrier function. J Cell
Biol 193, 565-582.
Rangel-Huerta, E., and Maldonado, E. (2017). Transit-Amplifying Cells in the Fast Lane
from Stem Cells towards Differentiation. Stem Cells Int 2017, 7602951.
Rani, R., Smulian, A.G., Greaves, D.R., Hogan, S.P., and Herbert, D.R. (2011). TGF-beta
limits IL-33 production and promotes the resolution of colitis through regulation of
macrophage function. Eur J Immunol 41, 2000-2009.
Reinhardt, R.L., Hong, S., Kang, S.J., Wang, Z.E., and Locksley, R.M. (2006).
Visualization of IL-12/23p40 in vivo reveals immunostimulatory dendritic cell migrants
that promote Th1 differentiation. J Immunol 177, 1618-1627.
Renes, I.B., Verburg, M., Van Nispen, D.J., Taminiau, J.A., Buller, H.A., Dekker, J., and
Einerhand, A.W. (2002). Epithelial proliferation, cell death, and gene expression in
experimental colitis: alterations in carbonic anhydrase I, mucin MUC2, and trefoil factor 3
expression. Int J Colorectal Dis 17, 317-326.

153

Reunanen, J., Kainulainen, V., Huuskonen, L., Ottman, N., Belzer, C., Huhtinen, H., de
Vos, W.M., and Satokari, R. (2015). Akkermansia muciniphila Adheres to Enterocytes and
Strengthens the Integrity of the Epithelial Cell Layer. Appl Environ Microbiol 81, 36553662.
Ribaldone, D.G., Pellicano, R., Vernero, M., Caviglia, G.P., Saracco, G.M., Morino, M.,
and Astegiano, M. (2019). Dual biological therapy with anti-TNF, vedolizumab or
ustekinumab in inflammatory bowel disease: a systematic review with pool analysis.
Scand J Gastroenterol 54, 407-413.
Ritsma, L., Ellenbroek, S.I.J., Zomer, A., Snippert, H.J., de Sauvage, F.J., Simons, B.D.,
Clevers, H., and van Rheenen, J. (2014). Intestinal crypt homeostasis revealed at singlestem-cell level by in vivo live imaging. Nature 507, 362-365.
Rodnick-Smith, M., Luan, Q., Liu, S.L., and Nolen, B.J. (2016). Role and structural
mechanism of WASP-triggered conformational changes in branched actin filament
nucleation by Arp2/3 complex. Proc Natl Acad Sci U S A 113, E3834-3843.
Rosenstiel, P., Sina, C., End, C., Renner, M., Lyer, S., Till, A., Hellmig, S., Nikolaus, S.,
Folsch, U.R., Helmke, B., et al. (2007). Regulation of DMBT1 via NOD2 and TLR4 in
intestinal epithelial cells modulates bacterial recognition and invasion. J Immunol 178,
8203-8211.
Roulis, M., Armaka, M., Manoloukos, M., Apostolaki, M., and Kollias, G. (2011).
Intestinal epithelial cells as producers but not targets of chronic TNF suffice to cause
murine Crohn-like pathology. Proc Natl Acad Sci U S A 108, 5396-5401.
Royce, S.G., Lim, C., Muljadi, R.C., Samuel, C.S., Ververis, K., Karagiannis, T.C., Giraud,
A.S., and Tang, M.L. (2013). Trefoil factor-2 reverses airway remodeling changes in

154

allergic airways disease. Am J Respir Cell Mol Biol 48, 135-144.
Rubtsov, Y.P., Rasmussen, J.P., Chi, E.Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P.,
Siewe, L., Roers, A., Henderson, W.R., Jr., et al. (2008). Regulatory T cell-derived
interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546-558.
Saenz, S.A., Siracusa, M.C., Monticelli, L.A., Ziegler, C.G., Kim, B.S., Brestoff, J.R.,
Peterson, L.W., Wherry, E.J., Goldrath, A.W., Bhandoola, A., and Artis, D. (2013). IL-25
simultaneously elicits distinct populations of innate lymphoid cells and multipotent
progenitor type 2 (MPPtype2) cells. J Exp Med 210, 1823-1837.
Saha, N., Kolev, M., and Nikolov, D.B. (2014). Structural features of the Nogo receptor
signaling complexes at the neuron/myelin interface. Neurosci Res 87, 1-7.
Sakurai, S., Shimizu, T., and Ohto, U. (2017). The crystal structure of the AhRR-ARNT
heterodimer reveals the structural basis of the repression of AhR-mediated transcription. J
Biol Chem 292, 17609-17616.
Salti, S.M., Hammelev, E.M., Grewal, J.L., Reddy, S.T., Zemple, S.J., Grossman, W.J.,
Grayson, M.H., and Verbsky, J.W. (2011). Granzyme B regulates antiviral CD8+ T cell
responses. J Immunol 187, 6301-6309.
Salzman, N.H., Chou, M.M., de Jong, H., Liu, L., Porter, E.M., and Paterson, Y. (2003).
Enteric salmonella infection inhibits Paneth cell antimicrobial peptide expression. Infect
Immun 71, 1109-1115.
Sands, B.E., Sandborn, W.J., Panaccione, R., O'Brien, C.D., Zhang, H., Johanns, J.,
Adedokun, O.J., Li, K., Peyrin-Biroulet, L., Van Assche, G., et al. (2019). Ustekinumab as
Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med 381, 1201-1214.
Sass, V., Schneider, T., Wilmes, M., Korner, C., Tossi, A., Novikova, N., Shamova, O.,

155

and Sahl, H.G. (2010). Human beta-defensin 3 inhibits cell wall biosynthesis in
Staphylococci. Infect Immun 78, 2793-2800.
Sato, T., and Clevers, H. (2013). Growing self-organizing mini-guts from a single intestinal
stem cell: mechanism and applications. Science 340, 1190-1194.
Sato, T., Vries, R.G., Snippert, H.J., van de Wetering, M., Barker, N., Stange, D.E., van
Es, J.H., Abo, A., Kujala, P., Peters, P.J., and Clevers, H. (2009). Single Lgr5 stem cells
build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262-265.
Satoh, J., Tabunoki, H., Yamamura, T., Arima, K., and Konno, H. (2007). TROY and
LINGO- 1 expression in astrocytes and macrophages/microglia in multiple sclerosis
lesions. Neuropathol Appl Neurobiol 33, 99-107.
Schauer, D.B., and Falkow, S. (1993a). Attaching and effacing locus of a Citrobacter
freundii biotype that causes transmissible murine colonic hyperplasia. Infect Immun 61,
2486-2492.
Schauer, D.B., and Falkow, S. (1993b). The eae gene of Citrobacter freundii biotype 4280
is necessary for colonization in transmissible murine colonic hyperplasia. Infect Immun
61, 4654-4661.
Schiavi, E., Smolinska, S., and O'Mahony, L. (2015). Intestinal dendritic cells. Curr Opin
Gastroenterol 31, 98-103.
Schiering, C., Krausgruber, T., Chomka, A., Frohlich, A., Adelmann, K., Wohlfert, E.A.,
Pott, J., Griseri, T., Bollrath, J., Hegazy, A.N., et al. (2014). The alarmin IL-33 promotes
regulatory T-cell function in the intestine. Nature 513, 564-568.
Schlickum, S., Sennefelder, H., Friedrich, M., Harms, G., Lohse, M.J., Kilshaw, P., and
Schon, M.P. (2008). Integrin alpha E(CD103)beta 7 influences cellular shape and motility

156

in a ligand-dependent fashion. Blood 112, 619-625.
Schmidt, H., Braubach, P., Schilpp, C., Lochbaum, R., Neuland, K., Thompson, K., Jonigk,
D., Frick, M., Dietl, P., and Wittekindt, O.H. (2019). IL-13 Impairs Tight Junctions in
Airway Epithelia. Int J Mol Sci 20.
Schmitt, M., Schewe, M., Sacchetti, A., Feijtel, D., van de Geer, W.S., Teeuwssen, M.,
Sleddens, H.F., Joosten, R., van Royen, M.E., van de Werken, H.J.G., et al. (2018). Paneth
Cells Respond to Inflammation and Contribute to Tissue Regeneration by Acquiring Stemlike Features through SCF/c-Kit Signaling. Cell Rep 24, 2312-2328 e2317.
Schon, M.P., Arya, A., Murphy, E.A., Adams, C.M., Strauch, U.G., Agace, W.W., Marsal,
J., Donohue, J.P., Her, H., Beier, D.R., et al. (1999). Mucosal T lymphocyte numbers are
selectively reduced in integrin alpha E (CD103)-deficient mice. J Immunol 162, 66416649.
Schulz, O., Jaensson, E., Persson, E.K., Liu, X., Worbs, T., Agace, W.W., and Pabst, O.
(2009). Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph
and serve classical dendritic cell functions. J Exp Med 206, 3101-3114.
Severson, E.A., Lee, W.Y., Capaldo, C.T., Nusrat, A., and Parkos, C.A. (2009). Junctional
adhesion molecule A interacts with Afadin and PDZ-GEF2 to activate Rap1A, regulate
beta1 integrin levels, and enhance cell migration. Mol Biol Cell 20, 1916-1925.
Shale, M., Schiering, C., and Powrie, F. (2013). CD4(+) T-cell subsets in intestinal
inflammation. Immunol Rev 252, 164-182.
Shapiro, L., and Weis, W.I. (2009). Structure and biochemistry of cadherins and catenins.
Cold Spring Harb Perspect Biol 1, a003053.
Shen, L., Black, E.D., Witkowski, E.D., Lencer, W.I., Guerriero, V., Schneeberger, E.E.,

157

and Turner, J.R. (2006). Myosin light chain phosphorylation regulates barrier function by
remodeling tight junction structure. J Cell Sci 119, 2095-2106.
Shiomi, H., Masuda, A., Nishiumi, S., Nishida, M., Takagawa, T., Shiomi, Y., Kutsumi,
H., Blumberg, R.S., Azuma, T., and Yoshida, M. (2010). Gamma interferon produced by
antigen-specific CD4+ T cells regulates the mucosal immune responses to Citrobacter
rodentium infection. Infect Immun 78, 2653-2666.
Silvey, K.J., Hutchings, A.B., Vajdy, M., Petzke, M.M., and Neutra, M.R. (2001). Role of
immunoglobulin A in protection against reovirus entry into Murine Peyer's patches. J Virol
75, 10870-10879.
Simmons, C.P., Clare, S., Ghaem-Maghami, M., Uren, T.K., Rankin, J., Huett, A., Goldin,
R., Lewis, D.J., MacDonald, T.T., Strugnell, R.A., et al. (2003). Central role for B
lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing
pathogen Citrobacter rodentium. Infect Immun 71, 5077-5086.
Simmons, C.P., Goncalves, N.S., Ghaem-Maghami, M., Bajaj-Elliott, M., Clare, S., Neves,
B., Frankel, G., Dougan, G., and MacDonald, T.T. (2002). Impaired resistance and
enhanced pathology during infection with a noninvasive, attaching-effacing enteric
bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma. J
Immunol 168, 1804-1812.
Snippert, H.J., van der Flier, L.G., Sato, T., van Es, J.H., van den Born, M., KroonVeenboer, C., Barker, N., Klein, A.M., van Rheenen, J., Simons, B.D., and Clevers, H.

158

(2010). Intestinal crypt homeostasis results from neutral competition between
symmetrically dividing Lgr5 stem cells. Cell 143, 134-144.
Sonnenberg, G.F., Monticelli, L.A., Elloso, M.M., Fouser, L.A., and Artis, D. (2011).
CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34,
122- 134.
Soriano-Izquierdo, A., Gironella, M., Massaguer, A., May, F.E., Salas, A., Sans, M.,
Poulsom, R., Thim, L., Pique, J.M., and Panes, J. (2004). Trefoil peptide TFF2 treatment
reduces VCAM-1 expression and leukocyte recruitment in experimental intestinal
inflammation. J Leukoc Biol 75, 214-223.
Specian, R.D., and Neutra, M.R. (1980). Mechanism of rapid mucus secretion in goblet
cells stimulated by acetylcholine. J Cell Biol 85, 626-640.
Stein, M., Keshav, S., Harris, N., and Gordon, S. (1992). Interleukin 4 potently enhances
murine macrophage mannose receptor activity: a marker of alternative immunologic
macrophage activation. J Exp Med 176, 287-292.
Subrata, L.S., Bizzintino, J., Mamessier, E., Bosco, A., McKenna, K.L., Wikstrom, M.E.,
Goldblatt, J., Sly, P.D., Hales, B.J., Thomas, W.R., et al. (2009). Interactions between
innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma
exacerbations in children. J Immunol 183, 2793-2800.
Suemori, S., Lynch-Devaney, K., and Podolsky, D.K. (1991). Identification and
characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil
protein family. Proc Natl Acad Sci U S A 88, 11017-11021.
Suffia, I., Reckling, S.K., Salay, G., and Belkaid, Y. (2005). A role for CD103 in the
retention of CD4+CD25+ Treg and control of Leishmania major infection. J Immunol 174,

159

5444-5455.
Szpakowski, P., Biet, F., Locht, C., Paszkiewicz, M., Rudnicka, W., Druszczynska, M.,
Allain, F., Fol, M., Pestel, J., and Kowalewicz-Kulbat, M. (2015). Dendritic Cell Activity
Driven by Recombinant Mycobacterium bovis BCG Producing Human IL-18, in Healthy
BCG Vaccinated Adults. J Immunol Res 2015, 359153.
Tagliabue, A., Boraschi, D., Villa, L., Keren, D.F., Lowell, G.H., Rappuoli, R., and
Nencioni, L. (1984). IgA-dependent cell-mediated activity against enteropathogenic
bacteria: distribution, specificity, and characterization of the effector cells. J Immunol 133,
988- 992.
Tagliabue, A., Nencioni, L., Villa, L., Keren, D.F., Lowell, G.H., and Boraschi, D. (1983).
Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with
secretory IgA. Nature 306, 184-186.
Takahashi, K., Nakanishi, H., Miyahara, M., Mandai, K., Satoh, K., Satoh, A., Nishioka,
H., Aoki, J., Nomoto, A., Mizoguchi, A., and Takai, Y. (1999). Nectin/PRR: an
immunoglobulin-like cell adhesion molecule recruited to cadherin-based adherens
junctions through interaction with Afadin, a PDZ domain-containing protein. J Cell Biol
145, 539-549.
Takai, Y., and Nakanishi, H. (2003). Nectin and afadin: novel organizers of intercellular
junctions. J Cell Sci 116, 17-27.
Taupin, D.R., Kinoshita, K., and Podolsky, D.K. (2000). Intestinal trefoil factor confers
colonic epithelial resistance to apoptosis. Proc Natl Acad Sci U S A 97, 799-804.
Taylor, B.C., Zaph, C., Troy, A.E., Du, Y., Guild, K.J., Comeau, M.R., and Artis, D.
(2009). TSLP regulates intestinal immunity and inflammation in mouse models of helminth

160

infection and colitis. J Exp Med 206, 655-667.
Tenaillon, O., Skurnik, D., Picard, B., and Denamur, E. (2010). The population genetics of
commensal Escherichia coli. Nat Rev Microbiol 8, 207-217.
Tensen, C.P., Van Kesteren, E.R., Planta, R.J., Cox, K.J., Burke, J.F., van Heerikhuizen,
H., and Vreugdenhil, E. (1994). A G protein-coupled receptor with low density lipoproteinbinding motifs suggests a role for lipoproteins in G-linked signal transduction. Proc Natl
Acad Sci U S A 91, 4816-4820.
Thanabalasuriar, A., Kim, J., and Gruenheid, S. (2013). The inhibition of COPII trafficking
is important for intestinal epithelial tight junction disruption during enteropathogenic
Escherichia coli and Citrobacter rodentium infection. Microbes Infect 15, 738-744.
Thiemann, S., Smit, N., Roy, U., Lesker, T.R., Galvez, E.J.C., Helmecke, J., Basic, M.,
Bleich, A., Goodman, A.L., Kalinke, U., et al. (2017). Enhancement of IFNgamma
Production by Distinct Commensals Ameliorates Salmonella-Induced Disease. Cell Host
Microbe 21, 682-694 e685.
Thim, L. (1989). A new family of growth factor-like peptides. 'Trefoil' disulphide loop
structures as a common feature in breast cancer associated peptide (pS2), pancreatic
spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Lett 250, 8590.
Thim, L., and Mortz, E. (2000). Isolation and characterization of putative trefoil peptide
receptors. Regul Pept 90, 61-68.
Tlaskalova-Hogenova, H., Stepankova, R., Kozakova, H., Hudcovic, T., Vannucci, L.,
Tuckova, L., Rossmann, P., Hrncir, T., Kverka, M., Zakostelska, Z., et al. (2011). The role
of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of

161

inflammatory and autoimmune diseases and cancer: contribution of germ-free and
gnotobiotic animal models of human diseases. Cell Mol Immunol 8, 110-120.
Tomita, M., Itoh, H., Ishikawa, N., Higa, A., Ide, H., Murakumo, Y., Maruyama, H., Koga,
Y., and Nawa, Y. (1995). Molecular cloning of mouse intestinal trefoil factor and its
expression during goblet cell changes. Biochem J 311 ( Pt 1), 293-297.
Toskala, E., and Kennedy, D.W. (2015). Asthma risk factors. Int Forum Allergy Rhinol 5
Suppl 1, S11-16.
Tran, C.P., Cook, G.A., Yeomans, N.D., Thim, L., and Giraud, A.S. (1999). Trefoil peptide
TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in
a rat model of colitis. Gut 44, 636-642.
Tsai, P.Y., Zhang, B., He, W.Q., Zha, J.M., Odenwald, M.A., Singh, G., Tamura, A., Shen,
L., Sailer, A., Yeruva, S., et al. (2017). IL-22 Upregulates Epithelial Claudin-2 to Drive
Diarrhea and Enteric Pathogen Clearance. Cell Host Microbe 21, 671-681 e674.
Tsuchiya, W., and Okada, Y. (1982). Membrane potential changes associated with
differentiation of enterocytes in the rat intestinal villi in culture. Dev Biol 94, 284-290.
Tunggal, J.A., Helfrich, I., Schmitz, A., Schwarz, H., Gunzel, D., Fromm, M., Kemler, R.,
Krieg, T., and Niessen, C.M. (2005). E-cadherin is essential for in vivo epidermal barrier
function by regulating tight junctions. EMBO J 24, 1146-1156.
Turner, J.R., Rill, B.K., Carlson, S.L., Carnes, D., Kerner, R., Mrsny, R.J., and Madara,
J.L. (1997). Physiological regulation of epithelial tight junctions is associated with myosin
light-chain phosphorylation. Am J Physiol 273, C1378-1385.
Ulluwishewa, D., Anderson, R.C., McNabb, W.C., Moughan, P.J., Wells, J.M., and Roy,
N.C. (2011). Regulation of tight junction permeability by intestinal bacteria and dietary

162

components. J Nutr 141, 769-776.
Vaishnava, S., Yamamoto, M., Severson, K.M., Ruhn, K.A., Yu, X., Koren, O., Ley, R.,
Wakeland, E.K., and Hooper, L.V. (2011). The antibacterial lectin RegIIIgamma promotes
the spatial segregation of microbiota and host in the intestine. Science 334, 255-258.
Van den Bossche, J., Malissen, B., Mantovani, A., De Baetselier, P., and Van Ginderachter,
J.A. (2012). Regulation and function of the E-cadherin/catenin complex in cells of the
monocyte-macrophage lineage and DCs. Blood 119, 1623-1633.
Van Itallie, C.M., Tietgens, A.J., Krystofiak, E., Kachar, B., and Anderson, J.M. (2015). A
complex of ZO-1 and the BAR-domain protein TOCA-1 regulates actin assembly at the
tight junction. Mol Biol Cell 26, 2769-2787.
Vancamelbeke, M., and Vermeire, S. (2017). The intestinal barrier: a fundamental role in
health and disease. Expert Rev Gastroenterol Hepatol 11, 821-834.
Viby, N.E., Pedersen, L., Lund, T.K., Kissow, H., Backer, V., Nexo, E., Thim, L., and
Poulsen, S.S. (2015). Trefoil factor peptides in serum and sputum from subjects with
asthma and COPD. Clin Respir J 9, 322-329.
Villani, A.C., Satija, R., Reynolds, G., Sarkizova, S., Shekhar, K., Fletcher, J., Griesbeck,
M., Butler, A., Zheng, S., Lazo, S., et al. (2017). Single-cell RNA-seq reveals new types
of human blood dendritic cells, monocytes, and progenitors. Science 356.
Walsh, S.V., Hopkins, A.M., Chen, J., Narumiya, S., Parkos, C.A., and Nusrat, A. (2001).
Rho kinase regulates tight junction function and is necessary for tight junction assembly in
polarized intestinal epithelia. Gastroenterology 121, 566-579.
Wang, L., Llorente, C., Hartmann, P., Yang, A.M., Chen, P., and Schnabl, B. (2015).
Methods to determine intestinal permeability and bacterial translocation during liver

163

disease. J Immunol Methods 421, 44-53.
Wang, Y., DiSalvo, M., Gunasekara, D.B., Dutton, J., Proctor, A., Lebhar, M.S.,
Williamson, I.A., Speer, J., Howard, R.L., Smiddy, N.M., et al. (2017). Self-renewing
Monolayer of Primary Colonic or Rectal Epithelial Cells. Cell Mol Gastroenterol Hepatol
4, 165-182 e167.
Waterhouse, C.C., and Stadnyk, A.W. (1999). Rapid expression of IL-1beta by intestinal
epithelial cells in vitro. Cell Immunol 193, 1-8.
Weibrecht, I., Leuchowius, K.J., Clausson, C.M., Conze, T., Jarvius, M., Howell, W.M.,
Kamali-Moghaddam, M., and Soderberg, O. (2010). Proximity ligation assays: a recent
addition to the proteomics toolbox. Expert Rev Proteomics 7, 401-409.
Wendt, M.K., Taylor, M.A., Schiemann, B.J., and Schiemann, W.P. (2011). Downregulation of epithelial cadherin is required to initiate metastatic outgrowth of breast
cancer. Mol Biol Cell 22, 2423-2435.
Wickstrom, C., Hamilton, I.R., and Svensater, G. (2009). Differential metabolic activity
by dental plaque bacteria in association with two preparations of MUC5B mucins in
solution and in biofilms. Microbiology 155, 53-60.
Wiles, S., Clare, S., Harker, J., Huett, A., Young, D., Dougan, G., and Frankel, G. (2004).
Organ specificity, colonization and clearance dynamics in vivo following oral challenges
with the murine pathogen Citrobacter rodentium. Cell Microbiol 6, 963-972.
Wiles, S., Pickard, K.M., Peng, K., MacDonald, T.T., and Frankel, G. (2006). In vivo
bioluminescence imaging of the murine pathogen Citrobacter rodentium. Infect Immun 74,
5391-5396.
Wills-Karp, M., Rani, R., Dienger, K., Lewkowich, I., Fox, J.G., Perkins, C., Lewis, L.,

164

Finkelman, F.D., Smith, D.E., Bryce, P.J., et al. (2012). Trefoil factor 2 rapidly induces
interleukin 33 to promote type 2 immunity during allergic asthma and hookworm infection.
J Exp Med 209, 607-622.
Wilson, C.L., Ouellette, A.J., Satchell, D.P., Ayabe, T., Lopez-Boado, Y.S., Stratman, J.L.,
Hultgren, S.J., Matrisian, L.M., and Parks, W.C. (1999). Regulation of intestinal alphadefensin activation by the metalloproteinase matrilysin in innate host defense. Science 286,
113-117.
Wittekindt, O.H. (2017). Tight junctions in pulmonary epithelia during lung inflammation.
Pflugers Arch 469, 135-147.
Workman, A.D., Kohanski, M.A., and Cohen, N.A. (2018). Biomarkers in Chronic
Rhinosinusitis with Nasal Polyps. Immunol Allergy Clin North Am 38, 679-692. Woting,
A., and Blaut, M. (2018). Small Intestinal Permeability and Gut-Transit Time
Determined with Low and High Molecular Weight Fluorescein Isothiocyanate-Dextrans in
C3H Mice. Nutrients 10.
Wu, C.S., Wei, K.L., Chou, J.L., Lu, C.K., Hsieh, C.C., Lin, J.M., Deng, Y.F., Hsu, W.T.,
Wang, H.M., Leung, C.H., et al. (2016). Aberrant JAK/STAT Signaling Suppresses TFF1
and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer. Int J Mol Sci 17.
Wu, Y., Jin, X., Harrison, O., Shapiro, L., Honig, B.H., and Ben-Shaul, A. (2010).
Cooperativity between trans and cis interactions in cadherin-mediated junction formation.
Proc Natl Acad Sci U S A 107, 17592-17597.
Xiao, Y., Huang, X., Zhao, Y., Chen, F., Sun, M., Yang, W., Chen, L., Yao, S., Peniche,
A., Dann, S.M., et al. (2019). Interleukin-33 Promotes REG3gamma Expression in
Intestinal Epithelial Cells and Regulates Gut Microbiota. Cell Mol Gastroenterol Hepatol

165

8, 21-36. Xu, K., Xu, Y., Rajashankar, K.R., Robev, D., and Nikolov, D.B. (2013). Crystal
structures of Lgr4 and its complex with R-spondin1. Structure 21, 1683-1689.
Xue, L., Aihara, E., Podolsky, D.K., Wang, T.C., and Montrose, M.H. (2010). In vivo
action of trefoil factor 2 (TFF2) to speed gastric repair is independent of cyclooxygenase.
Gut 59, 1184-1191.
Yang, F.C., Chiu, P.Y., Chen, Y., Mak, T.W., and Chen, N.J. (2019a). TREM-1-dependent
M1 macrophage polarization restores intestinal epithelium damaged by DSS-induced
colitis by activating IL-22-producing innate lymphoid cells. J Biomed Sci 26, 46.
Yang, J., Pemberton, A., Morrison, W.I., and Connelley, T. (2019b). Granzyme B Is an
Essential Mediator in CD8(+) T Cell Killing of Theileria parva-Infected Cells. Infect
Immun 87.
Yazbeck, R., Howarth, G.S., Butler, R.N., Geier, M.S., and Abbott, C.A. (2011).
Biochemical and histological changes in the small intestine of mice with dextran sulfate
sodium colitis. J Cell Physiol 226, 3219-3224.
Yen, T.H., and Wright, N.A. (2006). The gastrointestinal tract stem cell niche. Stem Cell
Rev 2, 203-212.
Yi, H., Hu, W., Chen, S., Lu, Z., and Wang, Y. (2017). Cathelicidin-WA Improves
Intestinal

Epithelial

Barrier

Function

and

Enhances

Host

Defense

against

Enterohemorrhagic Escherichia coli O157:H7 Infection. J Immunol 198, 1696-1705.
Yong, Z., Lin, W., Yong, S., Guang-Ping, L., Dan, W., Shang-Jun, L., Wei, W., and Xi, P.
(2013). Kinetic characterization of an intestinal trefoil factor receptor. PLoS One 8,
e74669.
Yu, L.C. (2018). Microbiota dysbiosis and barrier dysfunction in inflammatory bowel

166

disease and colorectal cancers: exploring a common ground hypothesis. J Biomed Sci 25,
79.
Yu, M., Wang, Q., Ma, Y., Li, L., Yu, K., Zhang, Z., Chen, G., Li, X., Xiao, W., Xu, P.,
and Yang, H. (2018). Aryl Hydrocarbon Receptor Activation Modulates Intestinal
Epithelial Barrier Function by Maintaining Tight Junction Integrity. Int J Biol Sci 14, 6977.
Zahn, A., Moehle, C., Langmann, T., Ehehalt, R., Autschbach, F., Stremmel, W., and
Schmitz, G. (2007). Aquaporin-8 expression is reduced in ileum and induced in colon of
patients with ulcerative colitis. World J Gastroenterol 13, 1687-1695.
Zeuthen, L.H., Fink, L.N., and Frokiaer, H. (2008). Epithelial cells prime the immune
response to an array of gut-derived commensals towards a tolerogenic phenotype through
distinct actions of thymic stromal lymphopoietin and transforming growth factor-beta.
Immunology 123, 197-208.
Zheng, Y., Valdez, P.A., Danilenko, D.M., Hu, Y., Sa, S.M., Gong, Q., Abbas, A.R.,
Modrusan, Z., Ghilardi, N., de Sauvage, F.J., and Ouyang, W. (2008). Interleukin-22
mediates early host defense against attaching and effacing bacterial pathogens. Nat Med
14, 282-289.
Zindl, C.L., Lai, J.F., Lee, Y.K., Maynard, C.L., Harbour, S.N., Ouyang, W., Chaplin,
D.D., and Weaver, C.T. (2013). IL-22-producing neutrophils contribute to antimicrobial
defense and restitution of colonic epithelial integrity during colitis. Proc Natl Acad Sci U
S A 110, 12768-12773.
Zwarycz, B., Gracz, A.D., Rivera, K.R., Williamson, I.A., Samsa, L.A., Starmer, J.,
Daniele, M.A., Salter-Cid, L., Zhao, Q., and Magness, S.T. (2019). IL22 Inhibits Epithelial

167

Stem Cell Expansion in an Ileal Organoid Model. Cell Mol Gastroenterol Hepatol 7, 1-17.

168

